FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Matos, ADB
   Carvalho, FMM
   Malta, DL
   Rodrigues, CL
   Felix, AC
   Pannuti, CS
   Lima, ADD
   Esposito, DLA
   dos Santos, LMB
   von Glehn, F
   Colares, JKB
   da Fonseca, BAL
   de Oliveira, ACP
   Romano, CM
AF Brasil Matos, Aline de Moura
   Maia Carvalho, Fernanda Martins
   Malta, Danielle Lima
   Rodrigues, Cleonisio Leite
   Felix, Alvina Clara
   Pannuti, Claudio Sergio
   da Rocha Lima, Amanda Dias
   Alves Esposito, Danilo Lucas
   Barbosa dos Santos, Leonilda Maria
   von Glehn, Felipe
   Baima Colares, Jeova Keny
   Lopes da Fonseca, Benedito Antonio
   Penalva de Oliveira, Augusto Cesar
   Romano, Camila Malta
TI High proportion of Guillain-Barre syndrome associated with chikungunya
   in Northeast Brazil
SO NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
LA English
DT Editorial Material
AB From 2013 to 2015, sanitary authorities reported an increased incidence of Guillain-Barre syndrome (GBS) associated with Zika virus (ZIKV) in French Polynesia, Caribbean, and Brazil.(1-3) After the end of ZIKV epidemics, GBS cases where still above the usual limits in countries where the arrival of chikungunya virus (CHIKV) was also a concern.(3)
   Here, we report the findings from Hospital Geral de Fortaleza (HGF), a neuroinvasive arboviral disease vigilance center in Ceara State, Northeast Brazil.
C1 [Brasil Matos, Aline de Moura; Felix, Alvina Clara; Pannuti, Claudio Sergio; Romano, Camila Malta] Univ Sao Paulo, Inst Med Trop, Fac Med, BR-05508 Sao Paulo, Brazil.
   [Maia Carvalho, Fernanda Martins; Rodrigues, Cleonisio Leite] Hosp Geral Fortaleza, Serv Neurol, Fortaleza, Ceara, Brazil.
   [Maia Carvalho, Fernanda Martins; Malta, Danielle Lima; Baima Colares, Jeova Keny] Univ Fortaleza, Programa Posgrad Ciencias Med, Fortaleza, Ceara, Brazil.
   [da Rocha Lima, Amanda Dias; Barbosa dos Santos, Leonilda Maria; von Glehn, Felipe] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
   [Alves Esposito, Danilo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med, Ribeirao Preto, Brazil.
   [Penalva de Oliveira, Augusto Cesar] Inst Infectol Emilio Ribas, Sao Paulo, SP, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lab Virol LIMHC 52, BR-05508 Sao Paulo, Brazil.
RP Romano, CM (corresponding author), Univ Sao Paulo, Inst Med Trop, Fac Med, BR-05508 Sao Paulo, Brazil.
EM cmromano@usp.br
RI de Moura Brasil Matos, Aline/AAH-6805-2020; Romano,
   Camila/ABC-2883-2020; Lima, Danielle/A-6108-2013
OI de Moura Brasil Matos, Aline/0000-0002-1854-2575; Romano,
   Camila/0000-0003-4550-1987; Dias da Rocha Lima,
   Amanda/0000-0003-1514-4237; Lima, Danielle/0000-0003-2734-6768; Maia,
   Fernanda/0000-0001-6548-7268
FU CNPq/BrazilNational Council for Scientific and Technological Development
   (CNPq) [2016/407429]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo-FAPESP/BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2014/26431-0, 2019/03859-9]
FX CNPq/Brazil under the grant number 2016/407429 and Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo-FAPESP/Brazil under the grants numbers
   2014/26431-0 and 2019/03859-9.
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   [Center for Disease Control and Prevention NNDSS], ARB DIS NEUR NONN 20
   Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Masuda T, 2017, CELL ADHES MIGR, V11, P524, DOI 10.1080/19336918.2016.1269998
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882
   Reddy V, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005238
NR 9
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2332-7812
J9 NEUROL-NEUROIMMUNOL
JI Neurol.-Neuroimmunol. Neuroinflammation
PD SEP
PY 2020
VL 7
IS 5
AR e833
DI 10.1212/NXI.0000000000000833
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NQ9PP
UT WOS:000571198600006
PM 32631972
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Bonifacio, LP
   Pereira, APS
   Araujo, DCDE
   Balbao, VDP
   da Fonseca, BAL
   Passos, ADC
   Bellissimo-Rodrigues, F
AF Bonifacio, Livia Pimenta
   Sulino Pereira, Ana Paula
   de Almeida e Araujo, Daniel Cardoso
   Pasti Balbao, Viviane da Mata
   Lopes da Fonseca, Benedito Antonio
   Costa Passos, Afonso Dinis
   Bellissimo-Rodrigues, Fernando
TI Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case
   report from Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Covid-19; SARS-CoV-2; Case Report; Reinfection; Recurrence
AB With the large number of individuals infected and recovered from Covid-19, there is intense discussion about the quality and duration of the immunity elicited by SARS-CoV-2 infection. including the possibility of disease recurrence. Here we report a case with strong clinical. epidemiological and laboratorial evidence of, not only reinfection by SARS-CoV-2, but also clinical recurrence of Covid-19.
C1 [Bonifacio, Livia Pimenta; Sulino Pereira, Ana Paula; Lopes da Fonseca, Benedito Antonio; Costa Passos, Afonso Dinis; Bellissimo-Rodrigues, Fernando] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [de Almeida e Araujo, Daniel Cardoso; Pasti Balbao, Viviane da Mata] Serv Vigilancia Epidemiol Municipal Ribeirao Pret, Ribeirao Preto, SP, Brazil.
   [Costa Passos, Afonso Dinis; Bellissimo-Rodrigues, Fernando] Univ Sao Paulo, Fac Med Ribeirao Preto, Nucleo Vigilancia Epidemiol Hosp, Hosp Clin, Ribeirao Preto, SP, Brazil.
RP Bellissimo-Rodrigues, F (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.; Bellissimo-Rodrigues, F (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Nucleo Vigilancia Epidemiol Hosp, Hosp Clin, Ribeirao Preto, SP, Brazil.
EM fbellissimo@usp.br
OI Bellissimo-Rodrigues, Fernando/0000-0002-3736-7127
FU National Council for Scientific and Technological Development (CNPq
   -Brazil)National Council for Scientific and Technological Development
   (CNPq) [402422/2020-1]
FX We thank the patient cited in the case who kindly provided all the
   necessary information, and made herself available to collaborate with
   this investigation. And we would like to thank the National Council for
   Scientific and Technological Development (CNPq -Brazil, grant number:
   402422/2020-1) for financial support of research activities related to
   Covid-19.
CR [Anonymous], 2020, DUR IS PREC AD COVID
   Centers for Disease Control and Prevention (CDC), 2020, INV COVID 19 CAS
   Cipitelli MD, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200200
   Duggan NM, 2020, AM J EMERG MED
   Korea Centers for Disease Control and Prevention (CDC), 2020, FIND INV AN REP CAS
   Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Smith J, 2020, S KOREA REPORTS MORE
   Takeda CFV, 2020, AM J TROP MED HYG, P1, DOI DOI 10.4269/AJTMH.20-0893/TPMD200893
   To Kelvin Kai-Wang, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa1275
   Wei B, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0372-2020
   Wu F, 2020, NATURE, DOI 10.1038/s41586-020-2008-3
   Xiao AT, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104346
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 14
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2020
VL 53
AR e20200619
DI 10.1590/0037-8682-0619-2020
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA OL2FS
UT WOS:000585157200001
PM 32965458
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Fabro, AT
   Engelman, GG
   Ferreira, NN
   Velloni, JMF
   Esposito, DLA
   da Fonseca, BAL
   Brunaldi, MO
AF Fabro, Alexandre Todorovic
   Engelman, Gustavo Goncalves
   Ferreira, Natasha Nicos
   Fagundes Velloni, Julia Maranhao
   Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
   Brunaldi, Mariangela Ottoboni
TI Yellow Fever-induced Acute Lung Injury
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Editorial Material
ID RESPIRATORY-DISTRESS-SYNDROME
C1 [Fabro, Alexandre Todorovic; Engelman, Gustavo Goncalves; Brunaldi, Mariangela Ottoboni] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Sao Paulo, Brazil.
   [Ferreira, Natasha Nicos; Fagundes Velloni, Julia Maranhao; Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Infect Dis Div, Sao Paulo, Brazil.
RP Fabro, AT (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Sao Paulo, Brazil.
RI Esposito, Danillo L.A./N-9261-2017; FABRO, ALEXANDRE/F-6792-2013
OI Esposito, Danillo L.A./0000-0002-2755-4471; FABRO,
   ALEXANDRE/0000-0002-7687-3161
CR Collard HR, 2016, MURRAY NADELS TXB RE, P1207
   Fabro AT, 2018, ARCH PATHOL LAB MED, V142, P1430
   Laffey JG, 2017, AM J RESP CRIT CARE, V196, P18, DOI 10.1164/rccm.201612-2415CI
   Middleton EA, 2018, AM J RESP CRIT CARE, V197, P1514, DOI 10.1164/rccm.201804-0670ED
   Namendys-Silva SA, 2018, AM J RESP CRIT CARE, V198, P1447, DOI 10.1164/rccm.201802-0345IM
   Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC
NR 6
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PD JUL 15
PY 2019
VL 200
IS 2
BP 250
EP 252
DI 10.1164/rccm.201711-2267IM
PG 3
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA II8TP
UT WOS:000475465500019
PM 30802414
DA 2020-12-08
ER

PT J
AU Nobre, AVV
   Polvora, TLS
   Silva, LRM
   Teles, VD
   Villafuerte, KV
   da Motta, RJG
   Fortes, JHP
   Silva, GA
   Ranieri, ALP
   de Macedo, LD
   Morejon, KML
   da Fonseca, BAL
   Tirapelli, C
   Saraiva, MCP
   Taba, M
   Lourenco, AG
   Motta, ACF
AF Nobre, Atila V. V.
   Polvora, Tabata L. S.
   Silva, Leticia R. M.
   Teles, Vanessa de O.
   Villafuerte, Kelly Vargas
   da Motta, Raphael J. G.
   Fortes, Joao H. P.
   Silva, Gilberto A.
   Ranieri, Ana Laura P.
   de Macedo, Leandro D.
   Morejon, Karen M. L.
   da Fonseca, Benedito A. L.
   Tirapelli, Camila
   Saraiva, Maria C. P.
   Taba, Mario, Jr.
   Lourenco, Alan G.
   Motta, Ana Carolina F.
TI Effects of non-surgical periodontal therapy on clinical and
   immunological profile and oral colonization of Candida spp in
   HIV-infected patients with chronic periodontitis
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Candida spp; chronic periodontitis; cytokine; HIV; non-surgical
   periodontal therapy
ID HUMAN-IMMUNODEFICIENCY-VIRUS; GINGIVAL CREVICULAR FLUID; SYSTEMIC
   INFLAMMATION; ASSOCIATION; ALBICANS; YEASTS; INTERLEUKIN-1-BETA;
   EPIDEMIOLOGY; EMERGENCE; MARKERS
AB Background After the introduction of antiretroviral therapy (ART), human immunodeficiency virus (HIV) infection has become a chronic controllable disease. For this reason, chronic conditions related to both HIV infection and senescence, such as chronic periodontitis (CP) need to be studied. This study investigated the impact of non-surgical periodontal therapy (NSPT) on clinical and immunological features of CP, and on oral colonization by Candida spp. in HIV-infected and non-HIV-infected individuals. Methods HIV-infected (test group) and non-HIV-infected (control group) adults patients with CP were selected. Gingival bleeding index (GI), probing depth (PD), clinical attachment level (CAL), number of teeth, CD4+ T lymphocytes and viral load (only for HIV-infected individuals), salivary cytokines (interleukin, [IL]-6, IL-8, and tumoral necrosis factor-alpha [TNF-alpha]), and oral Candida infection (colony forming units and species) were assessed at baseline, and 30 and 90 days after NSPT. Results Twenty-two HIV-infected patients and 20 non-HIV-infected patients were evaluated. Candida counts and salivary IL-6, IL-8, and TNF-a levels were higher in the test group than in the control group. Both groups showed a decrease in oral Candida counts, GI, PD, IL-6, and IL-8 as well as gain in CAL at 30 and 90 days after NSPT. In addition, patients in the test group showed an increase of CD4+ T lymphocytes and a decrease of viral load. Conclusion NSPT had a beneficial impact on clinical and immunological parameters of CP, reduction of oral Candida counts, and improvement of HIV-infection status.
C1 [Nobre, Atila V. V.; Villafuerte, Kelly Vargas; Taba, Mario, Jr.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Ribeirao Preto, SP, Brazil.
   [Polvora, Tabata L. S.] Univ Sao Paulo, Sch Dent, Dept Stomatol, Ribeirao Preto, SP, Brazil.
   [Silva, Leticia R. M.; Teles, Vanessa de O.; Motta, Ana Carolina F.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Stomatol Publ Hlth & Forens Dent, Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
   [da Motta, Raphael J. G.; Fortes, Joao H. P.; Tirapelli, Camila] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Dent Mat & Prosthodont, Ribeirao Preto, SP, Brazil.
   [Silva, Gilberto A.; Lourenco, Alan G.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, SP, Brazil.
   [Ranieri, Ana Laura P.; de Macedo, Leandro D.] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp, Div Dent & Stomatol, Ribeirao Preto, SP, Brazil.
   [Morejon, Karen M. L.; da Fonseca, Benedito A. L.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Med Clin, Ribeirao Preto, SP, Brazil.
   [Saraiva, Maria C. P.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Pediat Dent, Ribeirao Preto, SP, Brazil.
RP Motta, ACF (corresponding author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Stomatol Publ Hlth & Forens Dent, Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM anacfm@usp.br
RI Motta, Ana Carolina F/J-2683-2012; Tirapelli, Camila/O-4026-2019;
   Saraiva, Maria Conceicao P./H-1088-2012; Nobre, Atila/G-5923-2019;
   Villafuerte, Kelly Rocio V/A-8892-2019; Mario, Taba/K-2886-2016;
   Lourenco, Alan Grupioni/I-1190-2018
OI Motta, Ana Carolina F/0000-0002-3887-9239; Tirapelli,
   Camila/0000-0001-5020-6515; Saraiva, Maria Conceicao
   P./0000-0001-6858-7029; Villafuerte, Kelly Rocio V/0000-0002-0231-5482;
   Mario, Taba/0000-0002-7098-5090; Lourenco, Alan
   Grupioni/0000-0002-4005-157X; Nobre, Atila/0000-0002-5416-3994
FU Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/22476-5]; National Council for
   Scientific and Technological Development - CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX The authors thank the staff of the Special Unit for the Treatment of
   Infectious Diseases of Ribeirao Preto Medical School, University of Sao
   Paulo. This study was supported by grants from the Sao Paulo Research
   Foundation - FAPESP (grant: 2016/22476-5) and the National Council for
   Scientific and Technological Development - CNPq (grant: 404092/2016-0).
   Dr. Nobre also received a master's degree grant from the National
   Council for Scientific and Technological Development - CNPq. The authors
   report no conflicts of interest related to this study.
CR Ainamo J, 1976, Tandlaegebladet, V80, P149
   Alves M, 2006, J PERIODONTOL, V77, P773, DOI 10.1902/jop.2006.P04039
   Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
   BASS C C, 1954, J La State Med Soc, V106, P100
   Brailo V, 2012, MED ORAL PATOL ORAL, V17, pE10, DOI 10.4317/medoral.17323
   Brazil Ministry of Health Secretariat of Health Surveillance, 2017, HIV AIDS EP B
   Canabarro A, 2013, J PERIODONTAL RES, V48, P428, DOI 10.1111/jre.12022
   D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214
   Delgado ACD, 2009, CLIN MICROBIOL INFEC, V15, P364, DOI 10.1111/j.1469-0691.2009.02707.x
   Elizondo JE, 2017, CYTOKINE, V91, P96, DOI 10.1016/j.cyto.2016.12.019
   Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6
   ELWELL LP, 1987, ANTIMICROB AGENTS CH, V31, P274, DOI 10.1128/AAC.31.2.274
   Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x
   Goncalves LD, 2005, J PERIODONTOL, V76, P915, DOI 10.1902/jop.2005.76.6.915
   Jarvensivu A, 2004, ORAL DIS, V10, P106, DOI 10.1046/j.1354-523X.2003.00978.x
   Khammissa R, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/620962
   Lamont RJ, 2015, TRENDS MOL MED, V21, P172, DOI 10.1016/j.molmed.2014.11.004
   Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001
   LISTGARTEN MA, 1993, J PERIODONTOL, V64, P155, DOI 10.1902/jop.1993.64.3.155
   Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8
   Lourenco AG, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759029, 10.1590/s1678-9946201759029]
   Machado AG, 2011, J APPL ORAL SCI, V19, P384, DOI 10.1590/S1678-77572011005000014
   Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x
   Munro CA, 2002, TRENDS MICROBIOL, V10, P173, DOI 10.1016/S0966-842X(02)02330-2
   Nibali L, 2007, J CLIN PERIODONTOL, V34, P931, DOI 10.1111/j.1600-051X.2007.01133.x
   Nikawa H, 2002, J PROSTHET DENT, V88, P263, DOI 10.1067/mpr.2002.127907
   Noro GA, 2013, AIDS RES HUM RETROV, V29, P1040, DOI [10.1089/aid.2012.0359, 10.1089/AID.2012.0359]
   ODDEN K, 1994, J ORAL PATHOL MED, V23, P178, DOI 10.1111/j.1600-0714.1994.tb01109.x
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8
   Pereira VT, 2014, J PERIODONTOL, V85, P697, DOI 10.1902/jop.2013.130273
   Reynaud AH, 2001, J CLIN PERIODONTOL, V28, P860, DOI 10.1034/j.1600-051x.2001.028009860.x
   RILEY C, 1992, J ORAL PATHOL MED, V21, P124, DOI 10.1111/j.1600-0714.1992.tb00995.x
   Robinson P G, 1996, Oral Dis, V2, P45
   SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P386, DOI 10.1111/j.1600-0714.1986.tb00646.x
   SANGEORZAN JA, 1994, AM J MED, V97, P339, DOI 10.1016/0002-9343(94)90300-X
   Sardi Janaina C O, 2010, J Oral Sci, V52, P177
   SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501
   SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322
   Spear GT, 2005, FEMS IMMUNOL MED MIC, V45, P129, DOI 10.1016/j.femsim.2005.03.002
   TSAI CC, 1995, J PERIODONTOL, V66, P852, DOI 10.1902/jop.1995.66.10.852
   UNAIDS, JOINT UN PROGR HIV A
   Valentine J, 2016, ORAL DIS, V22, P87, DOI 10.1111/odi.12419
   Vargas-Villafuerte KR, 2016, J PERIODONTOL, V87, P1268, DOI 10.1902/jop.2016.160101
   Gama TGV, 2016, J ENDODONT, V42, P921, DOI 10.1016/j.joen.2016.03.008
   WHO, 2017, HIV AIDS DAT STAT
   Williams RC, 2000, PERIODONTOL 2000, V23, P9, DOI 10.1034/j.1600-0757.2000.2230101.x
NR 47
TC 2
Z9 2
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2019
VL 90
IS 2
BP 167
EP 176
DI 10.1002/JPER.18-0197
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA HJ4FK
UT WOS:000457129200008
PM 30118537
DA 2020-12-08
ER

PT J
AU Vernal, S
   Martini, CCR
   da Fonseca, BAL
AF Vernal, Sebastian
   Martini, Camila C. R.
   da Fonseca, Benedito A. L.
TI Oropouche Virus-Associated Aseptic Meningoencephalitis, Southeastern
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB Oropouche fever is a neglected arthropodborne disease and zoonosis responsible for several outbreaks of a febrile disease in Central and South America. We present a clinical case of aseptic meningoencephalitis in an immunocompetent patient that resulted from Oropouche virus acquired in northern Brazil but diagnosed in a nonendemic region.
C1 [Vernal, Sebastian] Univ Sao Paulo, Clin Med, Ribeirao Preto, Brazil.
   [Vernal, Sebastian] Univ Sao Paulo, Infect Dis, Ribeirao Preto, Brazil.
   [Martini, Camila C. R.; da Fonseca, Benedito A. L.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, 3900 Bandeirantes Av, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Vernal, Sebastian/AAS-7990-2020
OI Vernal, Sebastian/0000-0001-8589-0089; Martini Rodrigues, Camila
   Cristina/0000-0001-5340-5886
CR Alvarez-Falconi Pedro P., 2010, Rev. gastroenterol. Perú, V30, P334
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Luna LKD, 2017, J MED VIROL, V89, P1108, DOI 10.1002/jmv.24722
   Pinheiro F P, 1982, Rev Inst Med Trop Sao Paulo, V24, P246
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   VASCONCELOS PFD, 1989, REV INST MED TROP SP, V31, P271, DOI 10.1590/S0036-46651989000400011
NR 10
TC 1
Z9 1
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2019
VL 25
IS 2
BP 380
EP 382
DI 10.3201/eid2502.181189
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HI0LV
UT WOS:000456134000036
PM 30666950
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Siconelli, MJL
   Esposito, DLA
   Moraes, NC
   Ribeiro, JM
   Perles, L
   Dias, MA
   Carvalho, AAB
   Werther, K
   Fernandes, NCCD
   Iglezias, SD
   Burger, KP
   da Fonseca, BAL
AF Lima Siconelli, Marcio Junio
   Alves Esposito, Danillo Lucas
   Moraes, Nathalia Cristina
   Ribeiro, Julia Maria
   Perles, Livia
   Dias, Maria Angelica
   Bianco Carvalho, Adolorata Aparecida
   Werther, Karin
   Couto de Azevedo Fernandes, Natalia Coelho
   Iglezias, Silvia D'Andretta
   Burger, Karina Paes
   Lopes da Fonseca, Benedito Antonio
TI The Importance of Coordinated Actions in Preventing the Spread of Yellow
   Fever to Human Populations: The Experience from the 2016-2017 Yellow
   Fever Outbreak in the Northeastern Region of SAo Paulo State
SO CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY
LA English
DT Article
ID NONHUMAN-PRIMATES; BRAZIL; VIRUS; ALBOPICTUS; EXPRESSION; FOREST; DENGUE
AB Yellow fever (YF) is a zoonotic arthropod-borne disease that is caused by the yellow fever virus (YFV) and characterized by a sylvatic and urban cycle. Its most severe presentation is manifested as a hemorrhagic disease, and it has been responsible for thousands of deaths in the last decades. This study describes the public health approaches taken to control the 2016-2017 YF outbreak in nonhuman primates (NHPs) that took place in the northeastern region of SAo Paulo state, Brazil. NHPs recovered from the field were necropsied, and YF diagnoses were made at the Laboratory of Molecular Virology, RibeirAo Preto Medical School and the Center of Pathology, Adolfo Lutz Institute of SAo Paulo. NHP samples were inoculated into Vero cells for YFV isolation. RNA extraction was performed directly from NHP tissues and tested by RT-qPCR. YFV-positive samples were confirmed by sequencing. Based on the rapid RT-qPCR results, surveillance actions were implemented in the entire region. Confirmatory histopathology and immunohistochemistry for YFV were also performed. Among nine NHPs, gross hepatic involvement was observed in six animals, five of which were YFV-RT-qPCR-positive. One YFV was isolated from the serum of an infant NHP. YFV RNA sequences diverged from the virus responsible for the last epizootic that occurred in SAo Paulo state, but it was similar to the current Brazilian epizootic. Public health actions included dissemination of information on YF transmission, investigation of the probable location of NHP infection, characterization of the environment, and subsequent creation of the blueprint from which prevention and control measures were implemented. The YFV sylvatic cycle occurred in the periurban areas of the northeastern region of SAo Paulo state, but no human cases were reported during this period, showing that integrated actions between human, animal, and environmental health professionals were critical to restrain the virus to the sylvatic cycle.
C1 [Lima Siconelli, Marcio Junio; Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Dept Internal Med, Ave Bandeirantes,3900, BR-14049900 Sao Paulo, Brazil.
   [Moraes, Nathalia Cristina; Bianco Carvalho, Adolorata Aparecida; Burger, Karina Paes] Univ Estadual Paulista Julio de Mesquita Filho FC, Vet Prevent Med & Anim Reprod Dept, Fac Agr & Vet Sci, Access Way Prof Paulo Donato Castellane S-N, BR-14884900 Sao Paulo, Brazil.
   [Ribeiro, Julia Maria; Perles, Livia; Werther, Karin] Univ Estadual Paulista Julio de Mesquita Filho FC, Fac Agr & Vet Sci, Anim Pathol Dept, Access Way Prof Paulo Donato Castellane S-N, BR-14884900 Sao Paulo, Brazil.
   [Dias, Maria Angelica] Municipal Hlth Secretary, Ave Gen Glicerio,569, BR-14870520 Sao Paulo, Brazil.
   [Couto de Azevedo Fernandes, Natalia Coelho; Iglezias, Silvia D'Andretta] State Secretary Hlth, Adolfo Lutz Inst Sao Paulo, Pathol Ctr, Nucleus Pathol Anat, Ave Dr Arnaldo,351,7 Floor, BR-01246902 Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Dept Internal Med, Ave Bandeirantes,3900, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fernandes, Natalia/H-4537-2012;
   Siconelli, M\\xc3\\xa1rcio Junio Lima/T-8418-2019; Fonseca,
   Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fernandes,
   Natalia/0000-0003-4754-4200; Lima Siconelli, Marcio
   Junio/0000-0001-5340-0962; Fonseca, Benedito/0000-0003-3159-5687;
   Perles, Livia/0000-0002-0287-5252
FU Sao Paulo State Health Department (FESIMA-Oficio CAF) [003/2016]
FX The authors thank the staff from the Nucleus of Pathological (NAP),
   Center of Pathology and Nucleus of Diseases Transmitted by Vectors
   (NDTV), and Center of Virology from Adolfo Lutz Institute of Sao Paulo
   for YF diagnosis and antibody production and for their help in
   diagnosing some samples. This work was supported, in part, by a grant
   from the Sao Paulo State Health Department (FESIMA-Oficio CAF no.
   003/2016).
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125, DOI 10.4269/ajtmh.1980.29.125
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   da Rocha TC, 2015, REV SOC BRAS MED TRO, V48, P143, DOI 10.1590/0037-8682-0024-2015
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   Ezyaguirre E. J., 2013, DIAGNOSTIC IMMUNOHIS, P58
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   Kowalewski MM, 2011, AM J PRIMATOL, V73, P75, DOI 10.1002/ajp.20803
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Lima MA, 2010, REV INST MED TROP SP, V52, P11, DOI 10.1590/S0036-46652010000100002
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Mascheretti M, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004341
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   MILLER BR, 1988, T ROY SOC TROP MED H, V82, P476, DOI 10.1016/0035-9203(88)90168-X
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 1998, ZOONOSES, P487
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   MONATH TP, 1988, ARBOVIRUSES EPIDEMIO, V5, P139
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/s0037-86822011005000041, 10.1590/S0037-86822011005000041]
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   Nunes MRT, 2011, J VIROL METHODS, V174, P29, DOI 10.1016/j.jviromet.2011.02.025
   OIE, 2019, WORL ORG AN HLTH
   PAHO. Organizacion Panamericana de la Salud, 2017, AL EP FIEBR AM 9 EN
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Quaresma JAS, 2005, ACTA TROP, V94, P116, DOI 10.1016/j.actatropica.2005.03.003
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Quaresma JAS, 2006, MED HYPOTHESES, V67, P618, DOI 10.1016/j.mehy.2006.01.060
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Rolim G. S., 2014, RESENHA METEOROLOGIC
   Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/s1679-49742016000300009, 10.5123/S1679-49742016000300009]
   Saraiva JF, 2019, ACTA AMAZON, V49, P71, DOI 10.1590/1809-4392201802771
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Strode GK, 1951, YELLOW FEVER
   Thompson SA, 2000, COMPARATIVE MED, V50, P649
   TIGERTT W. D., 1960, TRANS NEW YORK ACAD SCI, V22, P323
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   VIEIRA WT, 1983, HISTOPATHOLOGY, V7, P195, DOI 10.1111/j.1365-2559.1983.tb02235.x
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
   World Health Organization, 2017, YELL FEV BRAS DIS OU
NR 55
TC 0
Z9 0
U1 2
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1712-9532
EI 1918-1493
J9 CAN J INFECT DIS MED
JI Can. J. Infect. Dis. Med. Microbiol.
PY 2019
VL 2019
AR 9464768
DI 10.1155/2019/9464768
PG 11
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IB3IE
UT WOS:000470160400001
PM 31236149
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Castro-Jorge, LA
   Siconelli, MJL
   Ribeiro, BD
   de Moraes, FM
   de Moraes, JB
   Agostinho, MR
   Klein, TM
   Floriano, VG
   da Fonseca, BAL
AF de Castro-Jorge, Luiza Antunes
   Lima Siconelli, Marcio Junio
   Ribeiro, Beatriz dos Santos
   de Moraes, Flavia Masson
   de Moraes, Jonathan Ballico
   Agostinho, Mayara Rovariz
   Klein, Taline Monteiro
   Floriano, Vitor Goncalves
   Lopes da Fonseca, Benedito Antonio
TI West Nile virus infections are here! Are we prepared to face another
   flavivirus epidemic?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE West Nile virus (WNV); Arbovirus; Outbreak; Surveillance
ID HUMANIZED MONOCLONAL-ANTIBODY; NEW-YORK; NEUTRALIZING ANTIBODIES;
   FUNCTIONAL OUTCOMES; ENCEPHALITIS; TRANSMISSION; VACCINE;
   ENCEPHALOMYELITIS; HORSES; BIRDS
AB Emerging arthropod-borne viruses (arboviruses), such as chikungunya and Zika viruses, are a major threat to public health in countries like Brazil where biodiversity is high and medical care is sometimes precarious. West Nile fever is a disease caused by the West Nile Virus (WNV), an RNA virus belonging to the Flaviviridae family. It is transmitted by infected mosquitoes to numerous animals like birds, reptiles and mammals, including human and non-human primates. In the last decade, the number of reported cases of WNV infection in humans and animals has increased in the Americas. Circulation of WNV in forests and rural areas in Brazil has been detected based on serological surveys and, in 2014, the first case of West Nile fever was confirmed in a patient from Piaui State. In 2018, the virus was isolated for the first time from a horse from a rural area in the state of Espirito Santo presenting with a neurological disorder; this raises the possibility that other cases of WNV encephalitis may have occurred without clinical recognition and without laboratory diagnosis by specific assays. The imminent WNV outbreak poses a challenge for Brazilian clinicians and researchers. In this review, we summarize the basic biological and ecological characteristics of this virus and the clinical presentation and treatment of febrile illnesses caused by WNV. We also discuss the epidemiological aspects, prophylaxis of WNV infections, and monitoring strategies that could be applied in the possibility of a WNV outbreak in Brazil.
C1 [de Castro-Jorge, Luiza Antunes; Lima Siconelli, Marcio Junio; Ribeiro, Beatriz dos Santos; de Moraes, Flavia Masson; de Moraes, Jonathan Ballico; Agostinho, Mayara Rovariz; Klein, Taline Monteiro; Floriano, Vitor Goncalves; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI de Castro Jorge, Luiza Antunes/D-3773-2009; Siconelli, M\\xc3\\xa1rcio
   Junio Lima/T-8418-2019; Fonseca, Benedito/F-3252-2012
OI Moraes, Jonathan/0000-0002-0021-3714; Lima Siconelli, Marcio
   Junio/0000-0001-5340-0962; Goncalves Floriano,
   Vitor/0000-0002-8069-6348; Fonseca, Benedito/0000-0003-3159-5687
CR Diaz LA, 2008, EMERG INFECT DIS, V14, P689, DOI 10.3201/eid1404.071257
   Agrawal AG, 2003, J INFECT DIS, V188, P1, DOI 10.1086/376871
   Alker A., 2015, BMJ CASE REP, V2015, P1
   [Anonymous], 2019, ALL SKETCH
   Araujo F., 2014, TRATADO ANIMAIS SELV, V2
   Assessoria de Comunicacao SESAPI, 2019, PORT SAUD SECR EST S
   Balasuriya U, 2015, AAEP VACC GUID, V1
   Beigel JH, 2010, ANTIMICROB AGENTS CH, V54, P2431, DOI 10.1128/AAC.01178-09
   BERNKOPF H, 1953, J INFECT DIS, V93, P207, DOI 10.1093/infdis/93.3.207
   Blau DM, 2013, EMERG INFECT DIS, V19, P1518, DOI 10.3201/eid1909.130365
   Bosch I, 2007, EMERG INFECT DIS, V13, P651, DOI 10.3201/eid1304.061383
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Coordenacao-Geral de Desenvolvimento da Epidemiologia em Servicos, 2016, COORD GER DES EP SER
   Bunning ML, 2002, EMERG INFECT DIS, V8, P380
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Callan RJ, 2004, VET CLIN N AM-FOOD A, V20, P327, DOI 10.1016/j.cvfa.2004.02.001
   Cannon AB, 2006, J VET INTERN MED, V20, P1219, DOI 10.1892/0891-6640(2006)20[1219:AEPAMA]2.0.CO;2
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Carboneras C, 2019, HDB BIRDS WORLD ALIV
   Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845
   Centers for Disease Control and Prevention (CDC), 2017, MOSQ SPEC WHICH W NI, P1999
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) D of V-BD (DVBD), 2018, SYMPT DIAGN AMP TREA
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Contigiani M.S, 2017, ARTHROPOD BORNE DIS, P73
   Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717
   D'Agostino JJ, 2004, JAVMA-J AM VET MED A, V224, P1640, DOI 10.2460/javma.2004.224.1640
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Diamond Michael S, 2005, Expert Rev Anti Infect Ther, V3, P931, DOI 10.1586/14787210.3.6.931
   Diaz LA, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00493
   El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002
   Emig M, 2004, CLIN INFECT DIS, V38, P289, DOI 10.1086/380458
   Ferguson DD, 2005, CLIN INFECT DIS, V41, P1204, DOI 10.1086/444506
   Fitzpatrick J., 2019, HDB BIRDS WORLD ALIV
   Flores EF, 2009, CIENC RURAL, V39, P604, DOI 10.1590/S0103-84782008005000070
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hawkes MA, 2018, NEUROCRIT CARE, V29, P47, DOI 10.1007/s12028-017-0500-x
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hayes EB, 2004, PEDIATRICS, V113, P1375, DOI 10.1542/peds.113.5.1375
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   International Society for Infectious Diseases, 2019, PROMEDMAIL
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200
   Jacobson ER, 2005, J WILDLIFE DIS, V41, P96, DOI 10.7589/0090-3558-41.1.96
   Joseph S, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.53
   Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945
   Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879
   Klenk K, 2004, EMERG INFECT DIS, V10, P2150, DOI 10.3201/eid1012.040264
   Klenk K, 2003, AM J TROP MED HYG, V69, P260, DOI 10.4269/ajtmh.2003.69.260
   Kokay Szabolcs, 2019, COMMON TERN STERNA H
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   KOSTYUKOV M A, 1985, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P49
   Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829
   LaDeau SL, 2011, ECOL APPL, V21, P1443, DOI 10.1890/09-1409.1
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lowe Nancy, 2004, RYNCHOPS NIGER
   Lustig Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02421
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Maharaj S, 2017, BMJ CASE REP
   Martins LC, 2018, MEM I O CRUZ, P1
   Mattar S, 2005, EMERG INFECT DIS, V11, P1497, DOI 10.3201/eid1109.050426
   Maximova OA, 2016, PLOS NEGLECT TROP D, V10, P1
   Ministerio da Saude, 2010, FEBR NIL OC GUIA V A
   Ministerio da Saude, 2017, GUIA VIG SAUD
   Ministerio da Saude, 2018, SECR VIG SAUD VIG NI
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2011, GUIA VIG CUL QUINQ A
   Mobley J., 2019, HDB BIRDS WORLD ALIV
   Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852
   Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293
   Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Ng T, 2003, Dev Biol (Basel), V114, P221
   OIE World Organisation for Animal Health, 2018, OIE TERR MAN 2018
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Ostlund EN, 2001, EMERG INFECT DIS, V7, P665
   Ostlund EN, 2000, VET CLIN N AM-EQUINE, V16, P427, DOI 10.1016/S0749-0739(17)30087-1
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Pepperell C, 2003, CAN MED ASSOC J, V168, P1399
   Pesko KN, 2012, INFECT GENET EVOL, V12, P181, DOI 10.1016/j.meegid.2011.11.014
   Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P1
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Rising J., 2019, HDB BIRDS WORLD ALIV
   Robinson RL, 2003, AM J MED, V115, P252, DOI 10.1016/S0002-9343(03)00291-2
   Saegerman C, 2016, TRANSBOUND EMERG DIS, V63, P184, DOI 10.1111/tbed.12243
   SBMT-Sociedade Brasileira de Medicina Tropical, 2017, NIL FEV PIAUI 285 IN
   SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194
   Sejvar James J, 2003, Ochsner J, V5, P6
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312
   Sejvar JJ, 2004, NEUROLOGY, V63, P206, DOI 10.1212/01.WNL.0000130361.62281.69
   Sejvar JJ, 2003, JAMA, V290
   Shimoni Z, 2001, EMERG INFECT DIS, V7, P759
   Silva JR, 2013, MEM I OSWALDO CRUZ, V108, P921, DOI 10.1590/0074-0276130052
   SILVASANCHEZ A, 2018, TRANSBOUND EMERG DIS, V1845, P1, DOI DOI 10.1007/978-1-4939-8709-2_1
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Smeraski CA, 2011, ANTIVIR RES, V91, P43, DOI 10.1016/j.antiviral.2011.04.011
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Snook CS, 2001, J AM VET MED ASSOC, V218, P1576, DOI 10.2460/javma.2001.218.1576
   Solomon T, 2003, CLIN INFECT DIS, V36, pE140, DOI 10.1086/374936
   Steinman A, 2003, EMERG INFECT DIS, V9, P887
   Summers-Smith D, 2019, HDB BIRDS WORLD ALIV
   TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579
   Trevejo RT, 2008, JAVMA-J AM VET MED A, V232, P1302, DOI 10.2460/javma.232.9.1302
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z
   van Gils J, 2019, HDB BIRDS WORLD ALIV
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Ward MP, 2006, VET MICROBIOL, V118, P255, DOI 10.1016/j.vetmic.2006.07.016
   Ward MP, 2005, PREV VET MED, V71, P253, DOI 10.1016/j.prevetmed.2005.07.008
   Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   WHO, 2017, W NIL VIR
   Winkelmann ER, 2016, F1000RES, V5, pF1000
   Zanoni F, 2018, EXP CLIN TRANSPLANT
   Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602
NR 126
TC 2
Z9 2
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20190089
DI 10.1590/0037-8682-0089-2018
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HR6BV
UT WOS:000463233900001
PM 30942263
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Scotta, MC
   Fabro, AT
   Machado, PRL
   Ramos, SG
   Cervi, MC
   da Fonseca, BAL
   Motta, F
   Negrini, BVD
AF Scotta, Marcelo Comerlato
   Fabro, Alexandre Todorovic
   Lima Machado, Paula Renata
   Ramos, Simone Gusmao
   Cervi, Maria Celia
   Lopes da Fonseca, Benedito Antonio
   Motta, Fabrizio
   de Moura Negrini, Bento Vidal
TI Human Herpesvirus 8 in Perinatally HIV-infected Children with
   Interstitial Lung Disease
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
DE human herpesvirus 8; interstitial lung disease; HIV; child
ID BARR-VIRUS INFECTION; KAPOSIS-SARCOMA; HERPESVIRUS-INFECTION; SEXUAL
   TRANSMISSION; HHV-8 INFECTION; DNA-SEQUENCES; RISK-FACTORS; AIDS;
   BRAZIL; PNEUMONITIS
AB Introduction: Human herpesvirus 8 (HHV-8) is associated with the pathogenesis of Kaposi Sarcoma and interstitial pneumonitis in adults. This study aims to evaluate association between HHV-8 and interstitial lung disease in HIV-infected children.
   Methods: HIV-infected children with interstitial pneumonitis underwent lung biopsies in a tertiary hospital and were investigated for HHV-8, Epstein-Barr virus (EBV) and cytomegalovirus (CMV) using polymerase chain reaction (PCR) and immunohistochemistry in lung tissue. Peripheral blood PCR was also performed for HHV-8.
   Results: From six patients included, PCR for HHV-8 was positive in lung samples in four children and in peripheral blood in one. PCR for EBV and CMV and immunohistochemical study for HHV-8, EBV and CMV in lung were negative in all patients.
   Conclusion: No previous cases of HHV-8-associated interstitial pneumonitis was described in HIV-infected children. An immunological disorder and an infectious agent might influence development of the lymphoid interstitial pneumonitis. HHV-8 may be this infectious trigger.
C1 [Scotta, Marcelo Comerlato] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Biomed Res Inst, BR-90610000 Porto Alegre, RS, Brazil.
   [Scotta, Marcelo Comerlato; Fabro, Alexandre Todorovic; Lima Machado, Paula Renata; Ramos, Simone Gusmao; Cervi, Maria Celia; Lopes da Fonseca, Benedito Antonio; Motta, Fabrizio; de Moura Negrini, Bento Vidal] Univ Sao Paulo, Clin Hosp, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Lima Machado, Paula Renata] Univ Fed Rio Grande do Norte, Dept Clin Anal & Toxicol, BR-59078970 Natal, RN, Brazil.
   [Motta, Fabrizio] Hosp Crianca Santo Antonio, Irmandade Santa Casa de Misericordia Porto Alegre, BR-90020090 Porto Alegre, RS, Brazil.
   [de Moura Negrini, Bento Vidal] Univ Fed Sao Carlos, BR-13565905 Sao Carlos, SP, Brazil.
RP Scotta, MC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Biomed Res Inst, Ave Ipiranga 6690,2nd Floor, BR-90610000 Porto Alegre, RS, Brazil.
EM marcelo.scotta@pucrs.br
RI Negrini, Bento VM/J-6471-2012; Cervi, Maria Celia/P-2567-2016
OI Negrini, Bento VM/0000-0002-9835-627X; Cervi, Maria
   Celia/0000-0002-6563-6507; Machado, Paula/0000-0002-3085-9778
CR ANDIMAN WA, 1985, LANCET, V2, P1390
   Ankermann T, 2003, PEDIATR PULM, V35, P234, DOI 10.1002/ppul.10244
   [Anonymous], 1994, Pediatrics, V94, P815
   Ansari MQ, 1996, AM J CLIN PATHOL, V105, P221
   Avelleira JCR, 2006, INT J DERMATOL, V45, P381, DOI 10.1111/j.1365-4632.2006.02523.x
   Becuwe C, 2005, ANN DERMATOL VENER, V132, P839, DOI 10.1016/S0151-9638(05)79501-6
   Berman DM, 2007, PEDIATR PULM, V42, P871, DOI 10.1002/ppul.20668
   Caterino-de-Araujo A, 2003, J TROP PEDIATRICS, V49, P247, DOI 10.1093/tropej/49.4.247
   Caterino-De-Araujo A, 2007, BRAZ J INFECT DIS, V11, P9, DOI 10.1590/S1413-86702007000100004
   Caterino-de-Araujo Adele, 2003, Braz J Infect Dis, V7, P395, DOI 10.1590/S1413-86702003000600007
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Cunha AMG, 2005, J GEN VIROL, V86, P2433, DOI 10.1099/vir.0.81087-0
   Das S, 2003, SEX TRANSM INFECT, V79, P88, DOI 10.1136/sti.79.2.88
   Cahu GGDOM, 2016, J MED VIROL, V88, P2016, DOI 10.1002/jmv.24550
   Deloose STP, 2005, LEUKEMIA, V19, P851, DOI 10.1038/sj.leu.2403709
   Engels EA, 2001, BRIT J CANCER, V85, P1298, DOI 10.1054/bjoc.2001.2052
   Filipek MS, 2004, J THORAC IMAG, V19, P200, DOI 10.1097/01.rti.0000099464.94973.51
   Ishak MDG, 2007, J MED VIROL, V79, P1537, DOI 10.1002/jmv.20995
   Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009
   Instituto Brasileiro de Geografia e Estatistica (IBGE), EST POP RES NOS MUN
   Katano H, 2000, MODERN PATHOL, V13, P77, DOI 10.1038/modpathol.3880012
   Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918
   LIEBOW AA, 1973, MED CLIN N AM, V57, P809, DOI 10.1016/S0025-7125(16)32278-7
   Lisco A, 2006, J CLIN MICROBIOL, V44, P3863, DOI 10.1128/JCM.00791-06
   Luppi M, 1996, NEW ENGL J MED, V335, P351, DOI 10.1056/NEJM199608013350514
   Magri MC, 2009, J MED VIROL, V81, P1292, DOI 10.1002/jmv.21513
   Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403
   Mbulaiteye SM, 2004, J INFECT DIS, V190, P1382, DOI 10.1086/424489
   Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0
   Mueller GA, 2003, PEDIATR PULM, V36, P447, DOI 10.1002/ppul.10341
   Muller A, 2000, J INFECTION, V40, P242, DOI 10.1053/jinf.2000.0639
   Nascimento MC, 2008, J MED VIROL, V80, P1202, DOI 10.1002/jmv.21188
   NICHOLSON AG, 1995, HISTOPATHOLOGY, V26, P405
   Parambil JG, 2006, CHEST, V130, P1489, DOI 10.1378/chest.130.5.1489
   RUBINSTEIN A, 1986, J PEDIATR-US, V108, P498, DOI 10.1016/S0022-3476(86)80822-8
   Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1
   Shipe R, 2013, AM J RESP CRIT CARE, V188, P510, DOI 10.1164/rccm.201206-1096IM
   Siqueira RC, 2004, OPHTHALMOLOGICA, V218, P43, DOI 10.1159/000074566
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Swigris JJ, 2002, CHEST, V122, P2150, DOI 10.1378/chest.122.6.2150
   Toro AADC, 2006, J TROP PEDIATRICS, V52, P360, DOI 10.1093/tropej/fml019
   Yamamoto Y, 2003, LEUKEMIA LYMPHOMA, V44, P1631, DOI 10.3109/10428190309178791
NR 42
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD OCT
PY 2018
VL 64
IS 5
BP 382
EP 388
DI 10.1093/tropej/fmx080
PG 7
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA GV5AZ
UT WOS:000446114500005
PM 29165615
OA Bronze
DA 2020-12-08
ER

PT J
AU Doltario, AB
   Menon, LJB
   Bollela, VR
   Martinez, R
   Araujo, DCDE
   da Fonseca, BAL
   Santana, RD
AF Doltario, Andrea Beltrami
   Bazzo Menon, Lucas Jose
   Bollela, Valdes Roberto
   Martinez, Roberto
   de Almeida e Araujo, Daniel Cardoso
   Lopes da Fonseca, Benedito Antonio
   Santana, Rodrigo de C.
TI Malaria and other febrile diseases among travellers: the experience of a
   reference centre located outside the Brazilian Amazon Region (vol 15,
   294, 2016)
SO MALARIA JOURNAL
LA English
DT Correction
C1 [Doltario, Andrea Beltrami; Bazzo Menon, Lucas Jose; Bollela, Valdes Roberto; Martinez, Roberto; Lopes da Fonseca, Benedito Antonio; Santana, Rodrigo de C.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [de Almeida e Araujo, Daniel Cardoso] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Med Social, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Santana, RD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Ribeirao Preto, SP, Brazil.
EM santanacrod@fmrp.usp.br
RI de C Santana, Rodrigo/C-4429-2014
OI de C Santana, Rodrigo/0000-0002-5887-8663
CR Doltrario AB, 2016, MALARIA J, V15, P294, DOI 10.1186/s12936-016-1347-x
NR 1
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JUL 30
PY 2018
VL 17
AR 277
DI 10.1186/s12936-018-2421-3
PG 1
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GO6TK
UT WOS:000440183000002
PM 30060737
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Fumagalli, MJ
   de Souza, WM
   Esposito, DLA
   Silva, A
   Romeiro, MF
   Martinez, EZ
   da Fonseca, BAL
   Figueiredo, LTM
AF Fumagalli, Marcilio Jorge
   de Souza, William Marciel
   Alves Esposito, Danillo Lucas
   Silva, Angelica
   Romeiro, Marilia Farignoli
   Martinez, Edson Zangiacomi
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
TI Enzyme-linked immunosorbent assay using recombinant envelope protein 2
   antigen for diagnosis of Chikungunya virus
SO VIROLOGY JOURNAL
LA English
DT Article
DE Chikungunya virus; Antibodies detection; Envelope protein 2; Serology
AB Background: Chikungunya (CHIKV) virus is an important mosquito-borne virus causing outbreaks of acute febrile illness with arthropathy. The detection of specific antibodies against CHIKV is used for diagnosis after the acute viremic phase of the disease. However, a major challenge for serologic diagnosis of CHIKV and other alphaviruses is the cross-reactivity of antibodies to common antigens among these viruses. In the present study, we have developed an enzyme-linked immunosorbend assay using a recombinant envelope protein 2 of CHIKV produced in Escherichia coli system, as a capture antigen.
   Results: High titers (1600 to 12,800) of anti-CHIKV antibodies were detected in human sera analyzed by the CHIKV assay, suggesting it may detect low levels of the antibodies presence. On the other side, cross-reactivity was not observed in mouse hyperimmune sera to Mayaro virus and other alphaviruses analyzed by the CHIKV immunosorbend assay, suggesting it is a CHIKV-specific test. Fifty-nine human serum samples of CHIKV infection suspected cases were tested for immunoglobulin G (IgG) and M (IgM) antibodies detection using the CHIKV immunosorbend assay. A total of 44% (26/59) of samples were positive for IgG to CHIKV, determining 89.66% sensitivity and 100% specificity when the assay is compared to a CHIKV-specific neutralization assay. In addition, 40.6% (24/59) of samples were positive for IgM, determining 92.48% sensitivity and 79.04% specificity by a Bayesian method in the absence of a gold standard. Moreover, CHIKV immunosorbend assay showed similar sensibilities to a commercial immunochromatography assay (Lumiquick, USA) for CHIKV IgG and IgM detection.
   Conclusion: In short, we have developed a rapid, simple, specific and sensitive CHIKV immunosorbend assay for IgG and IgM detection and our results showed potential applicability on the diagnosis of infections by this virus.
C1 [Fumagalli, Marcilio Jorge; de Souza, William Marciel; Alves Esposito, Danillo Lucas; Silva, Angelica; Romeiro, Marilia Farignoli; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Ribeirao Preto Med Sch, Virol Res Ctr, Ribeirao Preto, SP, Brazil.
   [Martinez, Edson Zangiacomi] Univ Sao Paulo, Ribeirao Preto Med Sch, Social Med, Ribeirao Preto, SP, Brazil.
RP Fumagalli, MJ (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Virol Res Ctr, Ribeirao Preto, SP, Brazil.
EM marcilio_jorge@hotmail.com
RI Fumagalli, Marcilio/ABE-1183-2020; Esposito, Danillo L.A./N-9261-2017;
   de Souza, William Marciel/D-3044-2017; Martinez, Edson
   Zangiacomi/A-3638-2008
OI Fumagalli, Marcilio/0000-0002-0207-5423; Esposito, Danillo
   L.A./0000-0002-2755-4471; de Souza, William Marciel/0000-0002-0025-8293;
   Martinez, Edson Zangiacomi/0000-0002-0949-3222
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, BrazilFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/02438-6,
   16/01414-1, 12/24150-9, 17/13981-0, 14/20851-8]
FX This work was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo, Brazil (Grant No. 14/02438-6, and Scholarships No.
   16/01414-1, 12/24150-9, 17/13981-0, 14/20851-8).
CR [Anonymous], 2017, NUMBER REPORTED CASE
   Azami NAM, 2016, METHODS MOL BIOL, V1426, P273, DOI 10.1007/978-1-4939-3618-2_25
   Bhatnagar S, 2015, VIRAL IMMUNOL, V28, P107, DOI 10.1089/vim.2014.0031
   Blacksell SD, 1810, CLIN VACCINE IMMUNOL, V2011, P1773
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   CALISHER CH, 1986, J CLIN MICROBIOL, V23, P155, DOI 10.1128/JCM.23.1.155-159.1986
   Cho B, 2008, YONSEI MED J, V49, P828, DOI 10.3349/ymj.2008.49.5.828
   Chua CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171989
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   FIGUEIREDO LTM, 1989, MEM I OSWALDO CRUZ, V84, P303, DOI 10.1590/S0074-02761989000300003
   FIGUEIREDO LTM, 1987, J VIROL METHODS, V17, P191, DOI 10.1016/0166-0934(87)90129-7
   Godaert L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005256
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428
   Kashyap RS, 2010, CLIN VACCINE IMMUNOL, V17, P291, DOI 10.1128/CVI.00326-09
   Khan M, 2014, J MED VIROL, V86, P1169, DOI 10.1002/jmv.23752
   Kumar P, 2014, J VIROL METHODS, V206, P67, DOI 10.1016/j.jviromet.2014.05.014
   LaBeaud AD, 2015, PLOS NEGLECT TROP D, V92
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Levett PN, 2005, J CLIN MICROBIOL, V43, P5873, DOI 10.1128/JCM.43.12.5873-5875.2005
   Mary JA, 2013, J BIOMOL STRUCT DYN, V31, P1077, DOI 10.1080/07391102.2012.721496
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Ramani S, 2010, CLIN INFECT DIS, V51, P1284, DOI 10.1086/657069
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thompson NN, 2012, VECTOR-BORNE ZOONOT, V12, P969, DOI 10.1089/vbz.2012.0959
   Tripathi NK, 2014, APPL MICROBIOL BIOT, V98, P2461, DOI 10.1007/s00253-013-5426-4
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Warter L, 1865, J IMMUNOL, V2011, P3258
   Weber C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005318
   Weber C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003684
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 44
TC 7
Z9 8
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 24
PY 2018
VL 15
AR 112
DI 10.1186/s12985-018-1028-1
PG 7
WC Virology
SC Virology
GA GO1GJ
UT WOS:000439697500002
PM 30041676
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Magnus, MM
   Esposito, DLA
   da Costa, VA
   de Melo, PS
   Costa-Lima, C
   da Fonseca, BAL
   Addas-Carvalho, M
AF Magnus, Mariana Munari
   Alves Esposito, Danillo Lucas
   da Costa, Victor Antonio
   de Melo, Priscila Silva
   Costa-Lima, Carolina
   Lopes da Fonseca, Benedito Antonio
   Addas-Carvalho, Marcelo
TI Risk of Zika virus transmission by blood donations in Brazil
SO HEMATOLOGY TRANSFUSION AND CELL THERAPY
LA English
DT Article
DE Zika; Blood transfusion; Transfusion risk; ZIKV
AB Background: Zika, a disease caused by Zika virus infections, has recently emerged and caused outbreaks in many parts of the world. The clinical manifestations of Zika are usually mild, mostly presenting as an exanthematic febrile disease, but on some occasions, it might be associated with microcephaly after intrauterine infection, and Guillain-Barre Syndrome. Zika virus is primarily transmitted by mosquito bites, but other means of transmission have been described, and potential risk for blood transmission has been reported in French Polynesia and Brazil.
   Methods: To investigate the risk of Zika virus infection after a blood transfusion in an area of Brazil where a possible transmission by a platelet concentrate has been described. Using a mini-pool format, 1857 blood donations were evaluated by real-time reverse transcriptase polymerase chain reaction designed to detect Zika virus RNA.
   Results: After testing samples individually from positive mini-pools, the prevalence of Zika virus RNA was only 0.16%, a result probably associated to the low circulation of this virus in the study area. In addition, it was evident that the implementation of post-surveillance programs is important to detect Zika virus infections in blood donors, as the post-donation surveillance program detected two blood donors with the disease in this study.
   Conclusion: This study shows that the risk for Zika virus transmission by blood transfusion is real, even in regions with a low circulation of the disease, but the combination of the detection of Zika virus RNA by polymerase chain reaction and post-donation surveillance might reduce the risk of transmission by blood transfusions. (C) 2018 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.
C1 [Magnus, Mariana Munari; da Costa, Victor Antonio; de Melo, Priscila Silva; Costa-Lima, Carolina; Addas-Carvalho, Marcelo] Univ Estadual Campinas, UNICAMP, Campinas, SP, Brazil.
   [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo FMRP USP, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Magnus, MM (corresponding author), Univ Estadual Campinas, UNICAMP, Hemoctr, Rua Carlos Chagas 480,Cidade Univ Zeferino Vaz, BR-13083878 Campinas, SP, Brazil.
EM mmagnus@unicamp.br
RI ; Fonseca, Benedito/F-3252-2012
OI Addas-Carvalho, Marcelo/0000-0003-0178-6191; Fonseca,
   Benedito/0000-0003-3159-5687
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2011, EURO SURVEILL, V19
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2013, FIELDS VIROLOGY, P712
   Musso D, 2014, EURO SURVEILL, V19
   PAHO, 2016, PROV REC BLOOD SERV
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   US Food and Drug Administration (FDA), 2016, FDA GUID REC DON SCR
NR 15
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2531-1379
J9 HEMATOL TRANSF CELL
JI Hematol. Transf. Cell Ther.
PD JUL-SEP
PY 2018
VL 40
IS 3
BP 250
EP 254
DI 10.1016/j.htct.2018.01.011
PG 5
WC Oncology; Hematology
SC Oncology; Hematology
GA VJ3QT
UT WOS:000587465200010
PM 30128434
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Esposito, DLA
   de Moraes, JB
   da Fonseca, BAL
AF Esposito, Danillo L. A.
   de Moraes, Jonathan B.
   Lopes da Fonseca, Benedito Antonio
TI Current priorities in the Zika response
SO IMMUNOLOGY
LA English
DT Review
DE comparative immunology; evolution; vaccination; viral; zika virus and
   infection
ID VIRUS-INFECTION; PROFILE
AB Zika virus (ZIKV), a single-stranded RNA virus of the Flaviviridae family, is an arbovirus (viruses transmitted by arthropods) transmitted to humans and non-human primates through the bites of infected female Aedes sp. mosquitoes. Although first isolated in 1947, it only recently emerged as a global threat, present in several countries resulting in a pandemic scenario. ZIKV infections may have severe outcomes, such as neurological impairment, and with the intrinsic ability of inducing microcephaly in fetuses of infected pregnant women, the virus has become a major public health problem. This review discusses some advances in diagnosis; vaccine development and the problems associated with their administration; the importance of the cross-reactivity with other flaviviruses in protecting or worsening the disease; the implications of the recent outbreak caused by the virus in the world; and future prospects for the complete understanding of this disease.
C1 [Esposito, Danillo L. A.; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, Sao Paulo, Brazil.
   [de Moraes, Jonathan B.] Univ Sao Paulo, Grad Studies Programme Basic & Appl Immunol Ribei, Ribeirao Preto Med Sch, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Disciplina Molestias Infecciosas, Dept Clin Med, Fac Med Ribeirao Preto, Ave Bandeirantes 3900, Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Moraes,
   Jonathan/0000-0002-0021-3714; Fonseca, Benedito/0000-0003-3159-5687
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505
   ANDRADE DV, 2017, VIRUS RES, P462, DOI DOI 10.4049/JIMMUNOL.1601949
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   BOWEN JR, 2017, PLOS PATHOG, V13, P6164, DOI DOI 10.1016/J.IT.2006.06.003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMPTON T, 2016, JAMA J AM MED ASSOC, V316, P1755
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jin Jill, 2016, JAMA, V315, P2482, DOI 10.1001/jama.2016.4741
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   KRAUSS MJ, AM J OBSTET GYNECOL, DOI DOI 10.1038/NI.3849
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuwabara S, 2007, CURR NEUROL NEUROSCI, V7, P57, DOI 10.1007/s11910-007-0022-6
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V19, P20720
   PARDY RD, 2017, PLOS PATHOG, V13, P6184, DOI DOI 10.1016/J.CHOM.2016.04.019
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rios A, 1996, Pediatr Rev, V17, P386
   Saude SdVe, 2017, B EP
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   *WHO, 2017, PREV SEX TRANSM ZIK, V29, DOI DOI 10.1016/J.CELREP.2016.08.079
   WHO, 2017, ZIK VIR SIT REP
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
NR 64
TC 3
Z9 3
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD APR
PY 2018
VL 153
IS 4
BP 435
EP 442
DI 10.1111/imm.12878
PG 8
WC Immunology
SC Immunology
GA FY3OD
UT WOS:000426728600004
PM 29243225
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU de Moraes, FM
   Esposito, DLA
   Klein, TM
   da Fonseca, BAL
AF de Moraes, F. M.
   Esposito, D. L. A.
   Klein, T. M.
   da Fonseca, B. A. L.
TI Searching for the best real-time RT-PCRs to detect Zika virus
   infections: the importance of comparing several protocols
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Zika virus; Flavivirus; real time RT-PCR; Diagnosis
AB Clinical manifestations of Zika, dengue, and chikungunya virus infections are very similar, making it difficult to reach a diagnosis based only on clinical grounds. In addition, there is an intense cross-reactivity between antibodies directed to Zika virus and other flaviviruses, and an accurate Zika diagnosis is best achieved by real-time RT-PCR. However, some real-time RT-PCR show better performance than others. To reach the best possible Zika diagnosis, the analytic sensitivity of some probe-based real-time RT-PCR amplifying Zika virus RNA was evaluated in spiked and clinical samples. We evaluated primers and probes to detect Zika virus, which had been published before, and tested sensitivity using serum spiked and patient samples by real-time RT-PCR. When tested against spiked samples, the previously described primers showed different sensitivity, with very similar results when samples from patients (serum and urine) were analyzed. Real-time RT-PCR designed to amplify Zika virus NS1 showed the best analytical sensitivity for all samples.
C1 [de Moraes, F. M.; Esposito, D. L. A.; da Fonseca, B. A. L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
   [Klein, T. M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil.
RP Esposito, DLA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM esposito@usp.br
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
FU Sao Paulo State Secretary of Health (FESIMA, Oficio CAF) [03/2016];
   CAPES/Zika Fast Track [88887.116621/2016-01]; Brazilian Ministry of
   Health [25000.161.997/2016-70]
FX This work was funded by grants from the Sao Paulo State Secretary of
   Health (FESIMA, Oficio CAF #03/2016), CAPES/Zika Fast Track
   (#88887.116621/2016-01) and the Brazilian Ministry of Health
   (#25000.161.997/2016-70).
CR Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Tappe D, 2014, EURO SURVEILL, V19, P20865
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 14
TC 1
Z9 1
U1 1
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2018
VL 51
IS 6
AR e7221
DI 10.1590/1414-431X20187221
PG 5
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA GG8WB
UT WOS:000432978400001
PM 29791591
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Correa-Oliveira, GE
   do Amaral, JL
   da Fonseca, BAL
   Del-Ben, CM
AF Correa-Oliveira, Gabriel Elias
   do Amaral, Julia Lopes
   Lopes da Fonseca, Benedito Antonio
   Del-Ben, Cristina Marta
TI Zika virus infection followed by a first episode of psychosis: another
   flavivirus leading to pure psychiatric symptomatology
SO REVISTA BRASILEIRA DE PSIQUIATRIA
LA English
DT Letter
C1 [Correa-Oliveira, Gabriel Elias; do Amaral, Julia Lopes; Del-Ben, Cristina Marta] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Serv Emergencias Psiquiatr, Ribeirao Preto, SP, Brazil.
   [Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Div Molestias Infecciosas & Trop, Ribeirao Preto, SP, Brazil.
RP Correa-Oliveira, GE (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Serv Emergencias Psiquiatr, Ribeirao Preto, SP, Brazil.
RI Del-Ben, Cristina Marta/X-1533-2019; Del-Ben, Cristina M/F-1817-2012;
   Fonseca, Benedito/F-3252-2012
OI Del-Ben, Cristina Marta/0000-0003-0145-9975; Del-Ben, Cristina
   M/0000-0003-0145-9975; Fonseca, Benedito/0000-0003-3159-5687
CR Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 5
TC 4
Z9 4
U1 0
U2 13
PU ASSOC BRASILEIRA PSIQUIATRIA
PI SAO PAULO
PA SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO,
   SP 04039-032  A, BRAZIL
SN 1516-4446
EI 1809-452X
J9 REV BRAS PSIQUIATR
JI Rev. Bras. Psiquiatr.
PD OCT-DEC
PY 2017
VL 39
IS 4
BP 381
EP 382
DI 10.1590/1516-4446-2017-2308
PG 3
WC Psychiatry
SC Psychiatry
GA FM9BR
UT WOS:000415387500020
PM 29160530
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Esposito, DLA
   da Fonseca, BAL
AF Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Will Mayaro virus be responsible for the next outbreak of an
   arthropod-borne virus in Brazil?
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Mayaro virus; Alphavirus; Chikungunya virus; Epidemiology; Outbreaks
ID HUMAN-DISEASE AGENT; AEDES-ALBOPICTUS; AMAZON BASIN; INFECTION;
   CHIKUNGUNYA; TRAVELER; STRAINS; VECTOR; FEVER; STATE
AB Mayaro virus is an alphavirus from the Togaviridae family and is transmitted mainly by Hemagogus mosquitoes. This virus circulates in high-density tropical forests or rural areas of Central and South America causing a disease characterized by high-grade fever, maculopapular skin rash and marked arthralgia that, in some patients, can persist for long periods after infection and may be misinterpreted as chikungunya. Although only a few outbreaks involving this virus have been reported, in the last years the number of Mayaro virus infections has increased in the central and northern regions of Brazil. In this review, we describe the reported prevalence of this infection over the years and discuss the circumstances that can contribute to the establishment of an urban mayaro virus epidemic in Brazil and the problems encountered with the specific diagnosis, especially the antigenic cross-reactivity of this pathogen with other viruses of the same family. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.
C1 [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Esposito D. L, 2015, GENOME ANNOUNC, V3
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Griffin D., 2013, FIELDS VIROLOGY, V2
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hassing RJ, 2010, EURO SURVEILL, V15
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Ministerio da Safide, 2017, B EPIDEMIOLOGICO, V48
   Ministerio da Safide, 2017, SIT EP MAYAR
   MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446
   Mota MT, 2015, GENOME ANNOUNC, V3
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Pinheiro F, 1998, ARBOVIRUSES EPIDEMIO, V3, P137
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Receveur MC, 2010, EURO SURVEILL, V15
   ROBINSON DM, 1976, MIL MED, V141, P163
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Slegers CAD, 2014, J CLIN VIROL, V60, P317, DOI 10.1016/j.jcv.2014.04.020
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   ten Dam E, 1999, J GEN VIROL, V80, P1879, DOI 10.1099/0022-1317-80-8-1879
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Theilacker C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-369
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 37
TC 32
Z9 33
U1 0
U2 6
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD SEP-OCT
PY 2017
VL 21
IS 5
BP 540
EP 544
DI 10.1016/j.bjid.2017.06.002
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FL5KS
UT WOS:000414276300009
PM 28688628
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, MVG
   Esposito, DLA
   da Fonseca, BAL
AF Gomes da Silva, Marcus Vinicius
   Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Digital disease data: what is the impact on the Zika virus epidemic?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 [Gomes da Silva, Marcus Vinicius; Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR Bittencourt Sonia Azevedo, 2006, Cad. Saúde Pública, V22, P19, DOI 10.1590/S0102-311X2006000100003
   Brasil Ministerio da Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Santos SR, 2014, COGITARE ENFERM, V19, P772
NR 6
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2017
VL 50
IS 4
BP 437
EP 438
DI 10.1590/0037-8682-0312-2017
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH9ZK
UT WOS:000411577300001
PM 28954062
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Esposito, DLA
   da Fonseca, BAL
AF Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Sensitivity and detection of chikungunya viral genetic material using
   several PCR-based approaches
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Chikungunya virus; Alphavirus; Digital polymerase chain reaction;
   Arboviruses quantitative polymerase chain reaction
ID INFECTIOUS-DISEASES; VIRUS; QUANTIFICATION; REEMERGENCE; STEP
AB Introduction: Chikungunya fever is a condition resulting from infection by chikungunya virus (CHIKV), an Aedes sp.- transmitted virus. This disease has been diagnosed in thousands of cases in the Americas, particularly in Brazil, in recent years, and there is an ongoing epidemic of chikungunya fever in Brazil that began in 2014. Clinical diagnosis is difficult; only a few cases have been confirmed by laboratory tests due to the low number of specific, efficient tests available for virus or antibody detection. Here, we aimed to evaluate different polymerase chain reaction (PCR) approaches for detection of CHIKV genetic material. Methods: Specific primers and probes within the viral capsid gene region were designed for this work. To evaluate the analytic sensitivity of detection, human sera were spiked with serial dilutions of the viral stock. Several PCR protocols were performed to investigate the sensitivity of CHIKV RNA detection in serum dilutions ranging from 10(6) to 1 PFU equivalents. Results: The technique showing the greatest sensitivity was a real- time PCR assay using specific probes that could detect the genetic material of the virus at all dilutions, followed by conventional PCR. Digital PCR showed low sensitivity and was much more expensive than other technologies. Digital PCR should be used for specific purposes other than clinical diagnosis. Conclusions: Although quantitative PCR using probes was more expensive than the use of intercalating dyes or conventional PCR, it had the highest sensitivity out of all tested PCR approaches.
C1 [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617
   Brasil Ministerio da Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Carletti F, 2007, AM J TROP MED HYG, V77, P521, DOI 10.4269/ajtmh.2007.77.521
   Enserink M, 2006, SCIENCE, V311, P1085, DOI 10.1126/science.311.5764.1085a
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075
   Kuhn R.J., 2013, FIELDS VIROLOGY, P629
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Parida MM, 2008, J BIOSCIENCES, V33, P617, DOI 10.1007/s12038-008-0079-7
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Rowland-Jones SL, T R SOC TROP MED HYG, V110, P85
   Sam I-C, 2006, Med J Malaysia, V61, P264
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203
   White RA, 2012, J VIROL METHODS, V179, P45, DOI 10.1016/j.jviromet.2011.09.017
   Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8
NR 19
TC 1
Z9 1
U1 0
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2017
VL 50
IS 4
BP 465
EP 469
DI 10.1590/0037-8682-0403-2016
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH9ZK
UT WOS:000411577300005
PM 28954066
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Moraes, FM
   Esposito, DLA
   Da Fonseca, BAL
AF de Moraes, Flavia Masson
   Alves Esposito, Danillo Lucas
   Lopes Da Fonseca, Benedito Antonio
TI Zika - The road from an obscure disease to an epidemic of information
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 [de Moraes, Flavia Masson; Alves Esposito, Danillo Lucas; Lopes Da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO, V47
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
NR 8
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2017
VL 50
IS 1
BP 1
EP 2
DI 10.1590/0037-8682-0541-2016
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO1ZY
UT WOS:000396497600001
PM 28327795
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Romeiro, MF
   de Souza, WM
   Tolardo, AL
   Vieira, LC
   Henriques, DA
   de Araujo, J
   Siqueira, CEH
   Colombo, TE
   Aquino, VH
   da Fonseca, BAL
   Bronzoni, RVD
   Nogueira, ML
   Durigon, EL
   Figueiredo, LTM
AF Romeiro, Marilia Farignoli
   de Souza, William Marciel
   Tolardo, Aline Lavado
   Vieira, Luiz Carlos
   Henriques, Dyana Alves
   de Araujo, Jansen
   Hassegawa Siqueira, Carlos Eduardo
   Colombo, Tatiana Elias
   Aquino, Victor Hugo
   Lopes da Fonseca, Benedito Antonio
   de Morais Bronzoni, Roberta Vieira
   Nogueira, Mauricio Lacerda
   Durigon, Edison Luiz
   Moraes Figueiredo, Luiz Tadeu
TI A real-time RT-PCR for rapid detection and quantification of
   mosquito-borne alphaviruses
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID EQUINE ENCEPHALITIS-VIRUS; CHAIN-REACTION ASSAY; MAYARO VIRUS;
   CHIKUNGUNYA; DENGUE
AB Mosquito-borne alphaviruses are widely distributed throughout the world, causing important human illnesses. Therefore, the development of methods to enable early diagnosis of infections by alphavirus is essential. We show here the development and evaluation of a quantitative real-time RT-PCR using genus-specific primers to the nsP1 viral gene of all mosquito-borne alphaviruses. The specificity and sensitivity of the assay were tested using seven alphaviruses and RNA transcribed from Venezuelan equine encephalitis virus. The detection limits of real-time RT-PCR ranged from 10 to 76 copies per ml. The melting temperature (T-M) values for amplification of the alphavirus genomes were 83.05 A degrees C and 85.28 A degrees C. Interestingly, the assay suggested the possibility the arthritogenic alphaviruses with T-M peaks of 84.83 to 85.28 A degrees C and encephalitic alphaviruses of 83.34 A degrees C to 84.68 A degrees C could be discriminated both diseases. Real-time RT-PCR may prove very useful for the screening and preliminary diagnosis in outbreaks and surveillance studies as well as for measuring the viral load in pathogenesis studies.
C1 [Romeiro, Marilia Farignoli; de Souza, William Marciel; Tolardo, Aline Lavado; Vieira, Luiz Carlos; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Virol Res Ctr, Sch Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
   [Henriques, Dyana Alves; de Araujo, Jansen; Durigon, Edison Luiz] Univ Sao Paulo, Inst Ciencias Biomed, Lab Virol Clin & Mol, Sao Paulo, Brazil.
   [Hassegawa Siqueira, Carlos Eduardo; de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso Mato Grosso, Ctr Univ Sinop, Inst Ciencias Saude, Sinop, Mato Grosso, Brazil.
   [Aquino, Victor Hugo] Univ Sao Paulo, Dept Anal Clin Toxicol & Bromatol, Lab Virol, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil.
   [Colombo, Tatiana Elias; Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio do Preto, Lab Pesquisa Virol, Sao Paulo, Brazil.
RP Romeiro, MF (corresponding author), Univ Sao Paulo, Virol Res Ctr, Sch Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM mafarignoli@hotmail.com; ltmfigue@fmrp.usp.br
RI Aquino, Victor Hugo/C-1922-2012; de Souza, William Marciel/D-3044-2017;
   Nogueira, Mauricio L/B-7599-2012; Fonseca, Benedito/F-3252-2012
OI Aquino, Victor Hugo/0000-0003-1910-0776; de Souza, William
   Marciel/0000-0002-0025-8293; Nogueira, Mauricio L/0000-0003-1102-2419;
   Araujo, Jansen/0000-0002-7250-3024; Fonseca,
   Benedito/0000-0003-3159-5687
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [13/14929-1, 12/02836-6,
   14/20851-8, 12/24150-9, 13/02256-2, 14/15079-4]; CNPq 1B senior
   fellowship [301677/2013-1]
FX This work was financially supported by Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (Grant No. 13/14929-1 and Scholarships No.
   12/02836-6; 14/20851-8; 12/24150-9; 13/02256-2 and 14/15079-4). LTM
   Figueiredo is the recipient of a CNPq 1B senior fellowship (No.
   301677/2013-1).
CR Pisano MB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002551
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Dutta SK, 2014, J MED VIROL, V86, P1386, DOI 10.1002/jmv.23794
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gutierrez S, 2015, J VIROL, V89, P4020, DOI 10.1128/JVI.03265-14
   Hueston L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065197
   Hull R, 2008, DIAGN MICR INFEC DIS, V62, P272, DOI 10.1016/j.diagmicrobio.2008.07.004
   Kang XP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-284
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Levanov L, 2014, J CLIN MICROBIOL, V52, P814, DOI 10.1128/JCM.02488-13
   Lundstrom K, 2014, VIRUSES-BASEL, V6, P2392, DOI 10.3390/v6062392
   Mathijs E, 2010, J GEN VIROL, V91, P2723, DOI 10.1099/vir.0.024109-0
   Medina G, 2015, AM J TROP MED HYG, V93, P7, DOI 10.4269/ajtmh.14-0543
   Mitsuhashi M, 1996, J CLIN LAB ANAL, V10, P285, DOI 10.1002/(SICI)1098-2825(1996)10:5<285::AID-JCLA9>3.3.CO;2-H
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Ni HL, 2007, AM J TROP MED HYG, V76, P774, DOI 10.4269/ajtmh.2007.76.774
   Perkins T Alex, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc
   Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709
   Powers AM, 2011, METHODS MOL BIOL, V665, P17, DOI 10.1007/978-1-60761-817-1_2
   Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406
   Sane J, 2012, J VIROL METHODS, V179, P185, DOI 10.1016/j.jviromet.2011.10.021
   Santhosh SR, 2007, J CLIN VIROL, V39, P188, DOI 10.1016/j.jcv.2007.04.015
   Smith DR, 2009, AM J TROP MED HYG, V81, P679, DOI 10.4269/ajtmh.2009.09-0138
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Vaney MC, 2013, CURR OPIN VIROL, V3, P151, DOI 10.1016/j.coviro.2013.04.003
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Weaver SC, 2012, ANTIVIR RES, V94, P242, DOI 10.1016/j.antiviral.2012.04.002
   Yang CF, 2010, J VIROL METHODS, V168, P147, DOI 10.1016/j.jviromet.2010.05.006
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   Zink SD, 2013, DIAGN MICR INFEC DIS, V77, P129, DOI 10.1016/j.diagmicrobio.2013.06.019
NR 39
TC 2
Z9 2
U1 0
U2 5
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD NOV
PY 2016
VL 161
IS 11
BP 3171
EP 3177
DI 10.1007/s00705-016-3019-0
PG 7
WC Virology
SC Virology
GA DY6QF
UT WOS:000385252100019
PM 27558120
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Esposito, DLA
   da Fonseca, BAL
AF Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Zika and chikungunya infections in Brazil: reviewing the epidemic and
   treatment options
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
ID VIRUS
C1 [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR Charrel RN, 2016, TRAVEL MED INFECT DI, V14, P11, DOI 10.1016/j.tmaid.2016.01.006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ministerio da Saude, 2016, MIN SAUD B EP, V47
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 6
TC 3
Z9 3
U1 0
U2 8
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 535
EP 536
DI 10.1590/0037-8682-0428-2016
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500001
PM 27812645
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Furtado, JM
   Esposito, DL
   Klein, TM
   Teixeira-Pinto, T
   da Fonseca, BA
AF Furtado, Joao M.
   Esposito, Danillo L.
   Klein, Taline M.
   Teixeira-Pinto, Tomas
   da Fonseca, Benedito A.
TI Uveitis Associated with Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Furtado, Joao M.; Esposito, Danillo L.; Klein, Taline M.; Teixeira-Pinto, Tomas; da Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RP Furtado, JM (corresponding author), Univ Sao Paulo, Ribeirao Preto, Brazil.
EM furtadojm@gmail.com
RI Esposito, Danillo L.A./N-9261-2017; Furtado, Joao/D-4436-2012; Fonseca,
   Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687; Furtado, Joao M./0000-0003-2490-5747
CR Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
NR 5
TC 90
Z9 92
U1 0
U2 35
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 28
PY 2016
VL 375
IS 4
BP 394
EP 396
DI 10.1056/NEJMc1603618
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0UV
UT WOS:000380313200030
PM 27332784
OA Bronze
DA 2020-12-08
ER

PT J
AU Barjas-Castro, ML
   Angerami, RN
   Cunha, MS
   Suzuki, A
   Nogueira, JS
   Rocco, IM
   Maeda, AY
   Vasami, FGS
   Katz, G
   Boin, IFSF
   Stucchi, RSB
   Resende, MR
   Esposito, DLA
   de Souza, RP
   da Fonseca, BA
   Addas-Carvalho, M
AF Barjas-Castro, Maria L.
   Angerami, Rodrigo N.
   Cunha, Mariana S.
   Suzuki, Akemi
   Nogueira, Juliana S.
   Rocco, Iray M.
   Maeda, Adriana Y.
   Vasami, Fernanda G. S.
   Katz, Gizelda
   Boin, Ilka F. S. F.
   Stucchi, Raquel S. B.
   Resende, Mariangela R.
   Esposito, Danillo L. A.
   de Souza, Renato P.
   da Fonseca, Benedito A.
   Addas-Carvalho, Marcelo
TI Probable transfusion-transmitted Zika virus in Brazil
SO TRANSFUSION
LA English
DT Article
ID WEST NILE VIRUS; BLOOD-TRANSFUSION; FRENCH-POLYNESIA; TRANSMISSION;
   DENGUE; OUTBREAK
AB BACKGROUNDZika virus (ZIKV) is an emerging arthropod-borne flavivirus transmitted by Aedes mosquitoes. Recent commentaries regarding ZIKV routes of transmission describe a potential transmission by transfusion. Herein, we report a probable case of transfusion-transmitted ZIKV infection through a platelet transfusion that was detected from postdonation information.
   CASE REPORTA blood donor made a voluntary telephone report to the blood donor facility 3 days after donation and informed the facility of a febrile illness (fever, malaise, and headaches). Due to the ongoing dengue epidemic, the initial clinical investigation included dengue among other possible diagnoses. The serology and molecular laboratory results excluded dengue infection. However, stored samples from the donation were positive for ZIKV on reverse transcription-polymerase chain reaction (RT-PCR) analysis. A retrospective investigation demonstrated that the platelet concentrate, which was part of a pool, had been transfused after a liver transplantation. A physician had evaluated the patient 4 days after surgery. Laboratory investigation showed enzyme-linked immunosorbent assay results that were negative for dengue immunoglobulin M antibodies; however, the results were positive for hemagglutination inhibition antibodies against flavivirus. ZIKV RT-PCR and virus isolation analyses in cell cultures from recipient serum were both positive. The sequencing confirmed ZIKV in the donor and patient samples. Ten partial nucleotide sequences from the ZIKV strain that were detected in the donor were aligned and compared with the ZIKV genome detected in the recipient, revealing a 99.8% homology between the two strains.
   CONCLUSIONSThis is a case of probable transmission of ZIKV through blood transfusion. The patient had been transfused with the blood product from an infected donor, most likely in the incubation period after ZIKV infection but prior to clinical disease onset. This report emphasizes the importance of postdonation information and recipient investigations during outbreaks of potentially blood-borne infections.
C1 [Barjas-Castro, Maria L.; Addas-Carvalho, Marcelo] Univ Estadual Campinas UNICAMP, Hematol & Transfus Ctr, Campinas, SP, Brazil.
   [Angerami, Rodrigo N.; Resende, Mariangela R.] Univ Estadual Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Cunha, Mariana S.; Suzuki, Akemi; Nogueira, Juliana S.; Rocco, Iray M.; Maeda, Adriana Y.; Vasami, Fernanda G. S.; de Souza, Renato P.] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Katz, Gizelda] Infect Dis Surveillance Ctr Prof Alexandre Vranja, Sao Paulo, SP, Brazil.
   [Boin, Ilka F. S. F.; Stucchi, Raquel S. B.; Resende, Mariangela R.] Univ Estadual Campinas UNICAMP, Dept Clin Med, Fac Med Sci, Campinas, SP, Brazil.
   [Esposito, Danillo L. A.; da Fonseca, Benedito A.] Univ Estadual Sao Paulo, Fac Ciencias Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Barjas-Castro, ML (corresponding author), Univ Estadual Campinas UNICAMP, Hemoctr Unicamp, Rua Carlos Chagas 480,Cidade Univ Zeferino Vaz, Campinas, SP, Brazil.
EM maluz@unicamp.br
RI Addas-Carvalho, Marcelo/D-9654-2018; Boin, Ilka FSF/C-7811-2009;
   Resende, Mariangela/U-9938-2019; Angerami, Rodrigo Nogueira/A-8926-2013;
   Boin, Ilka/M-7184-2019; Esposito, Danillo L.A./N-9261-2017; Fonseca,
   Benedito/F-3252-2012
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; Esposito, Danillo
   L.A./0000-0002-2755-4471; Fonseca, Benedito/0000-0003-3159-5687;
   Addas-Carvalho, Marcelo/0000-0003-0178-6191; Pereira de Souza,
   Renato/0000-0003-1315-7085
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Healthcare Safety Network [NHSN], 2016, NHSN BIOV COMP HEM M
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   US Food and Drug Administration (FDA), 2016, FDA GUID REC DON SCR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 118
Z9 120
U1 0
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1684
EP 1688
DI 10.1111/trf.13681
PG 5
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100006
PM 27329551
DA 2020-12-08
ER

PT J
AU Tolardo, AL
   de Souza, WM
   Romeiro, MF
   Vieira, LC
   Luna, LKD
   Henriques, DA
   de Araujo, J
   Siqueira, CEH
   Colombo, TE
   Aquino, VH
   da Fonseca, BAL
   Bronzoni, RVD
   Nogueira, ML
   Durigon, EL
   Figueiredo, LTM
AF Tolardo, Aline Lavado
   de Souza, William Marciel
   Romeiro, Marilia Farignoli
   Vieira, Luiz Carlos
   de Souza Luna, Luciano Kleber
   Henriques, Dyana Alves
   de Araujo, Jansen
   Hassegawa Siqueira, Carlos Eduardo
   Colombo, Tatiana Elias
   Aquino, Victor Hugo
   Lopes da Fonseca, Benedito Antonio
   de Morais Bronzoni, Roberta Vieira
   Nogueira, Mauricio Lacerda
   Durigon, Edison Luiz
   Moraes Figueiredo, Luiz Tadeu
TI A real-time reverse transcriptase polymerase chain reaction for
   detection and quantification of Vesiculovirus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Vesiculovirus; quantitative real-time RT-PCR; diagnosis of vesicular
   stomatitis; zoonotic virus
ID VESICULAR-STOMATITIS-VIRUS; CHANDIPURA VIRUS; REACTION ASSAY; PCR ASSAY;
   BRAZIL; ANTIBODIES; MULTIPLEX; TRANSMISSION; DIAGNOSIS; SEROTYPE
AB Vesiculoviruses (VSV) are zoonotic viruses that cause vesicular stomatitis disease in cattle, horses and pigs, as well as sporadic human cases of acute febrile illness. Therefore, diagnosis of VSV infections by reliable laboratory techniques is important to allow a proper case management and implementation of strategies for the containment of virus spread. We show here a sensitive and reproducible real-time reverse transcriptase polymerase chain reaction (RT-PCR) for detection and quantification of VSV. The assay was evaluated with arthropods and serum samples obtained from horses, cattle and patients with acute febrile disease. The real-time RT-PCR amplified the Piry, Carajas, Alagoas and Indiana Vesiculovirus at a melting temperature 81.02 +/- 0.8 degrees C, and the sensitivity of assay was estimated in 10 RNA copies/mL to the Piry Vesiculovirus. The viral genome has been detected in samples of horses and cattle, but not detected in human sera or arthropods. Thus, this assay allows a preliminary differential diagnosis of VSV infections.
C1 [Tolardo, Aline Lavado; de Souza, William Marciel; Romeiro, Marilia Farignoli; Vieira, Luiz Carlos; de Souza Luna, Luciano Kleber; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, SP, Brazil.
   [Henriques, Dyana Alves; de Araujo, Jansen; Durigon, Edison Luiz] Univ Sao Paulo, Inst Ciencias Biomed, Lab Virol Clin & Mol, Sao Paulo, SP, Brazil.
   [Hassegawa Siqueira, Carlos Eduardo; de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso, Inst Ciencias Saude, Ctr Univ Sinop, Sinop, MT, Brazil.
   [Colombo, Tatiana Elias; Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto, Lab Pesquisa Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Aquino, Victor Hugo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Lab Virol, Ribeirao Preto, SP, Brazil.
RP Tolardo, AL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, SP, Brazil.
EM alinetolardo@hotmail.com
RI Aquino, Victor Hugo/C-1922-2012; Nogueira, Mauricio L/B-7599-2012; de
   Souza, William Marciel/D-3044-2017; de Souza Luna, Luciano
   Kleber/AAG-6418-2019; de Souza Luna, Luciano Kleber/L-1213-2013;
   Fonseca, Benedito/F-3252-2012
OI Aquino, Victor Hugo/0000-0003-1910-0776; Nogueira, Mauricio
   L/0000-0003-1102-2419; de Souza, William Marciel/0000-0002-0025-8293; de
   Souza Luna, Luciano Kleber/0000-0002-3552-5507; de Souza Luna, Luciano
   Kleber/0000-0002-3552-5507; Araujo, Jansen/0000-0002-7250-3024; Fonseca,
   Benedito/0000-0003-3159-5687
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [13/14929-1, 13/02256-2, 12/02836-6, 12/24150-9, 14/15079-4]; CNPq 1B
   senior fellowship [301677/2013-1]
FX FAPESP (grant no 13/14929-1 and scholarships 13/02256-2, 12/02836-6,
   12/24150-9, 14/15079-4).; LTMF is recipient of a CNPq 1B senior
   fellowship (301677/2013-1).
CR AFSHAR A, 1993, J VET DIAGN INVEST, V5, P26, DOI 10.1177/104063879300500107
   Bonutti DW, 2005, MEM I OSWALDO CRUZ, V100, P193, DOI 10.1590/S0074-02762005000200014
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Cargnelutti JF, 2014, J VET DIAGN INVEST, V26, P788, DOI 10.1177/1040638714553428
   DAROSA APAT, 1984, AM J TROP MED HYG, V33, P999, DOI 10.4269/ajtmh.1984.33.999
   Fernandez J, 2008, J VIROL METHODS, V147, P301, DOI 10.1016/j.jviromet.2007.09.010
   FIGUEIREDO LTM, 1985, REV I MED TROP, V27, P157, DOI 10.1590/S0036-46651985000300008
   Figueiredo LTM, 2011, MOL DETECTION HUMAN, P419
   Hole K, 2006, J VET DIAGN INVEST, V18, P139, DOI 10.1177/104063870601800201
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kumar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-168
   Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003
   Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x
   Mead DG, 2000, SCIENCE, V287, P485, DOI 10.1126/science.287.5452.485
   Menghani S, 2012, ACTA TROP, V124, P1, DOI 10.1016/j.actatropica.2012.06.001
   Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004
   Pauszek SJ, 2011, ARCH VIROL, V156, P1961, DOI 10.1007/s00705-011-1081-1
   Pinheiro F P, 1974, Bull Pan Am Health Organ, V8, P111
   Rajasekharan S, 2014, ACTA TROP, V135, P122, DOI 10.1016/j.actatropica.2014.03.028
   Rodriguez LL, 2002, VIRUS RES, V85, P211, DOI 10.1016/S0168-1702(02)00026-6
   RODRIGUEZ LL, 1993, J CLIN MICROBIOL, V31, P2016, DOI 10.1128/JCM.31.8.2016-2020.1993
   Schmitt B, 2002, VET CLIN N AM-FOOD A, V18, P453, DOI 10.1016/S0749-0720(02)00031-2
   Smith PF, 2009, J MED ENTOMOL, V46, P1537, DOI 10.1603/033.046.0643
   TAVARESNETO J, 1990, REV I MED TROP, V32, P211, DOI 10.1590/S0036-46651990000300011
   TESH R, 1977, AM J TROP MED HYG, V26, P299, DOI 10.4269/ajtmh.1977.26.299
   Wilson WC, 2009, J VET DIAGN INVEST, V21, P179, DOI 10.1177/104063870902100201
NR 26
TC 3
Z9 4
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2016
VL 111
IS 6
BP 385
EP 390
DI 10.1590/0074-02760150456
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ0LC
UT WOS:000378889800005
PM 27276185
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Dotrario, AB
   Menon, LJB
   Bollela, VR
   Martinez, R
   Araujo, DCDE
   da Fonseca, BAL
   Santana, RD
AF Dotrario, Andrea Beltrami
   Bazzo Menon, Lucas Jose
   Bollela, Valdes Roberto
   Martinez, Roberto
   de Almeida e Araujo, Daniel Cardoso
   Lopes da Fonseca, Benedito Antonio
   Santana, Rodrigo de C.
TI Malaria and other febrile diseases among travellers: the experience of a
   reference centre located outside the Brazilian Amazon Region
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Diagnosis; Acute febrile illness; Brazilian Amazon; Plasmodium
   falciparum; Plasmodium vivax
ID IMPORTED MALARIA; RETURNING TRAVELERS; CLINICAL CHARACTERISTICS; FEVER;
   DIAGNOSIS; PREDICTORS; ADULTS; DENGUE; AREA
AB Background: Malaria is endemic in countries located in tropical and sub-tropical regions. The increasing flow of domestic and international travellers has made malaria a relevant health problem even in non-endemic regions. Malaria has been described as the main diagnosis among travellers presenting febrile diseases after returning from tropical countries. In Brazil, malaria transmission occurs mainly in the Amazon region. Outside this area, malaria transmission is of low magnitude.
   Methods: This cross-sectional study aimed to describe the experience in the diagnosis of malaria in a reference centre located outside the Brazilian Amazon Region, emphasizing the differences in clinical and laboratory markers between cases of malaria and those of other febrile diseases (OFD). Medical charts from adult patients (>= 18 years) who underwent a thick smear test (TST) for malaria, between January 2001 and December 2014, were retrospectively reviewed.
   Results: A total of 458 cases referred to perform the TST were included. Malaria was diagnosed in 193 (42 %) episodes. The remaining 265 episodes (58 %) were grouped as OFD. The majority of malaria episodes were acquired in the Brazilian Amazon Region. The median time between the onset of symptoms and the TST was 7 days. Only 53 (11.5 %) episodes were tested within the first 48 h after symptom onset. Comparing malaria with OFD, jaundice, nausea, vomiting, and reports of fever were more prevalent in the malaria group. Low platelet count and elevated bilirubin levels were also related to the diagnosis of malaria.
   Conclusions: The results indicate that outside the endemic area travellers presenting febrile disease suspected of being malaria underwent diagnostic test after considerable delay. The reporting of fever combined with a recent visit to an endemic area should promptly evoke the hypothesis of malaria. In these cases, specific diagnostic tests for malaria should be a priority. For cases that jump this step, the presence of elevated bilirubin or thrombocytopaenia should also indicate a diagnosis of malaria.
C1 [Dotrario, Andrea Beltrami; Bazzo Menon, Lucas Jose; Bollela, Valdes Roberto; Martinez, Roberto; Lopes da Fonseca, Benedito Antonio; Santana, Rodrigo de C.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Sao Paulo, Brazil.
   [de Almeida e Araujo, Daniel Cardoso] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, BR-14049900 Sao Paulo, Brazil.
RP Santana, RD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Sao Paulo, Brazil.
EM santanacrod@fmrp.usp.br
RI de C Santana, Rodrigo/C-4429-2014; Fonseca, Benedito/F-3252-2012
OI de C Santana, Rodrigo/0000-0002-5887-8663; Fonseca,
   Benedito/0000-0003-3159-5687; Doltrario, Andrea/0000-0002-2624-7963
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/05337-6]
FX This work was supported by the Grant # 2014/05337-6, Sao Paulo Research
   Foundation (FAPESP).
CR Alfandari Serge, 1996, Clin Microbiol Infect, V2, P86, DOI 10.1111/j.1469-0691.1996.tb00211.x
   Ansart S, 2010, J TRAVEL MED, V17, P124, DOI 10.1111/j.1708-8305.2009.00382.x
   Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003
   Antinori S, 2004, J TRAVEL MED, V11, P135, DOI 10.2310/7060.2004.18557
   Antinori S, 2011, J TRAVEL MED, V18, P379, DOI 10.1111/j.1708-8305.2011.00554.x
   Bottieau E, 2007, MEDICINE, V86, P18, DOI 10.1097/MD.0b013e3180305c48
   Centers for Disease Control and Prevention, MAL BRAZ GOIAS RIO J
   Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116
   Cooper EC, 2014, J TRAVEL MED, V21, P235, DOI 10.1111/jtm.12122
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Cullen KA, 2013, MMWR SURVEILL SUMM, V62, P1
   D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481
   da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051
   Dorsey G, 2000, ARCH INTERN MED, V160, P2505, DOI 10.1001/archinte.160.16.2505
   Dos-Santos JCK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-280
   He DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055220
   Kutsuna S, 2015, J INFECT CHEMOTHER, V21, P272, DOI 10.1016/j.jiac.2014.12.004
   Martins AC, 2015, PEERJ, V3, DOI 10.7717/peerj.1325
   Mascarello M, 2008, J TRAVEL MED, V15, P229, DOI 10.1111/j.1708-8305.2008.00204.x
   Ministerio da Saude, 2015, B EP, V46
   Ministerio da Saude, 2000, B EP
   Ministerio da Saude, 2013, MAP RISC MAL MUN INF
   Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012
   O'Brien D, 2001, CLIN INFECT DIS, V33, P603, DOI 10.1086/322602
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Sanchez JL, 2000, J TRAVEL MED, V7, P275, DOI 10.2310/7060.2000.00077
   Taylor SM, 2010, JAMA-J AM MED ASSOC, V304, P2048, DOI 10.1001/jama.2010.1578
   Thierfelder C, 2008, J TRAVEL MED, V15, P432, DOI 10.1111/j.1708-8305.2008.00251.x
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2012, MAN SEV MAL PRACT HD
   Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173
NR 32
TC 0
Z9 0
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAY 26
PY 2016
VL 15
AR 294
DI 10.1186/s12936-016-1347-x
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DN6JG
UT WOS:000377179500004
PM 27230739
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Machado, PRL
   Farias, KJS
   Pereira, MGM
   de Freitas, PPD
   da Fonseca, BAL
AF Lima Machado, Paula Renata
   Silva Farias, Kleber Juvenal
   Martins Pereira, Maira Gabriela
   da Silva de Freitas, Patricia Pereira
   Lopes da Fonseca, Benedito Antonio
TI Human herpesvirus 8 (HHV-8) detected by nested polymerase chain reaction
   (PCR) in HIV patients with or without Kaposi's sarcoma. An analytic
   cross-sectional study
SO SAO PAULO MEDICAL JOURNAL
LA English
DT Article
DE Sarcoma, Kaposi; Herpesvirus 8, human; HIV; Polymerase chain reaction;
   Serology
ID BLOOD-DONORS; DNA-SEQUENCES; SAO-PAULO; LYTIC ANTIGENS; VIRAL LOAD;
   HERPESVIRUS; BRAZIL; SEROPREVALENCE; INFECTION; ANTIBODIES
AB CONTEXT AND OBJECTIVE: Kaposi's sarcoma (KS) is a common neoplastic disease in AIDS patients. The aim of this study was to evaluate the frequency of human herpesvirus 8 (HHV-8) infection in human immunodeficiency virus (HIV)-infected patients, with or without KS manifestations and correlate HHV-8 detection with KS staging.
   DESIGN AND SETTING: Analytic cross-sectional study conducted in a public tertiary-level university hospital in Ribeirao Preto, Sao Paulo, Brazil.
   METHODS: Antibodies against HHV-8 lytic-phase antigens were detected by means of the immunofluorescence assay. HHV-8 DNA was detected in the patient samples through a nested polymerase chain reaction (nested PCR) that amplified a region of open reading frame (ORF)-26 of HHV-8.
   RESULTS: Anti-HHV-8 antibodies were detected in 30% of non-KS patients and 100% of patients with KS. Furthermore, the HHV-8 DNA detection rates observed in HIV-positive patients with KS were 42.8% in serum, 95.4% in blood samples and 100% in skin biopsies; and in patients without KS, the detection rate was 4% in serum. Out of the 16 serum samples from patients with KS-AIDS who were classified as stage II, two were positive (12.5%); and out of the 33 samples from patients in stage IV, 19 (57.6%) were positive.
   CONCLUSION: We observed an association between HHV-8 detection and disease staging, which was higher in the serum of patients in stage IV. This suggests that detection of HHV-8 DNA in serum could be very useful for clinical assessment of patients with KS and for monitoring disease progression.
C1 [Lima Machado, Paula Renata; Silva Farias, Kleber Juvenal; Martins Pereira, Maira Gabriela; da Silva de Freitas, Patricia Pereira; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, FMRP, Virol Res Ctr, Sao Paulo, Brazil.
RP Machado, PRL (corresponding author), Univ Sao Paulo, FMRP, Virol Res Ctr, Sao Paulo, Brazil.; Machado, PRL (corresponding author), Av Bandeirantes 3-900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM paulamachado@usp.br
RI FARIAS, KLEBER/AAC-9815-2019; Fonseca, Benedito/F-3252-2012
OI Machado, Paula/0000-0002-3085-9778; Fonseca,
   Benedito/0000-0003-3159-5687
FU Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)National Council
   for Scientific and Technological Development (CNPq) [130622/04-4]
FX Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) (130622/04-4)
CR Ablashi DV, 2002, CLIN MICROBIOL REV, V15, P439, DOI 10.1128/CMR.15.3.439-464.2002
   AYRES M, 2007, BIOESTAT APLICACOES
   Batista MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005613
   Caterino-De-Araujo A, 1999, J INFECT DIS, V179, P1591, DOI 10.1086/314789
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Cunha AMG, 2005, J GEN VIROL, V86, P2433, DOI 10.1099/vir.0.81087-0
   Deback C, 2008, J VIROL METHODS, V149, P285, DOI 10.1016/j.jviromet.2008.01.026
   Duprez R, 2005, J CLIN MICROBIOL, V43, P4840, DOI 10.1128/JCM.43.9.4840-4843.2005
   Enbom M, 2000, J MED VIROL, V62, P498, DOI 10.1002/1096-9071(200012)62:4&lt;498::AID-JMV15&gt;3.0.CO;2-B
   FERRE F, 1989, CANCER CEL, V7, P215
   Ferreira S, 2003, TRANSFUSION, V43, P1764, DOI 10.1111/j.0041-1132.2003.00602.x
   FREITAS Ronaldo B., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P309, DOI 10.1590/S0036-46652002000600003
   Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403
   Ishak MDG, 2007, J MED VIROL, V79, P1537, DOI 10.1002/jmv.20995
   Hengge UR, 2002, LANCET INFECT DIS, V2, P281, DOI 10.1016/S1473-3099(02)00263-3
   Katano H, 2000, J VIROL, V74, P3478, DOI 10.1128/JVI.74.8.3478-3485.2000
   Kouri V, 2005, VIROLOGY, V337, P297, DOI 10.1016/j.virol.2005.04.033
   Leão Jair Carneiro, 2002, Rev. Hosp. Clin., V57, P175, DOI 10.1590/S0041-87812002000400008
   Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004
   LEMLICH G, 1987, J AM ACAD DERMATOL, V16, P319, DOI 10.1016/S0190-9622(87)70043-7
   Magri MC, 2009, J MED VIROL, V81, P1292, DOI 10.1002/jmv.21513
   MITSUYASU RT, 1984, SEMIN ONCOL, V11, P53
   Nascimento MC, 2008, J MED VIROL, V80, P1202, DOI 10.1002/jmv.21188
   Perez C, 2004, J MED VIROL, V72, P661, DOI 10.1002/jmv.20029
   Pierrotti LC, 2005, SEX TRANSM DIS, V32, P57, DOI 10.1097/01.olq.0000148300.33428.6e
   Polstra AM, 2003, J CLIN MICROBIOL, V41, P5488, DOI 10.1128/JCM.41.12.5488-5491.2003
   Rabkin CS, 1998, J INFECT DIS, V178, P304, DOI 10.1086/515649
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Souza VAUF, 2004, BRAZ J MED BIOL RES, V37, P123, DOI 10.1590/S0100-879X2004000100017
   Tedeschi R, 2002, EUR J CLIN MICROBIOL, V21, P831, DOI 10.1007/s10096-002-0836-8
   Tedeschi R, 2001, J CLIN MICROBIOL, V39, P4269, DOI 10.1128/JCM.39.12.4269-4273.2001
   Zago A, 2000, SEX TRANSM DIS, V27, P468, DOI 10.1097/00007435-200009000-00009
NR 33
TC 8
Z9 8
U1 0
U2 2
PU ASSOCIACAO PAULISTA MEDICINA
PI SAO PAULO
PA AV BRIG LUIS ANTONIO, 278-7 ANDAR, SAO PAULO, CEP01318-901, BRAZIL
SN 1516-3180
J9 SAO PAULO MED J
JI Sao Paulo Med. J.
PD MAY-JUN
PY 2016
VL 134
IS 3
BP 187
EP 192
DI 10.1590/1516-3180.2014.8973010
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS1IR
UT WOS:000380349600002
PM 25885486
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Cunha, MS
   Esposito, DLA
   Rocco, IM
   Maeda, AY
   Vasami, FGS
   Nogueira, JS
   de Souza, RP
   Suzuki, A
   Addas-Carvalho, M
   Barjas-Castro, MD
   Resende, MR
   Stucchi, RSB
   Boin, IDSF
   Katz, G
   Angerami, RN
   da Fonseca, BAL
AF Cunha, Mariana Sequetin
   Alves Esposito, Danillo Lucas
   Rocco, Iray Maria
   Maeda, Adriana Yurika
   Silva Vasami, Fernanda Gisele
   Nogueira, Juliana Silva
   de Souza, Renato Pereira
   Suzuki, Akemi
   Addas-Carvalho, Marcelo
   Barjas-Castro, Maria de Lourdes
   Resende, Mariangela Ribeiro
   Bello Stucchi, Raquel Silveira
   Santana Ferreira Boin, Ilka de Fatima
   Katz, Gizelda
   Angerami, Rodrigo Nogueira
   Lopes da Fonseca, Benedito Antonio
TI First Complete Genome Sequence of Zika Virus (Flaviviridae, Flavivirus)
   from an Autochthonous Transmission in Brazil
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We report here the genome sequence of Zika virus, strain ZikaSPH2015, containing all structural and nonstructural proteins flanked by the 5' and 3' untranslated region. It was isolated in Sao Paulo state, Brazil, in 2015, from a patient who received a blood transfusion from an asymptomatic donor at the time of donation.
C1 [Cunha, Mariana Sequetin; Rocco, Iray Maria; Maeda, Adriana Yurika; Silva Vasami, Fernanda Gisele; Nogueira, Juliana Silva; de Souza, Renato Pereira; Suzuki, Akemi] Adolfo Lutz Inst, Div Vector Borne Dis, Sao Paulo, Brazil.
   [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Div Infect Dis, Dept Internal Med, Ribeirao Preto, SP, Brazil.
   [Addas-Carvalho, Marcelo; Barjas-Castro, Maria de Lourdes; Angerami, Rodrigo Nogueira] State Univ Campinas UNICAMP, Blood Ctr, Campinas, SP, Brazil.
   [Resende, Mariangela Ribeiro] State Univ Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Bello Stucchi, Raquel Silveira; Santana Ferreira Boin, Ilka de Fatima] State Univ Campinas UNICAMP, Fac Med Sci, Clin Med Dept, Campinas, SP, Brazil.
   [Katz, Gizelda] Prof Alexandre Vranjac CCD, Sao Paulo, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Div Infect Dis, Dept Internal Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Resende, Mariangela/U-9938-2019; Angerami, Rodrigo Nogueira/A-8926-2013;
   Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; Esposito, Danillo
   L.A./0000-0002-2755-4471; Addas-Carvalho, Marcelo/0000-0003-0178-6191;
   Fonseca, Benedito/0000-0003-3159-5687
FU Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das
   Clinicas da Faculdade de Medicina de Ribeirao Preto (FAEPA)
FX This work, including the efforts of Benedito Antonio Lopes da Fonseca,
   was funded by Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do
   Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
   (FAEPA).
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
NR 8
TC 59
Z9 59
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAR-APR
PY 2016
VL 4
IS 2
AR e00032-16
DI 10.1128/genomeA.00032-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DP
UT WOS:000460655700006
PM 26941134
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Abrao, EP
   da Fonseca, BAL
AF Abrao, Emiliana Pereira
   Lopes da Fonseca, Benedito Antonio
TI Infection of Mosquito Cells (C6/36) by Dengue-2 Virus Interferes with
   Subsequent Infection by Yellow Fever Virus
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE C6/36 cells; dengue virus; viral interference; yellow fever virus
ID SUPERINFECTION EXCLUSION; IDENTIFICATION; CHIKUNGUNYA
AB Dengue is one of the most important diseases caused by arboviruses in the world. Yellow fever is another arthropod-borne disease of great importance to public health that is endemic to tropical regions of Africa and the Americas. Both yellow fever and dengue viruses are flaviviruses transmitted by Aedes aegypti mosquitoes, and then, it is reasonable to consider that in a given moment, mosquito cells could be coinfected by both viruses. Therefore, we decided to evaluate if sequential infections of dengue and yellow fever viruses (and vice-versa) in mosquito cells could affect the virus replication patterns. Using immunofluorescence and real-time PCR-based replication assays in Aedes albopictus C6/36 cells with single or sequential infections with both viruses, we demonstrated the occurrence of viral interference, also called superinfection exclusion, between these two viruses. Our results show that this interference pattern is particularly evident when cells were first infected with dengue virus and subsequently with yellow fever virus (YFV). Reduction in dengue virus replication, although to a lower extent, was also observed when C6/36 cells were initially infected with YFV followed by dengue virus infection. Although the importance that these findings have on nature is unknown, this study provides evidence, at the cellular level, of the occurrence of replication interference between dengue and yellow fever viruses and raises the question if superinfection exclusion could be a possible explanation, at least partially, for the reported lack of urban yellow fever occurrence in regions where a high level of dengue transmission occurs.
C1 [Abrao, Emiliana Pereira; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Clin Med, Av Bandeirantes 3900, BR-14040140 Ribeirao Preto, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Clin Med, Av Bandeirantes 3900, BR-14040140 Ribeirao Preto, Brazil.
EM baldfons@fmrp.usp.br
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2003/07959-0]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES;
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX The authors thank Dr. Pedro Vasconcellos (Evandro Chagas Institute) and
   Dr. Robert E. Shope for kindly donating the YFV-BeH111 wild strain and
   YFV-17D, respectively. This study was supported by the Sao Paulo State
   Research Foundation (FAPESP; grant no. 2003/07959-0), Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). E.P.A. held a
   fellowship from CAPES and BALF and a Research Fellowship from CNPq.
CR Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019
   EATON BT, 1979, J VIROL, V30, P45, DOI 10.1128/JVI.30.1.45-55.1979
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Izurieta RO, 2009, J GLOB INFECT DIS, V1, P111, DOI 10.4103/0974-777X.56257
   JOHNSTON RE, 1974, J VIROL, V14, P1076, DOI 10.1128/JVI.14.5.1076-1082.1974
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 1997, FACTORS IN THE EMERGENCE OF ARBOVIRUS DISEASES, P143
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388
   Prata A, 2000, MEM I OSWALDO CRUZ, V95, P183, DOI 10.1590/S0074-02762000000700031
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Xiao SY, 2003, AM J TROP MED HYG, V68, P695, DOI 10.4269/ajtmh.2003.68.695
NR 25
TC 13
Z9 13
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD FEB
PY 2016
VL 16
IS 2
BP 124
EP 130
DI 10.1089/vbz.2015.1804
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DK9QQ
UT WOS:000375266700009
PM 26808727
DA 2020-12-08
ER

PT J
AU Lauretti, F
   Chattopadhyay, A
   Franca, RFD
   Castro-Jorge, L
   Rose, J
   da Fonseca, BAL
AF Lauretti, Flavio
   Chattopadhyay, Anasuya
   de Oliveira Franca, Rafael Freitas
   Castro-Jorge, Luiza
   Rose, John
   da Fonseca, Benedito A. L.
TI Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate
   induces humoral response and protects mice against lethal infection
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE dengue 2; dengue vaccine candidate; mouse challenge; neutralizing
   antibodies; recombinant vesicular stomatitis virus
ID ANTIBODIES; IMMUNOGENICITY; NEUTRALIZATION; PROGRESS; BROAD
AB Dengue is the most important arbovirus disease throughout the world and it is responsible for more than 500,000 dengue hemorrhagic cases and 22,000 deaths every year. One vaccine was recently licensed for human use in Brazil, Mexico and Philippines and although at least seven candidates have been in clinical trials the results of the most developed CYD vaccine have demonstrated immunization problems, such as uneven protection and interference between serotypes. We constructed a vaccine candidate based on vesicular stomatitis virus (VSV) expression of pre-membrane (prM) and envelope (E) proteins of dengue-2 virus (DENV-2) and tested it in mice to evaluate immunogenicity and protection against DENV-2 infection. VSV has been successfully used as vaccine vectors for several viruses to induce strong humoral and cellular immune responses. The VSV-DENV-2 recombinant was constructed by inserting the DENV-2 structural proteins into a VSV plasmid DNA for recombinant VSV-DENV-2 recovery. Infectious recombinant VSV viruses were plaque purified and prM and E expression were confirmed by immunofluorescence and radiolabeling of proteins of infected cells. Forty Balb/C mice were inoculated through subcutaneous (s.c.) route with VSV-DENV-2 vaccine in a two doses schedule 15d apart and 29d after first inoculation, sera were collected and the mice were challenged with 50 lethal doses (LD50) of a neurovirulent DENV-2. The VSV-DENV-2 induced anti-DENV-2 antibodies and protected animals in the challenge experiment comparable to DENV-2 immunization control group. We conclude that VSV is a promising platform to test as a DENV vaccine and perhaps against others Flaviviridae.
C1 [Lauretti, Flavio; de Oliveira Franca, Rafael Freitas; Castro-Jorge, Luiza; da Fonseca, Benedito A. L.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, SP, Brazil.
   [Chattopadhyay, Anasuya; Rose, John] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
RP da Fonseca, BAL (corresponding author), Fac Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI de Castro Jorge, Luiza Antunes/D-3773-2009; Fonseca,
   Benedito/F-3252-2012
OI Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Fonseca,
   Benedito/0000-0003-3159-5687
FU National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [307703/2014-2]; U.S. National Institute of Allergy and
   Infectious Disease (NIAID/NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U54AI057158]; Coordination for
   the Improvement of Higher Education Personnel (CAPES)CAPES [PNPD
   07171532828]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U54AI057158, U54AI057158] Funding Source: NIH RePORTER
FX This work was supported in part by National Counsel of Technological and
   Scientific Development (CNPq), grant 307703/2014-2 and U.S. National
   Institute of Allergy and Infectious Disease (NIAID/NIH), grant
   U54AI057158. Flavio Lauretti was supported by Posdoctoral fellowship of
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   grant PNPD 07171532828. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barban V, 2012, VIROLOGY, V429, P91, DOI 10.1016/j.virol.2012.03.007
   Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Chattopadhyay A, 2013, J VIROL, V87, P395, DOI 10.1128/JVI.01860-12
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148
   Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225
   Guzman E, 2015, LANCET, V385, P453
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079
   Hernandez-Avila M, 2016, SALUD PUBLICA MEXICO, V58, P71, DOI 10.21149/spm.v58i1.7670
   Innis BL, 2003, AM J TROP MED HYG, V69, P1
   LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Norrby R, 2014, CLIN MICROBIOL INFEC, V20, P92, DOI 10.1111/1469-0691.12442
   Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176
   Reuter JD, 2002, J VIROL, V76, P8900, DOI 10.1128/JVI.76.17.8900-8909.2002
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640
   Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359
   Schwartz JA, 2011, J VIROL, V85, P4602, DOI 10.1128/JVI.02491-10
   STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995
   Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Wan SW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-37
   WHO media centre, 2015, DENG SEV DENG, V117
   World Health Organization, 2013, WEEKLY EPIDEMIOLOGIC, V20, P205
NR 31
TC 5
Z9 5
U1 0
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2016
VL 12
IS 9
BP 2327
EP 2333
DI 10.1080/21645515.2016.1183857
PG 7
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA DX2RA
UT WOS:000384217200028
PM 27185081
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Esposito, DLA
   Bollela, VR
   Feitosa, ALP
   da Fonseca, BAL
AF Alves Esposito, Danillo Lucas
   Bollela, Valdes Roberto
   Pereira Feitosa, Ana Luisa
   Lopes da Fonseca, Benedito Antonio
TI Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal
   Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative
   Pleural Effusions
SO LUNG
LA English
DT Article
DE Cytokine biology; Pleural disease; Tuberculosis; mRNA expression
ID REGULATORY T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS;
   DIFFERENTIATION; DIAGNOSIS; RESPONSES; MILIARY; DISEASE; GROWTH; CANCER
AB Introduction Tuberculosis (TB) and malignant diseases are the most common causes of lymphocytic pleural effusion in adults. Serum and pleural fluid cytokine levels have been analyzed to help in the differential diagnosis, but with limited results.
   Purpose This study investigates transcription levels of selected cytokine genes in pleural effusion of patients under investigation for TB.
   Methods This was a prospective study that included adult patients under investigation for pleural effusion in Brazil. The expression of 19 cytokine genes was analyzed by RT-qPCR.
   Results The majority of cytokine-related genes expressed in pleural fluid of TB patients were similar in non-TB patients, except for RORA and RORC genes, which showed a statistically higher level in TB. All cytokines in the Th17 pattern were induced in TB patients' pleural fluid. Patients with malignant pleural effusion expressed higher levels of IFN-alpha 1, IFN-beta 1, TNF-alpha, IL-4 and IL-6, and suppression of TGF beta-1.
   Conclusion There is still a lot to understand about the cytokine roles in the pro- and anti-inflammatory environment of exudative pleural effusions. The data presented here showed an increased expression of Th17 pattern cytokines genes in TB patients that could be used as markers to differentiate tuberculous pleuritis from other common causes of exudative pleural effusion.
C1 [Alves Esposito, Danillo Lucas; Bollela, Valdes Roberto; Pereira Feitosa, Ana Luisa] Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, Div Infect Dis, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, Ave Bandeirantes,3900 Bairro Monte Alegre, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2009/17305-3]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03505-0]
FX We would like to acknowledge Drs. Marcos de Carvalho Borges, Marcelo
   Bezerra de Menezes, and Flavia Alvarez for their help in assigning
   patients to our study. This study was supported by a grant from the Sao
   Paulo Research Foundation (FAPESP; Grant# 2009/17305-3). ALPF received a
   scholarship from FAPESP (Grant# 2011/03505-0).
CR Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062
   Babu S, 2010, J INFECT DIS, V201, P20, DOI 10.1086/648735
   Bollela VR, 1999, BRAZ J MED BIOL RES, V32, P1073, DOI 10.1590/S0100-879X1999000900003
   de Oliveira LRC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088572
   Chen YM, 2001, LUNG CANCER-J IASLC, V31, P25, DOI 10.1016/S0169-5002(00)00165-3
   Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063
   Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC
   Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC
   Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136
   Okamoto M, 2007, RESPIROLOGY, V12, P581, DOI 10.1111/j.1440-1843.2007.01059.x
   Porcel JM, 2006, AM FAM PHYSICIAN, V73, P1211
   Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277
   Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005
   SAHN SA, 1988, AM REV RESPIR DIS, V138, P184, DOI 10.1164/ajrccm/138.1.184
   Sales RKB, 2009, RESPIROLOGY, V14, P1128, DOI 10.1111/j.1440-1843.2009.01621.x
   Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200
   Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC
   Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886
   Tong ZH, 2013, TUBERCULOSIS, V93, P279, DOI 10.1016/j.tube.2013.02.014
   van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002
   Wang TT, 2011, TUBERCULOSIS, V91, P231, DOI 10.1016/j.tube.2011.02.002
   Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11
   Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002
NR 25
TC 4
Z9 4
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2040
EI 1432-1750
J9 LUNG
JI Lung
PD DEC
PY 2015
VL 193
IS 6
BP 1001
EP 1007
DI 10.1007/s00408-015-9809-4
PG 7
WC Respiratory System
SC Respiratory System
GA CW8YA
UT WOS:000365284200017
PM 26407584
DA 2020-12-08
ER

PT J
AU Bisordi, I
   Levis, S
   Maeda, AY
   Suzuki, A
   Nagasse-Sugahara, TK
   de Souza, RP
   Pereira, LE
   Garcia, JB
   Cerroni, MD
   Silva, FDE
   dos Santos, CLS
   da Fonseca, BAL
AF Bisordi, Ivani
   Levis, Silvana
   Maeda, Adriana Y.
   Suzuki, Akemi
   Nagasse-Sugahara, Teresa K.
   de Souza, Renato P.
   Pereira, Luiz E.
   Garcia, Jorge B.
   Cerroni, Matheus de P.
   de A. e Silva, Franko
   dos Santos, Cecilia L. S.
   da Fonseca, Benedito A. L.
TI Pinhal Virus, a New Arenavirus Isolated from Calomys tener in Brazil
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Arenavirus; Calomys tener; Pinhal virus; Sabia virus
ID HEMORRHAGIC-FEVER; AMERICA; RODENTS
AB Arenavirus Sabia was originally isolated from a fatal human infection in Brazil, and after the occurrence of the second fatal human case in SAo Paulo state, epidemiologic and virologic studies were performed in the area where the patient lived, aiming at the identification of the Sabia natural rodent reservoir. A broadly cross-reactive enzyme-linked immunosorbent assay (ELISA) was used to screen for antibody-positive samples. Antibodies to arenavirus were detected in two of the 55 samples of Calomys tener, and from these results, samples of rodents were analyzed by a broad RT-PCR assay. RT-PCR amplification detected arenavirus sequences in five of the 55 C. tener samples, and sequencing showed that this virus is a distinct form of Sabia virus. Thus, we describe here the evidence for the circulation of a new arenavirus in Brazil (proposed name Pinhal virus) and its genetic characterization compared to other arenaviruses. This study also suggests C. tener as a probable rodent reservoir for this virus and associates this new virus with the lineage C of New World arenaviruses. Although we have defined some characteristics of this virus, so far, there is no evidence of its involvement in human disease.
C1 [Bisordi, Ivani; Maeda, Adriana Y.; Suzuki, Akemi; Nagasse-Sugahara, Teresa K.; de Souza, Renato P.; Pereira, Luiz E.; Cerroni, Matheus de P.; de A. e Silva, Franko; dos Santos, Cecilia L. S.] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Levis, Silvana; Garcia, Jorge B.] Inst Nacl Enfermedades Virales Humanas Dr Julio I, Pergamino, BA, Argentina.
   [da Fonseca, Benedito A. L.] Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Bisordi, Ivani; Levis, Silvana; Maeda, Adriana Y.; Suzuki, Akemi; Nagasse-Sugahara, Teresa K.; de Souza, Renato P.; Pereira, Luiz E.; Garcia, Jorge B.; Cerroni, Matheus de P.; de A. e Silva, Franko; dos Santos, Cecilia L. S.; da Fonseca, Benedito A. L.] Adolfo Lutz Inst, Sao Paulo State Hlth Secretary, Sao Paulo, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Ave Bandeirantes 3900, BR-14049 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687; Pereira de Souza,
   Renato/0000-0003-1315-7085
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [403023/2004-1]; Sao Paulo State Health Secretary
FX This study was partially supported by funds from CNPq/Proc.
   403023/2004-1 and Sao Paulo State Health Secretary.
CR Archer AM, 2002, VIROLOGY, V304, P274, DOI 10.1006/viro.2002.1695
   BARRY M, 1995, NEW ENGL J MED, V333, P294, DOI 10.1056/NEJM199508033330505
   Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248
   Buchen-Osmond C, 2006, ICTVDB UNIVERSAL VIR
   COIMBRA TLM, 1994, LANCET, V343, P391, DOI 10.1016/S0140-6736(94)91226-2
   Coimbra TLM, 2001, VIRUS REV RES, V6, P14
   DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Gonzalez JE, 2007, CURR TOP MICROBIOL, V315, P253
   Mills JN, 1995, METHODS TRAPPING SAM
   Morales MA, 2002, J VIROL METHODS, V103, P57, DOI 10.1016/S0166-0934(01)00452-9
   PINHEIRO FP, 1966, P SOC EXP BIOL MED, V122, P531, DOI 10.3181/00379727-122-31182
   PINHEIRO FP, 1977, MEDICINA-BUENOS AIRE, V37, P175
   Salazar-Bravo J, 2002, INFECT GENET EVOL, V1, P191, DOI 10.1016/S1567-1348(02)00026-6
   TESH RB, 1994, ANN NY ACAD SCI, V740, P129, DOI 10.1111/j.1749-6632.1994.tb19863.x
   Vasconcelos PFC, 1993, REV INST MED TROP SP, V36, P521
NR 18
TC 6
Z9 6
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD NOV 1
PY 2015
VL 15
IS 11
BP 694
EP 700
DI 10.1089/vbz.2014.1708
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CV8NL
UT WOS:000364544700009
PM 26501215
DA 2020-12-08
ER

PT J
AU Esposito, DLA
   da Fonseca, BAL
AF Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Complete Genome Sequence of Mayaro Virus (Togaviridae, Alphavirus)
   Strain BeAr 20290 from Brazil
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We report here the complete genome sequence of Mayaro virus strain BeAr 20290 isolated from Haemagogus mosquitoes in 1960. The sequence presented here includes all nonstructural and structural proteins and the 5'- and 3'-untranslated (UTR) regions.
C1 [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
FU Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das
   Clinicas da Faculdade de Medicina de Ribeirao Preto (FAEPA)
FX This study was supported by the Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia do Hospital das Clinicas da Faculdade de Medicina de
   Ribeirao Preto (FAEPA). The funder had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Pinheiro F, 1998, ARBOVIRUSES EPIDEMIO, V3, P137
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
NR 5
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD NOV-DEC
PY 2015
VL 3
IS 6
AR e01372-15
DI 10.1128/genomeA.01372-15
PG 1
WC Microbiology
SC Microbiology
GA VI1DN
UT WOS:000460645200102
PM 26679574
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Melo-Lima, BL
   Esposito, DLA
   da Fonseca, BAL
   Figueiredo, LTM
   Moreau, P
   Donadi, EA
AF Melo-Lima, Breno Luiz
   Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
   Moreau, Philippe
   Donadi, Eduardo Antonio
TI TRANSCRIPTIONAL ACTIVATION OF MURINE FUNCTIONAL HOMOLOGS OF HLA-G (Qa-2)
   AND HLA-E (Qa-1), AND REPRESSION OF AIRE AND FOXP3 MAY BE RELATED TO THE
   ONSET OF AUTOIMMUNITY AFTER IMMUNIZATION WITH YFV17D
SO TISSUE ANTIGENS
LA English
DT Meeting Abstract
C1 [Melo-Lima, Breno Luiz; Donadi, Eduardo Antonio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Med, Div Clin Immunol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Melo-Lima, Breno Luiz; Moreau, Philippe] Hop St Louis, Serv Rech Hemato Immunol, Inst Malad Emergentes & Therapies Innovantes, Commissariat Enrgie Atom & Energies Alternat, Paris, France.
   [Melo-Lima, Breno Luiz; Moreau, Philippe] Univ Paris Diderot, Sorbonne Paris Cite,Hop St Louis, UMR E5, Inst Univ Hematol, Paris, France.
   [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Ribeirao Preto Med Sch, Virol Res Ctr, BR-14049 Ribeirao Preto, SP, Brazil.
EM brenol@usp.br
RI Esposito, Danillo L.A./N-9261-2017; donadi, eduardo A/H-7080-2013
OI Esposito, Danillo L.A./0000-0002-2755-4471; donadi, eduardo
   A/0000-0002-9457-9601
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD AUG
PY 2015
VL 86
IS 2
BP 80
EP 80
PG 1
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA CN2NF
UT WOS:000358257700015
DA 2020-12-08
ER

PT J
AU Farias, KJS
   Machado, PRL
   Muniz, JAPC
   Imbeloni, AA
   da Fonseca, BAL
AF Silva Farias, Kleber Juvenal
   Lima Machado, Paula Renata
   Pereira Carneiro Muniz, Jose Augusto
   Imbeloni, Aline Amaral
   Lopes da Fonseca, Benedito Antonio
TI Antiviral Activity of Chloroquine Against Dengue Virus Type 2
   Replication in Aotus Monkeys
SO VIRAL IMMUNOLOGY
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; HUMAN DENDRITIC CELLS; DNA VACCINE;
   HETEROLOGOUS INFECTIONS; NANCYMAE MONKEYS; HIV PATIENTS; ACIDIC PH;
   TNF-ALPHA; FEVER; CYTOKINES
AB Dengue virus (DENV) of the Flaviviridae family is a single positive-stranded RNA virus that is transmitted by Aedes aegypti and Aedes albopictus mosquitoes. The objective of this study was to investigate the use of chloroquine (CLQ) as an antiviral drug against dengue virus in monkeys. To analyze the action of the drug in vivo, nonhuman primates groups (Aotus azarai infulatus) were inoculated with a subcutaneous injection of a virulent strain of DENV-2, treated and untreated CLQ. Blood hematological, viremia, and serum biochemical values were obtained from 16 DENV-2-inoculated, treated and untreated; four received only CLQ and one mock-infected Aotus monkeys. Monkey serum samples (day 0-10 post-inoculation) were assayed by reverse transcription polymerase chain reaction and Cytometric Bead Array for determination of viremia and inflammatory cytokines, respectively. Additionally, body temperature and activity levels were determined. In the present work, CLQ was effective on replication of DENV-2 in Aotus monkeys; a time viremia reduction was observed compared with the controls. The concentration of tumor necrosis factor alpha and interferon gamma in the serum of the animals had a statistically significant reduction in the groups treated with CLQ after infection compared with the controls. A significant decrease in systemic levels of the liver enzyme aspartate aminotransferase (AST) was also observed in the animals treated with CLQ after infection compared with the controls. These results suggest that CLQ interferes in DENV-2 replication in Aotus monkeys.
C1 [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Sao Paulo, Brazil.
   [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata] Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl Microbiol & Immunol, Sao Paulo, Brazil.
   [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, Sao Paulo, Brazil.
   [Pereira Carneiro Muniz, Jose Augusto; Imbeloni, Aline Amaral] Natl Primate Ctr CENP, Evandro Chagas Inst IEC Sect, Ananindeua, Para, Brazil.
RP Farias, KJS (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, SP, Brazil.
EM kfarias@usp.br
RI FARIAS, KLEBER/AAC-9815-2019; Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687; Machado,
   Paula/0000-0002-3085-9778
FU FAPESP (Sao Paulo Foundation for Research)Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [05/04450-4]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [06/55789-4]
FX This study was supported by FAPESP (Sao Paulo Foundation for Research;
   Grant no. 05/04450-4). K.J.S.F. was supported by a FAPESP fellowship
   (Grant no. 06/55789-4).
CR ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Blair PJ, 2006, VACCINE, V24, P1427, DOI 10.1016/j.vaccine.2005.09.032
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Burke D, 2001, FIELDS VIROLOGY, V4, P1043
   Chen XP, 2003, CHINESE MED J-PEKING, V116, P1016
   da Fonseca BAL, 2002, CURR OPIN PEDIATR, V14, P67
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   Heimlich HJ, 1997, MECH AGEING DEV, V93, P79, DOI 10.1016/S0047-6374(96)01813-1
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Joshi Shashank R, 2004, J Assoc Physicians India, V52, P597
   Karres I, 1998, AM J PHYSIOL-REG I, V274, pR1058
   Kochel TJ, 2000, VACCINE, V18, P3166, DOI 10.1016/S0264-410X(00)00105-5
   Kochel TJ, 2005, J INFECT DIS, V191, P1000, DOI 10.1086/427511
   Koraka P, 2007, MICROBES INFECT, V9, P940, DOI 10.1016/j.micinf.2007.03.012
   Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23
   Marianneau P, 1998, J INFECT DIS, V178, P1270, DOI 10.1086/314466
   Nishimura M, 1998, TRANSFUSION MED, V8, P209, DOI 10.1046/j.1365-3148.1998.00160.x
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019
   Raviprakash K, 2003, VIROLOGY, V315, P345, DOI 10.1016/S0042-6822(03)00542-7
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015
   Schiavetta AM, 2003, CONTEMP TOP LAB ANIM, V42, P12
   Soundravally R, 2014, INT J INFECT DIS, V18, P68, DOI 10.1016/j.ijid.2013.09.022
   Stiasny K, 2001, J VIROL, V75, P7392, DOI 10.1128/JVI.75.16.7392-7398.2001
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Valecha N, 2006, T R SOC TROP MED HYG, V424, P1
   Velzing J, 1999, VACCINE, V17, P1312, DOI 10.1016/S0264-410X(98)00393-4
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wozniacka A, 2006, LUPUS, V15, P268, DOI 10.1191/0961203306lu2299oa
   Zhou H, 2004, INT IMMUNOPHARMACOL, V4, P223, DOI 10.1016/j.intimp.2003.12.006
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 42
TC 39
Z9 42
U1 0
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD APR 1
PY 2015
VL 28
IS 3
BP 161
EP 169
DI 10.1089/vim.2014.0090
PG 9
WC Immunology; Virology
SC Immunology; Virology
GA CF1XG
UT WOS:000352340700005
PM 25664975
OA Green Published
DA 2020-12-08
ER

PT J
AU Abrao, EP
   Esposito, DLA
   Lauretti, F
   da Fonseca, BAL
AF Abrao, Emiliana Pereira
   Alves Esposito, Danillo Lucas
   Lauretti, Flavio
   Lopes da Fonseca, Benedito Antonio
TI Dengue vaccines: what we know, what has been done, but what does the
   future hold?
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Dengue Vaccines; Dengue, prevention & control; Scientific Research and
   Technological Development; Communicable Disease Control
ID ANTIBODY-RESPONSE; PROTECTIVE EFFICACY; HEMORRHAGIC-FEVER; DISEASE
   SEVERITY; HEALTHY-ADULTS; VIRUS-VACCINE; IMMUNOGENICITY; RECOMBINANT;
   SAFETY; NEUTRALIZATION
AB Dengue, a disease caused by any of the four serotypes of dengue viruses, is the most important arthropod-borne viral disease in the world in terms of both morbidity and mortality. The infection by these viruses induces a plethora of clinical manifestations ranging from asymptomatic infections to severe diseases with involvement of several organs. Severe forms of the disease are more frequent in secondary infections by distinct serotypes and, consequently, a dengue vaccine must be tetravalent. Although several approaches have been used on the vaccine development, no vaccine is available against these viruses, especially because of problems on the development of a tetravalent vaccine. Here, we describe briefly the vaccine candidates available and their ability to elicit a protective immune response. We also discuss the problems and possibilities of any of the vaccines in final development stage reaching the market for human use.
C1 [Abrao, Emiliana Pereira; Alves Esposito, Danillo Lucas; Lauretti, Flavio; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, FMRP, Dept Clin Med, Ave Bandeirantes 3900, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, FMRP, Dept Clin Med, Ave Bandeirantes 3900, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cassetti MC, 2014, VACCINE, V32, P3115, DOI 10.1016/j.vaccine.2014.04.017
   Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Fernandez ST, 2012, 61 ANN M AM SOC TROP
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Normile D, 2014, SCIENCE, V345, P367, DOI 10.1126/science.345.6195.367
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085
   Pugachev KV, 2005, CURR OPIN INFECT DIS, V18, P387, DOI 10.1097/01.qco.0000178823.28585.ad
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RUSSELL PK, 1972, AM J TROP MED HYG, V21, P97, DOI 10.4269/ajtmh.1972.21.97
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sun W, 2003, AM J TROP MED HYG, V69, P24
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Watanaveeradej V, 2014, AM J TROP MED HYG, V91, P119, DOI 10.4269/ajtmh.13-0452
   Watanaveeradej V, 2011, AM J TROP MED HYG, V85, P341, DOI 10.4269/ajtmh.2011.10-0501
   Wilder-Smith A, 2014, LANCET, V384, P1327, DOI 10.1016/S0140-6736(14)61142-9
NR 35
TC 4
Z9 4
U1 0
U2 5
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2015
VL 49
AR 60
DI 10.1590/S0034-8910.2015049006146
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DB2ZJ
UT WOS:000368378900062
PM 26398877
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Melo-Lima, BL
   Esposito, DLA
   da Fonseca, BAL
   Figueiredo, LTM
   Moreau, P
   Donadi, EA
AF Melo-Lima, Breno Luiz
   Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
   Moreau, Philippe
   Donadi, Eduardo Antonio
TI The Attenuated Live Yellow Fever Virus 17D Infects the Thymus and
   Induces Thymic Transcriptional Modifications of Immunomodulatory Genes
   in C57BL/6 and BALB/C Mice
SO AUTOIMMUNE DISEASES
LA English
DT Article
ID REGULATORY T-CELLS; CLASS-I MOLECULE; HLA-G; EPITHELIAL-CELLS;
   EXPRESSION; VACCINATION; IDENTIFICATION; MECHANISMS; SELECTION; IMMUNITY
AB Thymus is involved in induction of self-tolerance in T lymphocytes, particularly due to Aire activity. In peripheral tissues, Treg cells and immunomodulatory molecules, like the major histocompatibility complex (MHC) class Ib molecules, are essential for maintenance of autotolerance during immune responses. Viral infections can trigger autoimmunity and modify thymic function, and YFV17D immunization has been associated with the onset of autoimmunity, being contraindicated in patients with thymic disorders. Aiming to study the influence of YFV17D immunization on the transcriptional profiles of immunomodulatory genes in thymus, we evaluated the gene expression of AIRE, FOXP3, H2-Q7 (Qa-2/HLA-G), H2-T23 (Qa-1/HLA-E), H2-Q10, and H2-K1 following immunization with 10,000 LD50 of YFV17D in C57BL/6 and BALB/c mice. The YFV17D virus replicated in thymus and induced the expression of H2-Q7 (Qa-2/HLA-G) and H2-T23 (Qa-1/HLA-E) transcripts and repressed the expression of AIRE and FOXP3. Transcriptional expression varied according to tissue and mouse strain analyzed. Expression of H2-T23 (Qa-1/HLA-E) and FOXP3 was induced in thymus and liver of C57BL/6 mice, which exhibited defective control of viral load, suggesting a higher susceptibility to YFV17D infection. Since the immunization with YFV17D modulated thymus gene expression in genetically predisposed individuals, the vaccine may be related to the onset of autoimmunity disorders.
C1 [Melo-Lima, Breno Luiz; Donadi, Eduardo Antonio] Univ Sao Paulo, Div Clin Immunol, Dept Med, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Melo-Lima, Breno Luiz; Moreau, Philippe] Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, F-75475 Paris 10, France.
   [Melo-Lima, Breno Luiz; Moreau, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, UMR E5,Inst Univ Hematol, F-75475 Paris 10, France.
   [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Virol Res Ctr, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Melo-Lima, BL (corresponding author), Univ Sao Paulo, Div Clin Immunol, Dept Med, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM brenol@usp.br
RI Esposito, Danillo L.A./N-9261-2017; donadi, eduardo A/H-7080-2013;
   Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; donadi, eduardo
   A/0000-0002-9457-9601; Fonseca, Benedito/0000-0003-3159-5687; Moreau,
   Philippe/0000-0002-2868-7401
FU CAPES/COFECB [653/09]
FX The authors would like to thank Sandra Rodrigues, Flavia Tremmeschin,
   Soraya Badra, and Vinicius Reis for technical support during the study.
   This work was supported by grants from the binational collaborative
   CAPES/COFECB program (no. 653/09).
CR Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x
   [Anonymous], 2008, Wkly Epidemiol Rec, V83, P287
   Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Bethke N., 2011, THESIS
   Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0
   Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103
   Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005
   Carrio R, 2013, IMMUNOL RES, V57, P106, DOI 10.1007/s12026-013-8446-3
   Castro P, 2014, JAIDS-J ACQ IMM DEF, V66, P466, DOI 10.1097/QAI.0000000000000207
   Cavanaugh VJ, 2007, J GEN VIROL, V88, P1440, DOI 10.1099/vir.0.82444-0
   Chaves M, 2009, J NEUROVIROL, V15, P348, DOI 10.1080/13550280903062805
   Comiskey M, 2003, HUM IMMUNOL, V64, P999, DOI 10.1016/j.humimm.2003.08.352
   Cooke A, 2008, CLIN EXP RHEUMATOL, V26, pS1
   Crisa L, 1997, J EXP MED, V186, P289, DOI 10.1084/jem.186.2.289
   de la Fuente H, 2012, FEBS LETT, V586, P2897, DOI 10.1016/j.febslet.2012.07.032
   Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7
   Eidex RB, 2004, LANCET, V364, P936, DOI 10.1016/S0140-6736(04)17017-7
   Ely KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108385
   Finlay C, 1992, Salud Publica Mex, V34, P474
   Fodil-Cornu N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001368
   Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Ge Q, 1999, IMMUNOLOGY, V97, P665
   Ge Q, 2000, INT IMMUNOL, V12, P1127, DOI 10.1093/intimm/12.8.1127
   Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677
   Gout O, 2001, NEUROL SCI, V22, P151, DOI 10.1007/s100720170014
   Guerau-De-Arellano M, 2008, P NATL ACAD SCI USA, V105, P14011, DOI 10.1073/pnas.0806616105
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   He HQ, 2011, IMMUNOBIOLOGY, V216, P678, DOI 10.1016/j.imbio.2010.11.002
   Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874
   Holderried TAW, 2013, P NATL ACAD SCI USA, V110, P21089, DOI 10.1073/pnas.1320999110
   Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203
   Jiang H, 2008, HUM IMMUNOL, V69, P721, DOI 10.1016/j.humimm.2008.08.279
   KAISERLIAN D, 1984, CLIN IMMUNOL IMMUNOP, V32, P316, DOI 10.1016/0090-1229(84)90275-7
   KLEIN J, 1983, IMMUNOGENETICS, V17, P553, DOI 10.1007/BF00366126
   Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   LEW AM, 1986, J IMMUNOL, V136, P254
   Li C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003140
   Lu LR, 2006, IMMUNOL REV, V212, P51, DOI 10.1111/j.0105-2896.2006.00418.x
   Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50
   Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381
   Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209
   Martins MA, 2007, CLIN EXP IMMUNOL, V148, P90, DOI 10.1111/j.1365-2249.2006.03317.x
   Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532
   Melo-Lima BL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/159247
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817
   Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393
   Nobrega C, 2013, J IMMUNOL, V190, P1646, DOI 10.4049/jimmunol.1202412
   O'Callaghan CA, 1998, IMMUNOL REV, V163, P129, DOI 10.1111/j.1600-065X.1998.tb01192.x
   Oliveira ACV, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/473170
   Owen J. A., 2013, KUBY IMMUNOLOGY
   Palmer DR, 2007, J GEN VIROL, V88, P148, DOI 10.1099/vir.0.82272-0
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ramsdell F, 2003, CURR OPIN IMMUNOL, V15, P718, DOI 10.1016/j.coi.2003.09.008
   Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   ROBINSON PJ, 1989, NATURE, V342, P85, DOI 10.1038/342085a0
   Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152
   Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062
   Schmoeller D, 2009, PEDIATR INFECT DIS J, V28, P1037, DOI 10.1097/INF.0b013e3181bbc571
   Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002
   Soderberg-Naucler C, 1999, INTERVIROLOGY, V42, P314, DOI 10.1159/000053966
   Sojan A., 2011, FLAVIVIRUS ENCEPHALI
   Stroynowski I, 1996, RES IMMUNOL, V147, P290, DOI 10.1016/0923-2494(96)89642-8
   Suvas S, 2006, J IMMUNOL, V176, P1703, DOI 10.4049/jimmunol.176.3.1703
   Takamura S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003937
   Tishler M, 2004, ISR MED ASSOC J, V6, P430
   Oliveira ACV, 2013, REV BRAS REUMATOL, V53, P206, DOI 10.1590/S0482-50042013000200008
   WIETIES K, 1990, P NATL ACAD SCI USA, V87, P6604, DOI 10.1073/pnas.87.17.6604
   Xie XF, 2009, J IMMUNOL, V182, P7163, DOI 10.4049/jimmunol.0803933
   Zumer K, 2013, J IMMUNOL, V190, P2479, DOI 10.4049/jimmunol.1203210
NR 75
TC 2
Z9 2
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-0422
EI 2090-0430
J9 AUTOIMMUN DIS
JI Autoimmun. Dis.
PY 2015
VL 2015
AR 503087
DI 10.1155/2015/503087
PG 12
WC Immunology
SC Immunology
GA CU2GI
UT WOS:000363341500001
PM 26457200
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Maia, FGM
   Chavez, JH
   de Souza, WM
   Romeiro, MF
   de Castro-Jorge, LA
   da Fonseca, BAL
   Figueiredo, LTM
AF Motta Maia, Felipe Goncalves
   Chavez, Juliana Helena
   de Souza, William Marciel
   Romeiro, Marilia Farignoli
   de Castro-Jorge, Luiza Antunes
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
TI Infection with Saint Louis encephalitis virus in the city of Ribeirao
   Preto, Brazil: report of one case
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Saint Louis encephalitis virus; Arbovirus; Flavivirus; Brazil
ID CIRCULATION
AB Saint Louis encephalitis virus (SLEV) is a mosquito-borne flavivirus from the Americas. In this report we describe aspects of the laboratory diagnosis of a patient with an acute febrile illness induced by SLEV that was initially diagnosed as dengue by positive IgM-ELISA. Infection with this virus is probably not rare in Brazil, but cases remain undiagnosed. It is necessary to improve the surveillance system, including laboratories, for the diagnosis of SLEV in Brazil. (C) 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Motta Maia, Felipe Goncalves; Chavez, Juliana Helena; de Souza, William Marciel; Romeiro, Marilia Farignoli; de Castro-Jorge, Luiza Antunes; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, BR-14049900 Sao Paulo, Brazil.
RP Figueiredo, LTM (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM wmarciel@usp.br; ltmfigue@fmrp.usp.br
RI Maia, Felipe Goncalves Motta/A-9692-2013; de Castro Jorge, Luiza
   Antunes/D-3773-2009; de Souza, William Marciel/D-3044-2017; Fonseca,
   Benedito/F-3252-2012
OI Maia, Felipe Goncalves Motta/0000-0002-7729-9579; de Souza, William
   Marciel/0000-0002-0025-8293; Fonseca, Benedito/0000-0003-3159-5687
FU FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/50617-6,
   06/01179-0, 12/02836-6, 12/24150-9]; CNPq - Conselho Nacional de
   PesquisaNational Council for Scientific and Technological Development
   (CNPq) [301677/2013-1]
FX This study was supported by a grant from FAPESP - Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (No. 08/50617-6), Fellowship No.
   06/01179-0, 12/02836-6, and 12/24150-9, and CNPq - Conselho Nacional de
   Pesquisa No. 301677/2013-1.
CR Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chavez JH, 2013, REV SOC BRAS MED TRO, V46, P97, DOI 10.1590/0037-868214142013
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pauvolid-Correa A, 2010, MEM I OSWALDO CRUZ, V105, P829, DOI 10.1590/S0074-02762010000600017
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P145, DOI 10.4269/ajtmh.1981.30.145
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008
   Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537
   Shope RE, 1979, DIAGNOSTIC PROCEDURE
   Spinsanti L, 2003, EMERG INFECT DIS, V9, P271
   Tsai TF, 1988, ARBOVIRUSES EPIDEMIO, P431
NR 17
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD SEP
PY 2014
VL 26
BP 96
EP 97
DI 10.1016/j.ijid.2014.05.018
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA AR8IH
UT WOS:000343818300021
PM 24998462
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Machado, PRL
   Farias, KJS
   Genre, J
   Oliveira, CJF
   Guedes, PMM
   da Fonseca, BAL
AF Lima Machado, Paula Renata
   Silva Farias, Kleber Juvenal
   Genre, Julieta
   Freire Oliveira, Carlo Jose
   Matta Guedes, Paulo Marcos
   Lopes da Fonseca, Benedito Antonio
TI Disseminated Kaposi's Sarcoma in Patients with HIV Infection Correlates
   to High Serum Levels of IL-10
SO VIRAL IMMUNOLOGY
LA English
DT Article
ID MULTICENTRIC CASTLEMAN-DISEASE; DNA-SEQUENCES; HERPESVIRUS;
   INTERLEUKIN-10; CANCER; CARCINOMA; CYTOKINES
AB Human herpesvirus 8 (HHV-8) is the etiologic agent of all Kaposi's sarcoma (KS), the outcome of which is associated with immuno-dysregulation, resulting in the abnormal production of inflammatory cytokines and chemokines. We quantified by enzyme-linked immunosorbent assay serum levels of interleukin (IL)-10, IL-17, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha from patients with KS-AIDS, classic KS, and human immunodeficiency virus (HIV) without KS. A correlation between HHV-8 molecular detection and cytokine production was also performed. We observed that IL-10 production was higher in patients with KS-AIDS when compared to those with classic KS or HIV. However, no significant differences were seen for IFN-gamma, TNF-alpha, or IL-17 production between studied groups. When patients with KS-AIDS were analyzed according to lesion topography, IL-10 levels were higher in patients with disseminated disease than those observed in patients with only cutaneous lesions or cutaneous and digestive and/or respiratory tract lesions. Finally, patients with KS-AIDS that presented viral DNA for HHV-8 in serum showed a higher production of IL-10 when compared with those patients with a negative result for nested polymerase chain reaction for the virus. The results presented here are the first to demonstrate that there exists a stratification of patients with KS-AIDS according to lesion topography where IL-10 levels are higher in those individuals with disseminated disease than those with only localized lesions.
C1 [Lima Machado, Paula Renata; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Virol Res Ctr, Sch Med Ribeirao Preto, Dept Internal Med, BR-14049900 Sao Paulo, Brazil.
   [Lima Machado, Paula Renata] Univ Fed Rio Grande do Norte, Dept Clin Anal & Toxicol, BR-59072970 Natal, RN, Brazil.
   [Silva Farias, Kleber Juvenal; Matta Guedes, Paulo Marcos] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Genre, Julieta] Univ Fed Rio Grande do Norte, Hlth Sci Postgrad Programme, BR-59072970 Natal, RN, Brazil.
   [Freire Oliveira, Carlo Jose] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Uberaba, MG, Brazil.
RP Machado, PRL (corresponding author), Univ Sao Paulo, Virol Res Ctr, Sch Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM paulamachado@usp.br
RI Guedes, Paulo/Y-2546-2018; Oliveira, Carlo Jose Freire/AAY-8751-2020;
   FARIAS, KLEBER/AAC-9815-2019; Fonseca, Benedito/F-3252-2012
OI Machado, Paula/0000-0002-3085-9778; Fonseca,
   Benedito/0000-0003-3159-5687; Matta Guedes, Paulo
   Marcos/0000-0002-4564-6791
FU Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)National Council
   for Scientific and Technological Development (CNPq) [142858/2006-4]
FX P.R.L.M. was the recipient of a fellowship from Conselho Nacional de
   Pesquisa e Desenvolvimento (CNPq) (Grant #142858/2006-4).
CR Beckebaum S, 2004, CLIN CANCER RES, V10, P7260, DOI 10.1158/1078-0432.CCR-04-0872
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076
   Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672
   Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163
   Hatanaka H, 2000, ANN ONCOL, V11, P815, DOI 10.1023/A:1008375208574
   Ikeguchi M, 2009, GASTRIC CANCER, V12, P95, DOI 10.1007/s10120-009-0509-8
   Jebreel A, 2007, J LARYNGOL OTOL, V121, P246, DOI 10.1017/S0022215106002428
   Jensen KK, 2004, SEMIN CANCER BIOL, V14, P187, DOI 10.1016/j.semcancer.2003.10.005
   Kozlowski L, 2003, Rocz Akad Med Bialymst, V48, P82
   Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X
   Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073
   Onishi T, 1999, BJU INT, V83, P488
   Polizzotto MN, 2013, BLOOD, V122, P4189, DOI 10.1182/blood-2013-08-519959
   Polizzotto MN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00073
   Pugliese A, 2002, CELL BIOCHEM FUNCT, V20, P191, DOI 10.1002/cbf.935
   Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251
   Sato T, 1996, CLIN CANCER RES, V2, P1383
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039
   Weiss E, 2004, J AM ACAD DERMATOL, V50, P657, DOI 10.1016/j.jaad.2003.11.075
NR 22
TC 4
Z9 5
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD SEP
PY 2014
VL 27
IS 7
BP 356
EP 360
DI 10.1089/vim.2013.0134
PG 5
WC Immunology; Virology
SC Immunology; Virology
GA AO7BX
UT WOS:000341508100007
PM 25026101
OA Green Published
DA 2020-12-08
ER

PT J
AU Farias, KJS
   Machado, PRL
   de Almeida, RF
   de Aquino, AA
   da Fonseca, BAL
AF Silva Farias, Kleber Juvenal
   Lima Machado, Paula Renata
   de Almeida Junior, Renato Ferreira
   de Aquino, Ana Alice
   Lopes da Fonseca, Benedito Antonio
TI Chloroquine interferes with dengue-2 virus replication in U937 cells
SO MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE chloroquine; DENV-2; plaque assay; quantitative reverse transcription
   polymerase chain reaction
ID TUMOR-NECROSIS-FACTOR; PLASMACYTOID DENDRITIC CELLS; IN-VITRO
   INHIBITION; VIRAL-INFECTIONS; TNF-ALPHA; EXPRESSION; HYDROXYCHLOROQUINE;
   TYPE-1
AB The objective of this study was to investigate the use of chloroquine (CLQ) as an antiviral agent against dengue. Chloroquine, an amine acidotropic drug known to affect intracellular exocytic pathways by increasing endosomal pH, was used in the in vitro treatment of U937 cells infected with dengue virus type 2 (DENV-2). Viral replication was assessed by quantification of virus produced through detection of copy numbers of DENV-2 RNA, plaque assay and indirect immunofluorescence. qRT-PCR and plaque assays were used to quantify the DENV-2 load in infected U937 cells after CLQ treatment. It was found that a dose of 50mg/mL of CLQ was not toxic to the cells and resulted in significantly less virus production in infected U937 cells than occurred in untreated cells. In the present work, CLQ was effective against DENV-2 replication in U937 cells, and also caused a statistically significant reduction in expression of proinflammatory cytokines. The present study indicates that CLQ may be used to reduce viral yield in U937 cells.
C1 [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata] Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl Microbiol & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, BR-14049900 Ribeirao Preto, SP, Brazil.
   [de Almeida Junior, Renato Ferreira; de Aquino, Ana Alice] Univ Fed Rio Grande do Norte, Biosci Ctr, Program Grad Studies Biol Sci, BR-59072970 Natal, RN, Brazil.
RP Farias, KJS (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil.
EM kfarias3@hotmail.com
RI FARIAS, KLEBER/AAC-9815-2019; Fonseca, Benedito/F-3252-2012
OI Machado, Paula/0000-0002-3085-9778; Fonseca,
   Benedito/0000-0003-3159-5687
FU Sao Paulo Foundation for Research (FAPESP)Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [05/04450-4]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [06/55789-4]
FX This study was supported by the Sao Paulo Foundation for Research
   (FAPESP; Grant no. 05/04450-4). K.J.S. Farias was supported by a FAPESP
   fellowship (Grant no. 06/55789-4).
CR Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   BruceChwatt LJ, 1981, WHO MONOGRAPH SERIES, V27
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CIVITICO G, 1990, J MED VIROL, V31, P90, DOI 10.1002/jmv.1890310205
   De Clercq Erik, 2006, Expert Rev Anti Infect Ther, V4, P291, DOI 10.1586/14787210.4.2.291
   DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x
   Gandini M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002257
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gomes-Ruiz AC, 2006, J MED VIROL, V78, P760, DOI 10.1002/jmv.20620
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282
   Jeong JY, 2002, IMMUNOLOGY, V105, P83, DOI 10.1046/j.0019-2805.2001.01339.x
   Jeong JY, 1997, J IMMUNOL, V158, P4901
   Karabatsos N., 1985, INT CATALOGUE ARBOVI, P1147
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   KOYAMA AH, 1984, VIROLOGY, V138, P332, DOI 10.1016/0042-6822(84)90356-8
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Marianneau P, 1998, J INFECT DIS, V178, P1270, DOI 10.1086/314466
   MILLER N, 1992, J VIROL, V66, P3409, DOI 10.1128/JVI.66.6.3409-3414.1992
   Monath T.P., 2001, FIELDS VIROLOGY, V33, P1043
   OFFENSPERGER WB, 1991, VIROLOGY, V183, P415, DOI 10.1016/0042-6822(91)90157-7
   Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39
   Pardridge WM, 1998, IMMUNOL LETT, V64, P45, DOI 10.1016/S0165-2478(98)00096-0
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   RICE CM, 1996, FIELDS VIROLOGY, P931
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015
   Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Farias KJS, 2013, SCI WORLD J, DOI 10.1155/2013/282734
   Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07
   SPERBER K, 1993, AIDS RES HUM RETROV, V9, P91, DOI 10.1089/aid.1993.9.91
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   vandenBorne BEEM, 1997, J RHEUMATOL, V24, P55
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534
   Weber SM, 2002, J IMMUNOL, V168, P5303, DOI 10.4049/jimmunol.168.10.5303
   Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858
NR 40
TC 30
Z9 32
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0385-5600
EI 1348-0421
J9 MICROBIOL IMMUNOL
JI Microbiol. Immunol.
PD JUN
PY 2014
VL 58
IS 6
BP 318
EP 326
DI 10.1111/1348-0421.12154
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA AJ4YC
UT WOS:000337684900002
PM 24773578
OA Green Published
DA 2020-12-08
ER

PT J
AU Maruyama, SR
   Castro-Jorge, LA
   Ribeiro, JMC
   Gardinassi, LG
   Garcia, GR
   Brandao, LG
   Rodrigues, AR
   Okada, MI
   Abrao, EP
   Ferreira, BR
   da Fonseca, BAL
   de Miranda-Santos, IKF
AF Maruyama, Sandra Regina
   Castro-Jorge, Luiza Antunes
   Chaves Ribeiro, Jose Marcos
   Gardinassi, Luiz Gustavo
   Garcia, Gustavo Rocha
   Brandao, Lucinda Giampietro
   Rodrigues, Aline Rezende
   Okada, Marcos Ituo
   Abrao, Emiliana Pereira
   Ferreira, Beatriz Rossetti
   Lopes da Fonseca, Benedito Antonio
   Ferreira de Miranda-Santos, Isabel Kinney
TI Characterisation of divergent flavivirus NS3 and NS5 protein sequences
   detected in Rhipicephalus microplus ticks from Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Rhipicephalus microplus; tick; NS3; NS5; flavivirus
ID CODON ADAPTATION INDEX; WEST-NILE-VIRUS; PHYLOGENETIC-RELATIONSHIPS;
   DISEASE RESERVOIRS; COMPLEX-SYSTEMS; RNA-POLYMERASE; USAGE BIAS;
   IDENTIFICATION; EVOLUTION; ALIGNMENT
AB Transcripts similar to those that encode the nonstructural (NS) proteins NS3 and NS5 from flaviviruses were found in a salivary gland (SG) complementary DNA (cDNA) library from the cattle tick Rhipicephalus microplus. Tick extracts were cultured with cells to enable the isolation of viruses capable of replicating in cultured invertebrate and vertebrate cells. Deep sequencing of the viral RNA isolated from culture supernatants provided the complete coding sequences for the NS3 and NS5 proteins and their molecular characterisation confirmed similarity with the NS3 and NS5 sequences from other flaviviruses. Despite this similarity, phylogenetic analyses revealed that this potentially novel virus may be a highly divergent member of the genus Flavivirus. Interestingly, we detected the divergent NS3 and NS5 sequences in ticks collected from several dairy farms widely distributed throughout three regions of Brazil. This is the first report of flavivirus-like transcripts in R. microplus ticks. This novel virus is a potential arbovirus because it replicated in arthropod and mammalian cells; furthermore, it was detected in a cDNA library from tick SGs and therefore may be present in tick saliva. It is important to determine whether and by what means this potential virus is transmissible and to monitor the virus as a potential emerging tick-borne zoonotic pathogen.
C1 [Maruyama, Sandra Regina; Castro-Jorge, Luiza Antunes; Gardinassi, Luiz Gustavo; Garcia, Gustavo Rocha; Brandao, Lucinda Giampietro; Abrao, Emiliana Pereira; Lopes da Fonseca, Benedito Antonio; Ferreira de Miranda-Santos, Isabel Kinney] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
   [Ferreira, Beatriz Rossetti] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
   [Chaves Ribeiro, Jose Marcos] NIAID, NIH, Rockville, MD USA.
   [Brandao, Lucinda Giampietro; Okada, Marcos Ituo] Fac Tecnol, Aracatuba, SP, Brazil.
   [Rodrigues, Aline Rezende] Vallee SA, Sao Paulo, Brazil.
   [Rodrigues, Aline Rezende] Laticinios Vale Buritis, Buritis, MG, Brazil.
   [Okada, Marcos Ituo] Vetmais Med Anim, Campinas, SP, Brazil.
RP de Miranda-Santos, IKF (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
EM imsantos@fmrp.usp.br
RI Ribeiro, Jose/J-7011-2015; Garcia, Gustavo/E-5182-2013; Gardinassi,
   Luiz/V-2225-2019; Maruyama, Sandra R/G-1171-2012; de Miranda Santos,
   Isabel K. F./D-5261-2016; de Miranda Santos, Isabel KF/B-7597-2012; de
   Castro Jorge, Luiza Antunes/D-3773-2009; Gardinassi, Luiz Gustavo
   Araujo/K-6276-2012; Ferreira, Beatriz/C-2003-2012; Fonseca,
   Benedito/F-3252-2012
OI Gardinassi, Luiz/0000-0002-9027-2688; de Miranda Santos, Isabel
   KF/0000-0002-0438-4430; Gardinassi, Luiz Gustavo
   Araujo/0000-0002-9027-2688; Ferreira, Beatriz/0000-0002-6781-2236;
   /0000-0001-6807-1452; Fonseca, Benedito/0000-0003-3159-5687; Ribeiro,
   Jose/0000-0002-9107-0818
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2004/09992-7, 2009/53645-3, 2012/06374-7]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [559603/2009-6,
   471946/2010-9, 420067/2005-1, 505810/2004-2]; SRM [2006/54041-6,
   2007/59357-4/FAPESP]; LACJ [143354/2008-6/CNPq]; GRG
   [2009/51212-2/FAPESP]; NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [ZIAAI000810, ZIAAI000810,
   ZIAAI000810, ZIAAI000810, ZIAAI000810, ZIAAI000810, ZIAAI000810,
   ZIAAI000810, ZIAAI000810, ZIAAI000810] Funding Source: NIH RePORTER
FX FAPESP (2004/09992-7, 2009/53645-3, 2012/06374-7), CNPq (559603/2009-6,
   471946/2010-9, 420067/2005-1, 505810/2004-2); This work fulfils part of
   the Master's and PhD program requirements for SRM (scholarships
   2006/54041-6, 2007/59357-4/FAPESP), LACJ (scholarship
   143354/2008-6/CNPq) and GRG (scholarship 2009/51212-2/FAPESP). JMCR was
   supported by the Intramural Research Program of the NIAID.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400
   Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781
   Bingham AM, 2012, AM J TROP MED HYG, V87, P1140, DOI 10.4269/ajtmh.2012.12-0257
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Cope DR, 2004, J ANIM ECOL, V73, P807, DOI 10.1111/j.0021-8790.2004.00850.x
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Danielova V, 2002, FOLIA PARASIT, V49, P323, DOI 10.14411/fp.2002.060
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   de la Fuente J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-372
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Estrada-Pena A, 1999, VET PARASITOL, V81, P73, DOI 10.1016/S0304-4017(98)00238-6
   Evans LH, 2009, J VIROL, V83, P2429, DOI 10.1128/JVI.01926-08
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Ferron F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-255
   Figueiredo Luiz Tadeu Moraes, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P613, DOI 10.1590/S0037-86821999000600002
   Fitzpatrick KA, 2010, VIROLOGY, V404, P89, DOI 10.1016/j.virol.2010.04.029
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   GUGLIELMONE AA, 1995, VET PARASITOL, V57, P109, DOI 10.1016/0304-4017(94)03115-D
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0
   Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967
   Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LAIN S, 1989, GENE, V82, P357, DOI 10.1016/0378-1119(89)90063-2
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Laurenson MK, 2003, J ANIM ECOL, V72, P177, DOI 10.1046/j.1365-2656.2003.00688.x
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18
   Ma HL, 2011, J VIROL, V85, P6579, DOI 10.1128/JVI.00147-11
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281
   Maruyama SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-363
   MEGAW MWJ, 1978, NATURE, V271, P483, DOI 10.1038/271483a0
   Murphy FA, 1995, VIRUS TAXONOMY CLASS
   Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982
   O'Donovan Claire, 2002, Brief Bioinform, V3, P275
   Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Telis G, 2012, VIPERS GO VIRAL
   Thiel H. J., 2005, VIRUS TAXONOMY, P981
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
NR 69
TC 28
Z9 29
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2014
VL 109
IS 1
BP 38
EP +
DI 10.1590/0074-0276130166
PG 34
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AD2BU
UT WOS:000333038700006
PM 24626302
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Santana, RD
   Louzada, P
   Bollela, VR
   Cruz, AAV
   da Fonseca, BAL
AF Santana, Rodrigo de Carvalho
   Louzada, Paulo, Jr.
   Bollela, Valdes Roberto
   Vellasco Cruz, Antonio Augusto
   Lopes da Fonseca, Benedito Antonio
TI Orbital tuberculosis presenting as proptosis and fever: the risk of
   empiric corticosteroids
SO INTERNATIONAL OPHTHALMOLOGY
LA English
DT Article
ID OCULAR TUBERCULOSIS; DIAGNOSIS; UVEITIS; ASSAY
RP Santana, RD (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Div Infect Dis, Dept Internal Med, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM santanacrod@yahoo.com.br
RI de C Santana, Rodrigo/C-4429-2014; Bollela, Valdes Roberto/F-9182-2014;
   Louzada-Junior, Paulo/E-4132-2012; Fonseca, Benedito/F-3252-2012
OI de C Santana, Rodrigo/0000-0002-5887-8663; Bollela, Valdes
   Roberto/0000-0002-8221-4701; Louzada-Junior, Paulo/0000-0003-2585-3870;
   Fonseca, Benedito/0000-0003-3159-5687
CR Alvarez GG, 2009, INT J INFECT DIS, V13, P432, DOI 10.1016/j.ijid.2008.09.018
   Ang M, 2009, OPHTHALMOLOGY, V116, P1391, DOI 10.1016/j.ophtha.2009.02.005
   Bodaghi B, 2000, Curr Opin Ophthalmol, V11, P443, DOI 10.1097/00055735-200012000-00010
   Centers for Disease Control and Prevention, 2010, REP TUB US 2009
   Gupta V, 2003, OPHTHALMOLOGY, V110, P1744, DOI 10.1016/S0161-6420(03)00619-5
   Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015
   Hamade IH, 2010, ACTA OPHTHALMOL, V88, P905, DOI 10.1111/j.1755-3768.2009.01579.x
   Madge SN, 2008, ORBIT, V27, P267, DOI 10.1080/01676830802225152
   Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC
   Rockwood RR, 2007, NURSE PRACT, V32, P44, DOI 10.1097/01.NPR.0000282802.12314.dc
   Van Gelder RN, 2001, SURV OPHTHALMOL, V46, P248, DOI 10.1016/S0039-6257(01)00274-0
   Varma D, 2006, EYE, V20, P1068, DOI 10.1038/sj.eye.6702093
   World Health Organization, 2010, GLOB TUB CONTR WHO R
   Wroblewski KJ, 2011, OPHTHALMOLOGY, V118, P772, DOI 10.1016/j.ophtha.2010.08.011
NR 14
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-5701
EI 1573-2630
J9 INT OPHTHALMOL
JI Int. Ophthalmol.
PD FEB
PY 2014
VL 34
IS 1
BP 133
EP 136
DI 10.1007/s10792-013-9751-5
PG 4
WC Ophthalmology
SC Ophthalmology
GA AB3TS
UT WOS:000331713700024
PM 23474699
DA 2020-12-08
ER

PT J
AU Chavez, JH
   Franca, RFO
   Oliveira, CJF
   de Aquino, MTP
   Farias, KJS
   Machado, PRL
   de Oliveira, TFM
   Yokosawa, J
   Soares, EG
   da Silva, JS
   da Fonseca, BAL
   Figueiredo, LTM
AF Chavez, Juliana H.
   Franca, Rafael F. O.
   Oliveira, Carlo J. F.
   de Aquino, Maria T. P.
   Farias, Kleber J. S.
   Machado, Paula R. L.
   de Oliveira, Thelma F. M.
   Yokosawa, Jonny
   Soares, Edson G.
   da Silva, Joao S.
   da Fonseca, Benedito A. L.
   Figueiredo, Luiz T. M.
TI Influence of the CCR-5/MIP-1 alpha Axis in the Pathogenesis of Rocio
   Virus Encephalitis in a Mouse Model
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID NITRIC-OXIDE; MIP-1 ALPHA; CHEMOKINES; INFECTION; CCR5; RECEPTOR;
   BIOLOGY; SYSTEM
AB Rocio virus (ROCV) caused an outbreak of human encephalitis during the 1970s in Brazil and its immunopathogenesis remains poorly understood. CC-chemokine receptor 5 (CCR5) is a chemokine receptor that binds to macrophage inflammatory protein (MIP-1 alpha). Both molecules are associated with inflammatory cells migration during infections. In this study, we demonstrated the importance of the CCR5 and MIP-1 alpha, in the outcome of viral encephalitis of ROCV-infected mice. CCR5 and MIP-1 alpha knockout mice survived longer than wild-type (WT) ROCV-infected animals In addition, knockout mice had reduced inflammation in the brain. Assessment of brain viral load showed mice virus detection five days post-infection in wild-type and CCR5-/- mice, while MIP-1 alpha-/- mice had lower viral loads seven days post-infection. Knockout mice required a higher lethal dose than wild-type mice as well. The CCR5/MIP-1 alpha axis may contribute to migration of infected cells to the brain and consequently affect the pathogenesis during ROCV infection.
C1 [Chavez, Juliana H.; de Oliveira, Thelma F. M.; Yokosawa, Jonny] Univ Fed Uberlandia, Inst Ciencias Biomed, Virol Lab, BR-38405302 Uberlandia, MG, Brazil.
   Univ Sao Paulo, Fac Med, Dept Patol Ribeirao Preto, Ctr Pesquisa Virol,Dept Bioquim & Imunol, Sao Paulo, Brazil.
   [Oliveira, Carlo J. F.] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Uberaba, MG, Brazil.
   [Farias, Kleber J. S.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Machado, Paula R. L.] Univ Fed Rio Grande do Norte, Dept Anal Clin & Toxicol, BR-59072970 Natal, RN, Brazil.
RP Chavez, JH (corresponding author), Univ Fed Uberlandia, Inst Ciencias Biomed, Virol Lab, Av Amazonas 2210, BR-38405302 Uberlandia, MG, Brazil.
EM julianachavez@yahoo.com.br; rafaelfranca@usp.br; carlo@icbn.uftm.edu.br;
   teresaaq@terra.com.br; kfarias3@hotmail.com; paulamachado2@hotmail.com;
   thelmao@umuarama.ufu.br; jyokosawa@icbim.ufu.br; egsoares@fmrp.usp.br;
   jsdsilva@fmrp.usp.br; baldfons@fmrp.usp.br; ltmfigue@fmrp.usp.br
RI Silva, Joao S/A-4484-2008; FARIAS, KLEBER/AAC-9815-2019; Oliveira, Carlo
   Jose Freire/AAY-8751-2020; Fonseca, Benedito/F-3252-2012
OI Silva, Joao S/0000-0002-3410-3927; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Fonseca, Benedito/0000-0003-3159-5687
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/Brasil; Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo/BrasilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
FX This study was partially supported by Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais/Brasil and Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo/Brasil.
CR Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec
   Brenier-Pinchart MP, 2001, TRENDS PARASITOL, V17, P292, DOI 10.1016/S1471-4922(01)01902-X
   Chavez JH, 2006, VIRUS REV RES, V11, P28
   Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61
   DESOUZALOPES O, 1978, AM J EPIDEMIOL, V108, P394, DOI 10.1093/oxfordjournals.aje.a112637
   Barros VED, 2009, REV INST MED TROP SP, V51, P141, DOI 10.1590/S0036-46652009000300004
   de Barros VED, 2011, AM J TROP MED HYG, V85, P363, DOI 10.4269/ajtmh.2011.10-0246
   Ferreira Ivani B., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P265, DOI 10.1590/S0036-46651994000300011
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Frydas S, 2003, INT J IMMUNOPATH PH, V16, P221, DOI 10.1177/039463200301600306
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   Gubler DJ, 2007, FIELDS VIROLOGY, P1154
   Henriques DF, 2012, MEM I OSWALDO CRUZ, V107, P630, DOI 10.1590/S0074-02762012000500009
   Kasama Tsuyoshi, 2006, Recent Pat Antiinfect Drug Discov, V1, P275, DOI 10.2174/157489106778777655
   Kuhl SJ, 1998, WESTERN J MED, V168, P176
   Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691
   Lim JK, 2006, TRENDS IMMUNOL, V27, P308, DOI 10.1016/j.it.2006.05.007
   Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   MONATH TP, 1978, AM J TROP MED HYG, V27, P1251, DOI 10.4269/ajtmh.1978.27.1251
   Nansen A, 2002, BLOOD, V99, P1237, DOI 10.1182/blood.V99.4.1237
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Straatmann A, 1997, Rev Soc Bras Med Trop, V30, P511, DOI 10.1590/S0037-86821997000600012
   Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454
   Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X
NR 29
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2013
VL 89
IS 5
BP 1013
EP 1018
DI 10.4269/ajtmh.12-0591
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 251BZ
UT WOS:000326904100034
PM 24080631
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Miranda, CH
   Borges, MD
   Matsuno, AK
   Vilar, FC
   Gali, LG
   Volpe, GJ
   Schmidt, A
   Pazin, A
   da Silva, FMF
   de Castro-Jorge, LA
   de Oliveira, MF
   Saggioro, F
   Martines, RB
   da Fonseca, BAL
AF Miranda, Carlos Henrique
   Borges, Marcos de Carvalho
   Matsuno, Alessandra Kimie
   Vilar, Fernando Crivelenti
   Gali, Luis Gustavo
   Volpe, Gustavo Jardim
   Schmidt, Andre
   Pazin-Filho, Antonio
   Figueira da Silva, Fernanda Miquelitto
   de Castro-Jorge, Luiza Antunes
   de Oliveira, Mayra Fernanda
   Saggioro, Fabiano
   Martines, Roosecelis Brasil
   Lopes da Fonseca, Benedito Antonio
TI Evaluation of Cardiac Involvement During Dengue Viral Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE dengue; myocarditis; cardiac biomarkers; cardiogenic shock
ID VIRUS-INFECTIONS; EARLY-DIAGNOSIS; MYOCARDITIS; ANTIGEN; FEVER; HEART
AB Background. Dengue is a disease whose clinical manifestations range from asymptomatic infections to a severe disease. There have been some previous reports of myocardial involvement in dengue, but this association has not been completely established.
   Methods. From January to July of 2011, patients hospitalized with dengue, confirmed through dengue nonstructural protein 1 and/or immunoglobulin M detection, were included in this study and troponin I and N terminal fragment of B-type natriuretic peptide levels were determined. Patients with abnormal biomarkers underwent echocardiography and when any abnormality was detected, they underwent cardiac magnetic resonance imaging.
   Results. Eighty-one patients were evaluated and 12 patients (15%) presented with elevated biomarker levels. Compared to controls, they had higher leukocyte (P < .001) and platelet counts (P = .005); higher C-reactive protein (P = .02), and a lower viral load (P = .03). There was no difference according to clinical dengue classification; dengue hemorrhagic fever/dengue shock syndrome severity; duration of symptoms; or prevalence of secondary infection between the 2 groups. Two patients died secondary to cardiogenic shock before imaging studies. Necroscopic findings were compatible to myocarditis in both, and immunohistochemistry for dengue virus showed increased staining on mononuclear cells located in the myocardial tissue. Of the 10 patients who underwent echocardiography, depressed left ventricular ejection fraction (LVEF) was identified in 1, left ventricular segmental abnormalities with preserved LVEF in 2, and an important pericardial effusion with tamponade in another. Cardiac involvement was confirmed by CMR in these 4 patients.
   Conclusions. Dengue viruses were shown to cause cardiac disease with clinical manifestations ranging from mild elevation of biomarkers to myocarditis and/or pericarditis.
C1 [Miranda, Carlos Henrique; Borges, Marcos de Carvalho; Vilar, Fernando Crivelenti; Gali, Luis Gustavo; Volpe, Gustavo Jardim; Schmidt, Andre; Pazin-Filho, Antonio; Figueira da Silva, Fernanda Miquelitto; de Castro-Jorge, Luiza Antunes; de Oliveira, Mayra Fernanda; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Sao Paulo, Brazil.
   [Matsuno, Alessandra Kimie] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pediat, Sao Paulo, Brazil.
   [Saggioro, Fabiano] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil.
   [Martines, Roosecelis Brasil] Adolfo Lutz Inst, Pathol Ctr, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Disciplina Molestias Infecciosas & Tropicais, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Schmidt, Andre/G-1569-2011; de Castro Jorge, Luiza Antunes/D-3773-2009;
   Borges, Marcos Carvalho/A-3585-2014; Vilar, Fernando
   Crivelenti/AAK-4233-2020; Miranda, Carlos Henrique/B-6247-2014; Volpe,
   Gustavo J/E-5148-2019; Pazin-Filho, Antonio/E-9495-2010; Fonseca,
   Benedito/F-3252-2012; Matsuno, Alessandra Kimie/H-9507-2012
OI Schmidt, Andre/0000-0002-1090-8165; Borges, Marcos
   Carvalho/0000-0001-6280-0714; Miranda, Carlos
   Henrique/0000-0002-5968-4879; Pazin-Filho, Antonio/0000-0001-5242-329X;
   Fonseca, Benedito/0000-0003-3159-5687; vilar, fernando
   crivelenti/0000-0001-8232-5375; Matsuno, Alessandra
   Kimie/0000-0002-3491-1641
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2009/14449-4, 2011/22514-0]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP;
   grant numbers 2009/14449-4 and 2011/22514-0).
CR Castro-Jorge LA, 2010, J MED VIROL, V82, P1400, DOI 10.1002/jmv.21814
   Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d
   Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028
   da Fonseca BAL, 2002, CURR OPIN PEDIATR, V14, P67
   Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007
   Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000
   Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x
   Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee CH, 2009, INT J CARDIOL, V136, pE69, DOI 10.1016/j.ijcard.2008.05.023
   Salgado DM, 2010, PEDIATR INFECT DIS J, V29, P238, DOI 10.1097/INF.0b013e3181bc3c5b
   Miranda CH, 2013, EUR HEART J-ACUTE CA, V2, P127, DOI 10.1177/2048872613475889
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Salgado Doris M, 2009, Rev. salud pública, V11, P591
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Thomas L, 2010, MED MALADIES INFECT, V40, P480, DOI 10.1016/j.medmal.2009.10.001
   Levy NVYA, 2008, INVEST CLIN, V49, P135
   Wali JP, 1998, INT J CARDIOL, V64, P31, DOI 10.1016/S0167-5273(98)00008-4
   Weerakoon Kosala Gad, 2011, BMC Res Notes, V4, P268, DOI 10.1186/1756-0500-4-268
   Wichmann D, 2009, SE ASIAN J TROP MED, V40, P727
   World Health Organization, 2009, DENG GUID TREATM PRE
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 22
TC 40
Z9 43
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 15
PY 2013
VL 57
IS 6
BP 812
EP 819
DI 10.1093/cid/cit403
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 212YF
UT WOS:000324018100011
PM 23784923
OA Bronze
DA 2020-12-08
ER

PT J
AU Borges, MC
   Castro, LA
   da Fonseca, BAL
AF Borges, Marcos Carvalho
   Castro, Luiza Antunes
   Lopes da Fonseca, Benedito Antonio
TI Chloroquine use improves dengue-related symptoms
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; therapeutics; chloroquine; activities of daily living
ID ANTIMALARIAL-DRUG TOXICITY; TNF-ALPHA; VIRAL-INFECTIONS; NS1 ANTIGEN;
   INHIBITION; CYTOKINES; VIRUSES; IL-6
AB Dengue is the most important arboviral disease in the world. As chloroquine, an antimalarial agent, has shown some antiviral effects, this study evaluated its effect in patients with dengue. A randomised, double-blind study was performed by administering chloroquine or placebo for three days to 129 patients with dengue-related symptoms. Of these patients, 37 were confirmed as having dengue and completed the study; in total, 19 dengue patients received chloroquine and 18 received placebo. There was no significant difference in the duration of the disease or the degree and days of fever. However, 12 patients (63%) with confirmed dengue reported a substantial decrease in pain intensity and a great improvement in their ability to perform daily activities (p = 0.0004) while on the medication and the symptoms returned immediately after these patients stopped taking the medication. The same effect was not observed in patients with diseases other than dengue. Therefore, this study shows that patients with dengue treated with chloroquine had an improvement in their quality of life and were able to resume their daily activities. However, as chloroquine did not alter the duration of the disease or the intensity and days of fever, further studies are necessary to confirm the clinical effects and to assess the side effects of chloroquine in dengue patients.
C1 [Borges, Marcos Carvalho; Castro, Luiza Antunes; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Borges, Marcos Carvalho/A-3585-2014; de Castro Jorge, Luiza
   Antunes/D-3773-2009; Fonseca, Benedito/F-3252-2012
OI Borges, Marcos Carvalho/0000-0001-6280-0714; Fonseca,
   Benedito/0000-0003-3159-5687
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2005/04450-4]
FX FAPESP (2005/04450-4)
CR Adachi K, 2007, ARCH VIROL, V152, P2217, DOI 10.1007/s00705-007-1061-7
   Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767
   Castro-Jorge LA, 2010, J MED VIROL, V82, P1400, DOI 10.1002/jmv.21814
   Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martinson JA, 2010, ANTIMICROB AGENTS CH, V54, P871, DOI 10.1128/AAC.01246-09
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Tutor-Ureta P, 2005, REV CLIN ESP, V205, P230, DOI 10.1157/13075574
   Levy NVYA, 2008, INVEST CLIN, V49, P135
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
NR 26
TC 56
Z9 59
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2013
VL 108
IS 5
BP 596
EP 599
DI 10.1590/S0074-02762013000500010
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 192XI
UT WOS:000322520800010
PM 23903975
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Bellissimo-Rodrigues, F
   Bollela, VR
   Da Fonseca, BAL
   Martinez, R
AF Bellissimo-Rodrigues, Fernando
   Bollela, Valdes Roberto
   Lopes Da Fonseca, Benedito Antonio
   Martinez, Roberto
TI Endemic paracoccidioidomycosis: relationship between clinical
   presentation and patients' demographic features
SO MEDICAL MYCOLOGY
LA English
DT Article
DE paracoccidioidomycosis; clinical presentation; age; sex; ethnicity
ID HLA ANTIGENS; COCCIDIOIDOMYCOSIS; BRAZIL; BRASILIENSIS; SOUTHEAST
AB Paracoccidioidomycosis (PCM) is a systemic fungal disease endemic to Latin America and characterized by two clinical presentations, i.e., patients develop either acute/subacute or chronic clinical manifestations. The differences in clinical presentations are mainly dependent on the host immune response, but may also be related to demographic characteristics of some patients. In this retrospective study, 1,219 PCM cases treated between 1970 and 2009 in a university medical center, located in southeastern Brazil, were analyzed according to their clinical and demographic features. The most affected anatomical sites were lungs (63.8%) and oral mucosa (50.0%), with increasing involvement of these sites in accord with the age of the patients. Generalized lymphadenopathy (28.1%) and skin lesions (29.6%) were more frequent on the first decades of life. Involvement of the larynx (16.1%), gut (7.5%), spleen (4.7%), central nervous system (3.4%), bones and joints (2.2%), and adrenal (2.1%) were also variable according to the age of the host. The acute/subacute form of the disease accounted for 26.4% of PCM cases and, on a multivariate analysis, was inversely associated with aging (OR = 0.8 per year, P < 0.001), and directly associated with female sex (OR = 7.2, P < 0.001), mixed black and white racial background (OR = 2.3, P < 0.001) or black skin color (OR = 4.6, P < 0.001). Based on these findings, we have shown that host immune response, as well as age, gender and ethnicity may influence the clinical presentation of PCM.
C1 [Bellissimo-Rodrigues, Fernando] Univ Sao Paulo, Dept Social Med, BR-14049 Ribeirao Preto, SP, Brazil.
   [Bollela, Valdes Roberto; Lopes Da Fonseca, Benedito Antonio; Martinez, Roberto] Univ Sao Paulo, Div Infect Dis, Dept Internal Med, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
RP Bellissimo-Rodrigues, F (corresponding author), Ave Bandeirantes,3900,Campus Univ Monte Alegre, BR-14048900 Sao Paulo, Brazil.
EM fbellissimo@fmrp.usp.br
RI Bollela, Valdes Roberto/F-9182-2014; Bellissimo-Rodrigues,
   Fernando/E-7349-2012; Fonseca, Benedito/F-3252-2012
OI Bollela, Valdes Roberto/0000-0002-8221-4701; Fonseca,
   Benedito/0000-0003-3159-5687
FU Fundacao para o Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) do
   Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto of Sao
   Paulo University
FX This work was partially supported by Fundacao para o Apoio ao Ensino,
   Pesquisa e Assistencia (FAEPA) do Hospital das Clinicas da Faculdade de
   Medicina de Ribeirao Preto of Sao Paulo University. The authors are
   grateful to Gleici da Silva Castro Perdona, PhD, who assisted on the
   statistical analysis of data, and to Rosane Monteiro, who created and
   managed the data set.
CR Baransky MC, 1982, PARACOCCIDIODOMICOSE, P211
   Bellissimo-Rodrigues F, 2011, AM J TROP MED HYG, V85, P546, DOI 10.4269/ajtmh.2011.11-0084
   Bellissimo-Rodrigues F, 2010, INT J GYNECOL OBSTET, V111, P85, DOI 10.1016/j.ijgo.2010.05.015
   Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390
   DERESTREPO FM, 1983, SABOURAUDIA, V21, P35
   Fonseca E R, 1999, Rev Soc Bras Med Trop, V32, P31, DOI 10.1590/S0037-86821999000100006
   Franco M, 1987, Rev Soc Bras Med Trop, V20, P129, DOI 10.1590/S0037-86821987000200012
   Franco M, 1987, J MED VET MYCOL, V27, P5
   Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1
   GIRALDO R, 1976, MYCOPATHOLOGIA, V58, P63, DOI 10.1007/BF00707174
   GOLDANI LZ, 1991, MYCOPATHOLOGIA, V114, P89, DOI 10.1007/BF00436427
   Kauffman CA, 2007, CLIN MICROBIOL REV, V20, P115, DOI 10.1128/CMR.00027-06
   Lacaz CS, 1956, AN FAC ED U SAO PAUL, V29, P7
   Londero AT, 1990, J PNEUMOL, V16, P129
   Louie L, 1999, EMERG INFECT DIS, V5, P672, DOI 10.3201/eid0505.990508
   Marques AS, 1983, REV INST MED TROP SP, V25, P87
   Martinez R, 2010, REV SOC BRAS MED TRO, V43, P480, DOI 10.1590/S0037-86822010000400034
   Paniago Anamaria Mello Miranda, 2003, Rev. Soc. Bras. Med. Trop., V36, P455, DOI 10.1590/S0037-86822003000400004
   PAPPAGIANIS D, 1979, AM REV RESPIR DIS, V120, P959
   Pereira Ricardo Mendes, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P127, DOI 10.1590/S0036-46652004000300002
   Sadahiro A, 2007, MED MYCOL, V45, P35, DOI 10.1080/13693780600999132
   Saubolle MA, 2007, J CLIN MICROBIOL, V45, P26, DOI 10.1128/JCM.02230-06
   Shankar J, 2011, CLIN MICROBIOL REV, V24, P296, DOI 10.1128/CMR.00062-10
   Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017
   Silva SS, 2008, MYCOPATHOLOGIA, V165, P249, DOI 10.1007/s11046-007-9071-2
   Slevogt H, 2004, LANCET, V363, P1282, DOI 10.1016/S0140-6736(04)16001-7
   Valle ACF, 1992, AN BRAS DERMATOL, V67, P251
   Wanke B., 1994, PARACOCCIDIOIDOMYCOS, P109
NR 28
TC 44
Z9 45
U1 0
U2 3
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1369-3786
J9 MED MYCOL
JI Med. Mycol.
PD APR
PY 2013
VL 51
IS 3
BP 313
EP 318
DI 10.3109/13693786.2012.714529
PG 6
WC Infectious Diseases; Mycology; Veterinary Sciences
SC Infectious Diseases; Mycology; Veterinary Sciences
GA 107OQ
UT WOS:000316228100011
PM 22928923
OA Bronze
DA 2020-12-08
ER

PT J
AU Chavez, JH
   dos Reis, VP
   Silva, JR
   Laure, HJ
   Rosa, JC
   da Fonseca, BAL
   Figueiredo, LTM
AF Chavez, Juliana Helena
   dos Reis, Vinicius Pinho
   Silva, Jaqueline Raymondi
   Laure, Helen Julie
   Rosa, Jose Cesar
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
TI Production and diagnostic application of recombinant domain III of West
   Nile envelope protein in Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Diagnosis; WNV antibodies; ELISA
ID VIRUS; ENCEPHALITIS; FLAVIVIRUS; ANTIGENS
AB Introduction: West Nile virus (WNV) is a flavivirus with a natural cycle involving mosquitoes and birds. Over the last 11 years, WNV has spread throughout the Americas with the imminent risk of its introduction in Brazil. Methods: Envelope protein domain III of WNV (rDIII) was bacterially expressed and purified. An enzyme-linked immunosorbent assay with WNV rDIII antigen was standardized against mouse immune fluids (MIAFs) of different flavivirus. Results: WNV rDIII reacted strongly with St. Louis encephalitis virus (SLEV) MIAF but not with other flaviviruses. Conclusions: This antigen may be a potentially useful tool for serologic diagnosis and may contribute in future epidemiological surveillance of WNV infections in Brazil.
C1 [Chavez, Juliana Helena; dos Reis, Vinicius Pinho; Silva, Jaqueline Raymondi; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Ctr Pesquisa Virol, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Laure, Helen Julie; Rosa, Jose Cesar] Univ Sao Paulo, Ctr Pesquisa Virol, Ctr Quim Prot, Ribeirao Preto, SP, Brazil.
   [Laure, Helen Julie; Rosa, Jose Cesar] Univ Sao Paulo, Fundacao Hemoctr Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Figueiredo, LTM (corresponding author), Ctr Pesquisa Virol FMRP USP, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM julianachavez@icbim.ufu.br; ltmfigue@fmrp.usp.br
RI Rosa, Jose C/A-1966-2013; Fonseca, Benedito/F-3252-2012
OI Rosa, Jose C/0000-0002-6917-0230; Fonseca, Benedito/0000-0003-3159-5687
FU Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2006/01179-0]
FX This research was supported by Fundacao de Amparo a Pesquisa de Sao
   Paulo (FAPESP), grant 2006/01179-0.
CR Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   FONSECA BAL, 1991, AM J TROP MED HYG, V44, P500, DOI 10.4269/ajtmh.1991.44.500
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002
   Mattar S, 2005, EMERG INFECT DIS, V11, P1497, DOI 10.3201/eid1109.050426
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852
   Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185
   Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Simmons M, 1998, AM J TROP MED HYG, V58, P144, DOI 10.4269/ajtmh.1998.58.144
NR 15
TC 4
Z9 4
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2013
VL 46
IS 1
BP 97
EP 99
DI 10.1590/0037-868214142013
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 106EV
UT WOS:000316126400020
PM 23563834
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Farias, KJS
   Machado, PRL
   da Fonseca, BAL
AF Silva Farias, Kleber Juvenal
   Lima Machado, Paula Renata
   Lopes da Fonseca, Benedito Antonio
TI Chloroquine Inhibits Dengue Virus Type 2 Replication in Vero Cells but
   Not in C6/36 Cells
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID HEMORRHAGIC-FEVER; SINDBIS VIRUS; INFECTIONS
AB Dengue viruses are the most important arthropod-borne viruses in terms of morbidity and mortality in the world. Since there is no dengue vaccine available for human use, we have set out to investigate the use of chloroquine as an antiviral drug against dengue. Chloroquine, an amine acidotropic drug known to affect intracellular exocytic pathways by increasing endosomal pH, was used in the in vitro treatment of Vero and C6/36 cells infected with dengue virus type 2 (DENV-2). Real-time RT-PCR and plaque assays were used to quantify the DENV-2 load in infected Vero and C6/36 cells after chloroquine treatment. Our results showed that a dose of 50 mu g/ml of chloroquine was not toxic to the cells and induced a statistically significant inhibition of virus production in infected Vero cells when compared to untreated cells. In C6/36 cells, chloroquine does not induce a statistically significant difference in viral replication when compared to untreated cells, showing that this virus uses an unlikely pathway of penetration in these cells, and results were also confirmed by the plaque assay (PFU). These data suggest that the inhibition of virus infection induced by chloroquine is due to interference with acidic vesicles in mammalian cells.
C1 [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Silva Farias, Kleber Juvenal; Lima Machado, Paula Renata] Univ Sao Paulo, Program Grad Studies Appl Microbiol & Immunol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Farias, KJS (corresponding author), Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
EM kfarias3@hotmail.com
RI FARIAS, KLEBER/AAC-9815-2019; Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687; Machado,
   Paula/0000-0002-3085-9778; Farias, Kleber/0000-0003-3927-444X
FU FAPESP (Sao Paulo Foundation for Research)Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [05/04450-4]; FAPESP fellowshipFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/03635-8]
FX This study was supported by FAPESP (Sao Paulo Foundation for Research)
   (Grant no. 05/04450-4). K. J. S. Farias was supported by a FAPESP
   fellowship (Grant no. 04/03635-8).
CR COOMBS K, 1981, J VIROL, V37, P1060, DOI 10.1128/JVI.37.3.1060-1065.1981
   da Fonseca BAL, 2002, CURR OPIN PEDIATR, V14, P67
   DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x
   Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39
   Eng E. O., 2006, VIROL J, V3
   Gomes-Ruiz AC, 2006, J MED VIROL, V78, P760, DOI 10.1002/jmv.20620
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hernandez R, 2001, J VIROL, V75, P2010, DOI 10.1128/JVI.75.4.2010-2013.2001
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   KULL FC, 1988, NAT IMMUN CELL GROW, V7, P254
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   SPERBER K, 1993, AIDS RES HUM RETROV, V9, P91, DOI 10.1089/aid.1993.9.91
   TSAI WP, 1990, AIDS RES HUM RETROV, V6, P481, DOI 10.1089/aid.1990.6.481
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
NR 17
TC 32
Z9 33
U1 0
U2 4
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2013
AR 282734
DI 10.1155/2013/282734
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 084MU
UT WOS:000314544400001
PM 23431254
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Markon, A
   Passos, LMR
   da Fonseca, B
   Wilson, M
AF Markon, A.
   Passos, L. M. R.
   da Fonseca, B.
   Wilson, M.
TI Knowledge, attitudes and practices related to dengue in Ribeirao Preto,
   Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Markon, A.; Wilson, M.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
   [Passos, L. M. R.; da Fonseca, B.] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2012
VL 16
SU 1
BP E353
EP E353
DI 10.1016/j.ijid.2012.05.434
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 999YX
UT WOS:000308353101420
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Lanca, AM
   Collares, JKB
   Ferreira, JLD
   Lima, DM
   Brigido, LFD
   Rodrigues, R
   da Fonseca, BAL
AF Lanca, Andre Minhoto
   Baima Collares, Jeova Keny
   de Paula Ferreira, Joao Leandro
   Lima, Danielle Malta
   de Macedo Brigido, Luis Fernando
   Rodrigues, Rosangela
   Lopes da Fonseca, Benedito Antonio
TI HIV-1 tropism and CD4 T lymphocyte recovery in a prospective cohort of
   patients initiating HAART in Ribeirao Preto, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE HIV-1; disease progression; CD4 T lymphocytes; viral tropism; diversity;
   brazil
ID HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; CORECEPTOR TROPISM;
   VARIANT; TYPE-1; V3-LOOP; AIDS
AB While human immunodeficiency virus (HIV)-1 chemokine co-receptors 5 tropism and the GWGR motif in the envelope third variable region (V3 loop) have been associated with a slower disease progression, their influence on antiretroviral response remains unclear. The impact of baseline V3 characteristics on treatment response was evaluated in a randomised, double blind, prospective cohort study with patients initiating highly active antiretroviral therapy with lopinavir or efavirenz plus azithothymidine/3TC (1:1) over 48 weeks. Similar virological and immunological responses were observed for both treatment regimens. The 43 individuals had a mean baseline CD4 T cell count of 119 cells/mm(3) [standard deviation (SD) = 99] and a mean viral load of 5.09 log(10) copies/mL (SD = 0.49). The GWGR motif was not associated with a CD4 T cell response, but predicted R5 tropism by the geno2pheno([clinical20%]) algorithm correlated with higher CD4 T cell levels at all monitoring points (p < 0.05). Moreover, higher false-positive rates (FPR) values from this analysis revealed a strong correlation with CD4 T cell recovery (p < 0.0001). Transmitted drug resistance mutations, documented in 3/41 (7.3%) cases, were unrelated to the assigned antiretroviral regimen and had no impact on patient outcomes. In conclusion, naive HIV-1 R5 infected patients exhibited higher CD4 T cell counts at baseline; this difference was sustained throughout therapy. The geno2pheno[clinical] option FPR positively correlated with CD4 T cell gain and may be useful in predicting CD4 T cell recovery.
C1 [Lanca, Andre Minhoto; de Paula Ferreira, Joao Leandro; de Macedo Brigido, Luis Fernando; Rodrigues, Rosangela] Adolfo Lutz Inst, Lab Retrovirus, Ctr Virol, Sao Paulo, Brazil.
   [Baima Collares, Jeova Keny; Lima, Danielle Malta] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Ctr Pesquisa Virol, Fac Med, BR-14049 Ribeirao Preto, SP, Brazil.
RP Brigido, LFD (corresponding author), Adolfo Lutz Inst, Lab Retrovirus, Ctr Virol, Sao Paulo, Brazil.
EM lubrigido@gmail.com
RI Colares, Jeova Keny Baima/C-5257-2014; Brigido, Luis F M/C-2155-2011;
   Rodrigues, Rosangela/C-2447-2011; Lima, Danielle/A-6108-2013; Fonseca,
   Benedito/F-3252-2012
OI Colares, Jeova Keny Baima/0000-0003-1367-6272; Brigido, Luis F
   M/0000-0002-1022-7837; Lima, Danielle/0000-0003-2734-6768; Fonseca,
   Benedito/0000-0003-3159-5687
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/8215-0, 2006/61311-0]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [144076/2010-1]
FX FAPESP (2009/8215-0, 2006/61311-0), CNPq (144076/2010-1)
CR CABELLO A, 1995, AIDS RES HUM RETROV, V11, P1135, DOI 10.1089/aid.1995.11.1135
   Casseb J, 2004, MEM I OSWALDO CRUZ, V99, P69, DOI 10.1590/S0074-02762004000100012
   Casseb J, 2002, INT J INFECT DIS, V6, P64
   da Silva J, 2006, GENETICS, V174, P1689, DOI 10.1534/genetics.106.062885
   de Brito A, 2006, CLIN INFECT DIS, V43, P1476, DOI 10.1086/508875
   Ferreira JLD, 2008, MEM I OSWALDO CRUZ, V103, P800, DOI 10.1590/S0074-02762008000800010
   Franca RFO, 2011, AIDS RES HUM RETROV, V27, P903, DOI [10.1089/aid.2010.0266, 10.1089/AID.2010.0266]
   Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b
   Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029
   Pinto ME, 2008, GENET MOL RES, V7, P1031, DOI 10.4238/vol7-4gmr383
   POTTS KE, 1993, AIDS, V7, P1191, DOI 10.1097/00002030-199309000-00007
   Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56
   RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968
   Santoro-Lopes G, 2000, AIDS RES HUM RETROV, V16, P953, DOI 10.1089/08892220050058362
   SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0
   Sing T, 2007, ANTIVIR THER, V12, P1097
   Tanuri A, 1999, J ACQ IMMUN DEF SYND, V20, P60, DOI 10.1097/00042560-199901010-00009
   Vandekerckhove LPR, 2011, EUROPEAN GUIDELINES
NR 18
TC 6
Z9 6
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2012
VL 107
IS 1
BP 96
EP 101
DI 10.1590/S0074-02762012000100014
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 889GU
UT WOS:000300062500014
PM 22310542
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Lima, DM
   Sabino-Santos, G
   Oliveira, ACA
   Fontes, RM
   Colares, JKB
   Araujo, FMD
   Cavalcanti, LPD
   da Fonseca, BAL
   Figueiredo, LTM
   Pompeu, MMD
AF Lima, Danielle Malta
   Sabino-Santos Junior, Gilberto
   Aragao Oliveira, Augusto Cesar
   Fontes, Raissa Matos
   Baima Colares, Jeova Keny
   de Carvalho Araujo, Fernanda Montenegro
   de Goes Cavalcanti, Luciano Pamplona
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
   de Lima Pompeu, Margarida Maria
TI Hantavirus infection in suspected dengue cases from State of Ceara,
   Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Letter
ID POLYMERASE CHAIN-REACTION; CARDIOPULMONARY SYNDROME
C1 [Lima, Danielle Malta; Baima Colares, Jeova Keny] Univ Fortaleza, Curso Med, Fortaleza, CE, Brazil.
   [Lima, Danielle Malta; Aragao Oliveira, Augusto Cesar; Fontes, Raissa Matos; de Lima Pompeu, Margarida Maria] Univ Fed Ceara, Dept Patol & Med Legal, Fortaleza, CE, Brazil.
   [Sabino-Santos Junior, Gilberto; Lopes da Fonseca, Benedito Antonio; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med, Ctr Pesquisa Virol, BR-14049 Ribeirao Preto, SP, Brazil.
   [de Carvalho Araujo, Fernanda Montenegro] Lab Cent Saude Publ Estado Ceara, Setor Virol, Fortaleza, CE, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Secretaria Estadual Saude Estado Ceara, Nucleo Vigilancia Epidemiol, Fortaleza, CE, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Dept Saude Publ, Fortaleza, CE, Brazil.
RP Lima, DM (corresponding author), Rua Marcos Macedo 135-801, BR-60150190 Fortaleza, Ceara, Brazil.
EM danimalta@uol.com.br
RI Colares, Jeova Keny Baima/C-5257-2014; Figueiredo, Luiz T/E-3702-2012;
   Sabino-Santos, Gilberto GSSJ/B-4305-2011; Lima, Danielle/A-6108-2013; G,
   Sabino-Santos Jr/Q-5164-2019; Cavalcanti, Luciano/N-4391-2015; Fonseca,
   Benedito/F-3252-2012
OI Colares, Jeova Keny Baima/0000-0003-1367-6272; Sabino-Santos, Gilberto
   GSSJ/0000-0002-5462-5386; Lima, Danielle/0000-0003-2734-6768; G,
   Sabino-Santos Jr/0000-0002-5462-5386; Cavalcanti,
   Luciano/0000-0002-3440-1182; Fonseca, Benedito/0000-0003-3159-5687
CR Campos GM, 2003, J MED VIROL, V71, P417, DOI 10.1002/jmv.10489
   Chioratto Gerlane Tavares de Souza, 2010, Revista de Patologia Tropical, V39, P1
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289
   *GOV EST CEAR, 2011, INF SEM DENG DAT
   Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Limongi JE, 2007, REV SOC BRAS MED TRO, V40, P295, DOI 10.1590/S0037-86822007000300009
   Mendes WS, 2010, EMERG INFECT DIS, V16, P889, DOI 10.3201/eid1605.090766
   *MIN SAUD, 2010, CAS OB HANT BRAS 199
   Figueiredo LTM, 2009, AM J TROP MED HYG, V81, P273, DOI 10.4269/ajtmh.2009.81.273
   Moreli ML, 2004, MEM I OSWALDO CRUZ, V99, P633, DOI 10.1590/S0074-02762004000600018
NR 12
TC 17
Z9 20
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2011
VL 44
IS 6
BP 795
EP 796
DI 10.1590/S0037-86822011000600031
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 874WX
UT WOS:000298989900031
PM 22231261
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Barros, VED
   Saggioro, FP
   Neder, L
   Franca, RFD
   Mariguela, V
   Chavez, JH
   Penharvel, S
   Forjaz, J
   da Fonseca, BAL
   Figueiredo, LTM
AF Dias de Barros, Veridiana Ester
   Saggioro, Fabiano P.
   Neder, Luciano
   de Oliveira Franca, Rafael Freitas
   Mariguela, Viviane
   Chavez, Juliana Helena
   Penharvel, Sandra
   Forjaz, Jorge
   Lopes da Fonseca, Benedito Antonio
   Moraes Figueiredo, Luiz Tadeu
TI An Experimental Model of Meningoencephalomyelitis by Rocio Flavivirus in
   Balb/C Mice: Inflammatory Response, Cytokine Production, and
   Histopathology
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID YELLOW-FEVER VIRUS; ARBOVIRUS DISEASE; ENCEPHALITIS; INFECTION; CELLS;
   IDENTIFICATION; ASTROCYTES; EMERGENCE; BRAZIL
AB Rocio virus (ROCV) is a flavivirus, probably transmitted by Culex mosquitoes and maintained in nature as a zoonosis of wild birds. Rocio virus caused a human epidemic of severe encephalitis that lasted from 1973 to 1980 in the Ribeira valley, in the southeastern coast of Brazil. After this outbreak, serologic evidence of ROCV circulation has been reported and public health authorities are concerned about a return of ROCV outbreaks in Brazil. We show here a study on the pathogenesis and the physiopathology of ROCV disease in the central nervous system of a Balb/C young adult mice experimental model. The animals were intraperitoneally infected by ROCV and followed from 0 to 9 days after infection, when all of them died. Nervous tissue samples were collected from infected animals for immunohistochemistry and molecular biology analysis. We observed the virus in the central nervous system, the inflammatory changes induced by Th1 and Th2 cytokines, and the final irreversible damage of nervous tissues by neuronal degeneration and apoptosis. These findings can help to better understand the pathogenesis and physiopathology of the human meningoencephalomyelitis by ROCV and other flaviviruses.
C1 [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, Dept Pathol,Dept Surg & Anat, BR-14049900 Ribeirao Preto, Brazil.
RP Figueiredo, LTM (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, Dept Pathol,Dept Surg & Anat, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, Brazil.
EM veridias@yahoo.com.br; ltmfigue@fmrp.usp.br
RI Figueiredo, Luiz T/E-3702-2012; Mariguela, Viviane/F-6083-2013; Fonseca,
   Benedito/F-3252-2012
OI Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Fonseca,
   Benedito/0000-0003-3159-5687
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ)National Council for
   Scientific and Technological Development (CNPq) [141893/2005-2]
FX We are grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPQ) (141893/2005-2) for supporting this study.
CR ABBAS AK, 2005, IMMUNOLOGIA CELULAR, P268
   Barca O, 2003, J NEUROIMMUNOL, V139, P155, DOI 10.1016/S0165-5728(03)00160-7
   Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chavez JH, 2006, VIRUS REV RES, V11, P28
   DAROSA JFS, 1998, OVERVIEW ARBOVIROLOG, P19
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Fujii Y, 2008, JPN J INFECT DIS, V61, P40
   Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x
   IVERSSON LB, 1997, TRATADO INFEECT, P233
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   LOPES OD, 1981, AM J EPIDEMIOL, V113, P122
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   LOPES OS, 1978, AM J TROP MED HYG, V27, P418
   Matthews V, 2000, INT J EXP PATHOL, V81, P31, DOI 10.1046/j.1365-2613.2000.00135.x
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   MITCHELL CJ, 1981, AM J TROP MED HYG, V30, P465, DOI 10.4269/ajtmh.1981.30.465
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06
   Swarup V, 2007, NEUROSCI LETT, V420, P144, DOI 10.1016/j.neulet.2007.04.071
   Tiriba AC, 1975, THESIS ESCOLA PAULIS
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   2003, NAT REV IMMUNOL, V3, P493
NR 33
TC 6
Z9 6
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD AUG
PY 2011
VL 85
IS 2
BP 363
EP 373
DI 10.4269/ajtmh.2011.10-0246
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 803WN
UT WOS:000293613000029
PM 21813860
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Franca, RFO
   Castro-Jorge, LA
   Neto, RJP
   Jorge, DMM
   Lima, DM
   Colares, JKB
   Paula, SO
   da Fonseca, BAL
AF Franca, Rafael F. O.
   Castro-Jorge, Luiza A.
   Neto, Roberto J. P.
   Jorge, Daniel M. M.
   Lima, Danielle M.
   Colares, Jeova K. B.
   Paula, Sergio O.
   Lopes da Fonseca, Benedito A.
TI Genotypic Characteristics of HIV Type 1 Based on gp120 Hypervariable
   Region 3 of Isolates from Southern Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; PHENOTYPE; SEQUENCE; STRAINS; USAGE
AB The aim of this study was to investigate HIV-1 molecular diversity and the epidemiological profile of HIV-1-infected patients from Ribeirao Preto, Brazil. A nested PCR followed by sequencing of a 302-base pair fragment of the env gene (C2-V3 region) was performed in samples from HIV-1-positive patients. A total of 45 sequences were aligned with final manual adjustments. The phylogenetic analyses showed a higher prevalence of HIV-1 subtype B in the studied population (97.8%) with only one sample yielding an F1 subtype. The viral genotyping prediction showed that CCR5 tropism was the most prevalent in the studied cohort. Geno2pheno analysis showed that R5 and CXCR4 prediction were 69% and 31%, respectively. There was no statistical significance, either in viral load or in CD4(+) T cell count when R5 and X4 prediction groups were compared. Moreover, the GPGR tetramer was the most common V3 loop core motif identified in the HIV-1 strains studied (34.1%) followed by GWGR, identified in 18.1% of the samples. The high level of B subtype in this Brazilian population reinforces the nature of the HIV epidemic in Brazil, and corroborates previous data obtained in the Brazilian HIV-infected population.
C1 [Lopes da Fonseca, Benedito A.] Univ Sao Paulo, Mol Virol Lab, Dept Clin Med, Fac Med Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
   [Franca, Rafael F. O.; Castro-Jorge, Luiza A.; Lopes da Fonseca, Benedito A.] Univ Sao Paulo, Program Grad Studies Appl & Basic Immunol, Sch Med Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
   [Neto, Roberto J. P.] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil.
   [Jorge, Daniel M. M.] Univ Sao Paulo, Dept Genet, Sch Med Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
   [Paula, Sergio O.] Univ Fed Vicosa, Dept Biol, Vicosa, MG, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Mol Virol Lab, Dept Clin Med, Fac Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; de Castro Jorge, Luiza
   Antunes/D-3773-2009; Lima, Danielle/A-6108-2013; Jorge, Daniel
   M/B-4533-2010; da Justa Pires Neto, Roberto/AAB-3425-2020; Colares,
   Jeova Keny Baima/C-5257-2014; Fonseca, Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Lima,
   Danielle/0000-0003-2734-6768; Jorge, Daniel M/0000-0002-8387-3215; da
   Justa Pires Neto, Roberto/0000-0003-0291-9523; Colares, Jeova Keny
   Baima/0000-0003-1367-6272; Fonseca, Benedito/0000-0003-3159-5687;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
CR Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184
   Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014
   Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7
   FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992
   Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814
   Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029
   Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012
   Mefford ME, 2008, AIDS RES HUM RETROV, V24, P1215, DOI 10.1089/aid.2008.0009
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Santoro-Lopes G, 2000, AIDS RES HUM RETROV, V16, P953, DOI 10.1089/08892220050058362
   Saracino A, 2007, VIRUS RES, V130, P34, DOI 10.1016/j.virusres.2007.05.011
   Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2
   Veras NMC, 2007, AIDS RES HUM RETROV, V23, P1481, DOI 10.1089/aid.2007.0145
   WOLFS TFW, 1990, P NATL ACAD SCI USA, V87, P9938, DOI 10.1073/pnas.87.24.9938
NR 15
TC 6
Z9 6
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD AUG
PY 2011
VL 27
IS 8
BP 903
EP 909
DI 10.1089/aid.2010.0266
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 803IV
UT WOS:000293575900011
PM 21087177
DA 2020-12-08
ER

PT J
AU Lima, DM
   de Paula, SO
   Franca, RFD
   Palma, PVB
   Morais, FR
   Gomes-Ruiz, AC
   de Aquino, MTP
   da Fonseca, BAL
AF Lima, Danielle Malta
   de Paula, Sergio Oliveira
   de Oliveira Franca, Rafael Freitas
   Palma, Patricia V. B.
   Morais, Fabiana R.
   Gomes-Ruiz, Alessandra Cristina
   Prudente de Aquino, Maria Teresa
   Lopes da Fonseca, Benedito Antonio
TI A DNA vaccine candidate encoding the structural prM/E proteins elicits a
   strong immune response and protects mice against dengue-4 virus
   infection
SO VACCINE
LA English
DT Article
DE Dengue-4; Recombinant DNA; Vaccine; Plasmid
ID DOG KIDNEY-CELLS; NEUTRALIZING ANTIBODIES; JAPANESE-ENCEPHALITIS;
   DOMAIN-III; ENVELOPE PROTEIN; IMMUNOGENICITY; FEVER; IMMUNIZATION;
   INDUCTION; SEROTYPES
AB A DNA vaccine expressing dengue-4 virus premembrane (prM) and envelope (E) genes was produced by inserting these genes into a mammalian expression plasmid (pCI).
   Following a thorough screening, including confirmation of protein expression in vitro, a recombinant clone expressing these genes was selected and used to immunize BALB/c mice. After 3 immunizations all the animals produced detectable levels of neutralizing antibodies against dengue-4 virus. The cytokines levels and T cell proliferation, detected ex vivo from the spleen of the immunized mice, showed that our construction induced substantial immune stimulation after three doses. Even though the antibody levels, induced by our DNA vaccine, were lower than those obtained in mice immunized with dengue-4 virus the levels of protection were high with this vaccine.
   This observation is further supported by the fact that 80% of the vaccine immunized group was protected against lethal challenge. In conclusion, we developed a DNA vaccine employing the genes of the prM and E proteins from dengue-4 virus that protects mice against this virus. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Sch Med Ribeirao Preto,Lab Virol Mol, BR-14049900 Sao Paulo, Brazil.
   [de Oliveira Franca, Rafael Freitas; Prudente de Aquino, Maria Teresa] Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl & Basic Immunol, BR-14049900 Sao Paulo, Brazil.
   [de Paula, Sergio Oliveira] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.
   [Palma, Patricia V. B.; Morais, Fabiana R.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Lab Flow Cytometry, BR-14049900 Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Sch Med Ribeirao Preto,Lab Virol Mol, Ave Bandeirantes,3900 Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI de Aquino, M. Teresa P./AAD-9743-2020; de aquino, maria
   teresa/C-9012-2015; De Paula, Sergio/N-2609-2018; Lima,
   Danielle/A-6108-2013; Fonseca, Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Lima,
   Danielle/0000-0003-2734-6768; Fonseca, Benedito/0000-0003-3159-5687;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao
   Paulo, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2003/07959-0]; FAPESPFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [01/08523-5]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), Sao Paulo, Brazil (Grant #2003/07959-0). Danielle
   Malta Lima was supported by a FAPESP scholarship (Grant #01/08523-5).
CR Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   Blaney JE, 2006, VIRAL IMMUNOL, V19, P10, DOI 10.1089/vim.2006.19.10
   Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3
   Chattergoon MA, 1998, J IMMUNOL, V160, P5707
   De Paula SO, 2008, ARCH VIROL, V153, P2215, DOI 10.1007/s00705-008-0250-3
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Eckels KH, 2003, AM J TROP MED HYG, V69, P12, DOI 10.4269/ajtmh.2003.69.12
   Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48
   Etemad B, 2008, AM J TROP MED HYG, V79, P353, DOI 10.4269/ajtmh.2008.79.353
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Gurunathan S, 2000, CURR OPIN IMMUNOL, V12, P442, DOI 10.1016/S0952-7915(00)00118-7
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2003, AM J TROP MED HYG, V69, P5
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Imoto J, 2007, VACCINE, V25, P1076, DOI 10.1016/j.vaccine.2006.09.059
   Innis BL, 2003, AM J TROP MED HYG, V69, P1
   Jacobs M, 2000, T ROY SOC TROP MED H, V94, P7, DOI 10.1016/S0035-9203(00)90416-4
   Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4
   Khanam S, 2006, VACCINE, V24, P6513, DOI 10.1016/j.vaccine.2006.06.031
   Kitchener S, 2006, VACCINE, V24, P1238, DOI 10.1016/j.vaccine.2005.09.029
   Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mathenge EGM, 2004, J GEN VIROL, V85, P2503, DOI 10.1099/vir.0.80120-0
   Mellado-Sanchez G, 2010, ARCH VIROL, V155, P847, DOI 10.1007/s00705-010-0652-x
   Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028
   Pang TK, 2003, CURR OPIN BIOTECH, V14, P332, DOI 10.1016/S0958-1669(03)00061-2
   Putnak Robert, 2003, Adv Virus Res, V61, P445, DOI 10.1016/S0065-3527(03)61012-2
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Raviprakash K, 2006, VIROLOGY, V353, P166, DOI 10.1016/j.virol.2006.05.005
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Tighe H, 1998, IMMUNOL TODAY, V19, P89, DOI 10.1016/S0167-5699(97)01201-2
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
NR 41
TC 21
Z9 24
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JAN 17
PY 2011
VL 29
IS 4
BP 831
EP 838
DI 10.1016/j.vaccine.2010.10.078
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 715AT
UT WOS:000286853500031
PM 21115054
DA 2020-12-08
ER

PT J
AU Franca, RFD
   Zucoloto, S
   da Fonseca, BAL
AF de Oliveira Franca, Rafael Freitas
   Zucoloto, Sergio
   Lopes da Fonseca, Benedito Antonio
TI A BALB/c mouse model shows that liver involvement in dengue disease is
   immune-mediated
SO EXPERIMENTAL AND MOLECULAR PATHOLOGY
LA English
DT Article
DE Liver; Inflammation; Dengue; Cytokine; Animal model
ID NECROSIS-FACTOR-ALPHA; HEMORRHAGIC-FEVER; VIRUS-INFECTION; MICE;
   IDENTIFICATION; PATHOGENESIS; ANTIBODY; SHOCK
AB In the present study, BALB/c mice were used to develop a model for the hepatic injury associated to dengue infection. Histological analysis after subcutaneous inoculation with a low viral dose of dengue-2 virus showed Kupffer cell hyperplasia and an increased inflammatory cellular infiltrate next to the bile ducts on days 5, 7 and 14 post-inoculation, mainly characterized by the presence of mononuclear cells. The liver mRNA transcription level of IL-1 beta was highest on the 5th day post-infection (p.i.) and decreased by the 21st day, TNF-alpha showed a peak of mRNA transcription after 14 days p.i. coinciding with the regression of cellular infiltrates and elevated expression of TGF-beta mRNA. Serum AST and ALT levels were slightly elevated at 7 and 14 days post-infection. Dengue-2 RNA levels were undetectable in the liver on any of the days following inoculation. Our observations suggest that, as it is true for humans, the animals undergo a transient and slight liver inflammation, probably due to local cytokine production and cellular infiltration in the liver. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Mol Virol Lab, Dept Clin Med, Fac Med Ribeirao Preto,Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [de Oliveira Franca, Rafael Freitas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Program Grad Studies Appl & Basic Immunol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Zucoloto, Sergio] Univ Sao Paulo, Dept Pathol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Mol Virol Lab, Dept Clin Med, Fac Med Ribeirao Preto,Sch Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
CR An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887
   Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
   Barth OM, 2006, MEM I OSWALDO CRUZ, V101, P905, DOI 10.1590/S0074-02762006000800014
   Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014
   Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807
   BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826
   BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X
   Chakravarti A, 2006, INDIAN J MED RES, V123, P25
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   FRESH JW, 1969, J LAB CLIN MED, V73, P451
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   Hober D, 1996, MICROBIOL IMMUNOL, V40, P569, DOI 10.1111/j.1348-0421.1996.tb01110.x
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720
   ROSEN L, 1989, RES VIROLOGY, V140, P351, DOI 10.1016/S0923-2516(89)80115-3
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048
   YADAV M, 1991, FEMS MICROBIOL IMMUN, V89, P45, DOI 10.1111/j.1574-6968.1991.tb04969.x
NR 30
TC 25
Z9 27
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4800
J9 EXP MOL PATHOL
JI Exp. Mol. Pathol.
PD DEC
PY 2010
VL 89
IS 3
BP 321
EP 326
DI 10.1016/j.yexmp.2010.07.007
PG 6
WC Pathology
SC Pathology
GA 686FX
UT WOS:000284683300017
PM 20673760
DA 2020-12-08
ER

PT J
AU Bellissimo-Rodrigues, F
   da Fonseca, BAL
   Martinez, R
AF Bellissimo-Rodrigues, Fernando
   Lopes da Fonseca, Benedito Antonio
   Martinez, Roberto
TI Bacillary angiomatosis in a pregnant woman
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
DE Bacillary angiomatosis; Immunosuppression; Pregnancy
C1 [Bellissimo-Rodrigues, Fernando] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, Sao Paulo, Brazil.
   [Lopes da Fonseca, Benedito Antonio; Martinez, Roberto] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, Div Infect Dis, Sao Paulo, Brazil.
RP Bellissimo-Rodrigues, F (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Hosp Clin, Ave Bandeirantes,3900 Bairro Monte Alegre, BR-14048900 Sao Paulo, Brazil.
EM fbellissimo@ig.com.br
RI Bellissimo-Rodrigues, Fernando/E-7349-2012; Fonseca,
   Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
CR Chama CM, 2009, J OBSTET GYNAECOL, V29, P702, DOI 10.3109/01443610903182920
   Hunt JS, 2009, CURR OPIN PHARMACOL, V9, P462, DOI 10.1016/j.coph.2009.05.007
   IWATANI Y, 1988, AM J REPROD IMMUNOL, V18, P52
   Lamas C, 2008, MEM I OSWALDO CRUZ, V103, P221, DOI 10.1590/S0074-02762008000300001
NR 4
TC 2
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD OCT
PY 2010
VL 111
IS 1
BP 85
EP 86
DI 10.1016/j.ijgo.2010.05.015
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 661NN
UT WOS:000282735100022
PM 20650456
DA 2020-12-08
ER

PT J
AU De Paula, SO
   Lima, D
   Franca, RFD
   Gomes-Ruiz, AC
   da Fonseca, BAL
AF De Paula, Sergio Oliveira
   Lima, Danielle Malta
   de Oliveira Franca, Rafael Freitas
   Gomes-Ruiz, Alessandra Cristina
   Lopes da Fonseca, Benedito Antonio
TI A DNA vaccine candidate expressing dengue-3 virus prM and E proteins
   elicits neutralizing antibodies and protects mice against lethal
   challenge
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ENCEPHALITIS-VIRUS; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS;
   HEMORRHAGIC-FEVER; ENVELOPE PROTEIN; E-GLYCOPROTEIN; DOMAIN-III; TYPE-2;
   EFFICACY; IDENTIFICATION
AB In an effort to develop a suitable DNA vaccine candidate for dengue, using dengue-3 virus (DENV-3) as a prototype, the genes coding for premembrane (prM) and envelope proteins (E) were inserted into an expression plasmid. After selecting recombinant clones containing prM/E genes, protein expression in the cell monolayer was detected by indirect immunofluorescence and immunoprecipitation assays. After selecting three vaccine candidates (pVAC1DEN3, pVAC2DEN3 and pVAC3DEN3), they were analyzed in vivo to determine their ability to induce a DENV-3-specific immune response. After three immunizations, the spleens of the immunized animals were isolated, and the cells were cultivated to measure cytokine levels by ELISA and used for lymphoproliferation assays. All of the animals inoculated with the recombinant clones induced neutralizing antibodies against DENV-3 and produced a T cell proliferation response after specific stimuli. Immunized and control mice were challenged with a lethal dose of DENV-3 and observed in order to assess their survival capability. The groups that presented the best survival rate after the challenge were the animals vaccinated with the pVAC3DEN3 clones, with an 80% survival rate. Thus, these data show that we have manufactured a vaccine candidate for DENV-3 that is able to induce a specific immune response and protects mice against a lethal challenge.
C1 [De Paula, Sergio Oliveira] Univ Fed Vi, Dept Biol Geral, LaboratA, Rio Imunovirologia Mol, BR-36570000 CEP 36570000, Brazil.
   [Lima, Danielle Malta; Gomes-Ruiz, Alessandra Cristina] Preto, Univ SA, Sch Med Ribeirao, Dept Internal Med, Ribeirao Preto, SP, Brazil.
   [De Paula, Sergio Oliveira] Univ Fed Vicosa, Dept Biol Geral, Lab Imunovirol Mol, BR-36570000 Vicosa, MG, Brazil.
   [Lima, Danielle Malta; de Oliveira Franca, Rafael Freitas; Gomes-Ruiz, Alessandra Cristina; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Sch Med Ribeirao, Dept Internal Med, Ribeirao Preto, Brazil.
RP De Paula, SO (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Lab Imunovirol Mol, Av PH Rolfs,S-N, BR-36570000 Vicosa, MG, Brazil.
EM depaula@ufv.br
RI De Paula, Sergio/N-2609-2018; Fonseca, Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Fonseca,
   Benedito/0000-0003-3159-5687; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao
   Paulo, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [00/12957-8]; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [00/09287-0]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), Sao Paulo, Brazil (Grant 00/12957-8). SOP was
   supported by a FAPESP scholarship (Grants 00/09287-0). Thanks to Jeffrey
   Ryan Oar of Oregon State University for the revision and corrections
   made to the text.
CR Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223
   Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   Blair PJ, 2006, VACCINE, V24, P1427, DOI 10.1016/j.vaccine.2005.09.032
   Burke D, 2001, FIELDS VIROLOGY, V4, P1043
   CAZIONEZ RO, 2001, VACCINE, V19, P648
   Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107
   DHARAKUL T, 1994, J INFECT DIS, V170, P27, DOI 10.1093/infdis/170.1.27
   EDELMAN R, 2004, AM J TROP MED HYG, V70, P336
   Fauquet C. M., 2005, 8 INT COMM TAX VIR
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7
   Konishi E, 1998, J VIROL, V72, P4925, DOI 10.1128/JVI.72.6.4925-4930.1998
   KURANE I, 1989, J EXP MED, V170, P763, DOI 10.1084/jem.170.3.763
   LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rothman AL, 2001, VACCINE, V19, P4694, DOI 10.1016/S0264-410X(01)00236-5
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   TRIRAWATANAPONG T, 1992, GENE, V116, P139, DOI 10.1016/0378-1119(92)90509-N
   Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
NR 33
TC 22
Z9 22
U1 0
U2 4
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PD DEC
PY 2008
VL 153
IS 12
BP 2215
EP 2223
DI 10.1007/s00705-008-0250-3
PG 9
WC Virology
SC Virology
GA 391KJ
UT WOS:000262231900005
PM 19002647
DA 2020-12-08
ER

PT J
AU Vilar, FC
   Badiale, GB
   da Fonseca, BAL
AF Vilar, Fernando Crivelenti
   Badiale, Giovana Bachega
   da Fonseca, Benedito Antonio Lopes
TI Schistosomiasis of the uterine cervix
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 USP, FMRP, HC, Dept Clin Med,Div Molestias Infecciosas, BR-14048900 Ribeirao Preto, Brazil.
   USP, FMRP, HC, Serv Patol, BR-14048900 Ribeirao Preto, Brazil.
RP da Fonseca, BAL (corresponding author), USP, FMRP, HC, Dept Clin Med,Div Molestias Infecciosas, Av Brandeirantes 3900,Campus Univ, BR-14048900 Ribeirao Preto, Brazil.
EM baldfons@fmrp.usp.br
RI Vilar, Fernando Crivelenti/AAK-4233-2020; Fonseca, Benedito/F-3252-2012
OI vilar, fernando crivelenti/0000-0001-8232-5375; Fonseca,
   Benedito/0000-0003-3159-5687
CR Adeniran A, 2003, ARCH PATHOL LAB MED, V127, P1637
   ELMAHGOUB S, 1982, INT J GYNECOL OBSTET, V20, P201, DOI 10.1016/0020-7292(82)90072-8
   HellingGiese G, 1996, ACTA TROP, V62, P225, DOI 10.1016/S0001-706X(96)00025-3
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2007
VL 40
IS 2
BP 256
EP 257
DI 10.1590/S0037-86822007000200025
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 174KG
UT WOS:000246940200025
PM 17568903
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Gomes-Ruiz, AC
   Nascimento, RT
   de Paula, SO
   da Fonseca, BAL
AF Gomes-Ruiz, AC
   Nascimento, RT
   de Paula, SO
   da Fonseca, BAL
TI SYBR green and TaqMan real-time PCR assays are equivalent for the
   diagnosis of dengue virus type 3 infections
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE dengue; real-time PCR; TaqMan; Sybr Green
ID RT-PCR; IDENTIFICATION
AB Dengue is the most important arthropod-borne viral disease in the world. A rapid diagnostic test for dengue is warranted, and real-time polymerase chain reaction may improve diagnosis. Taq-Man and Sybr Green systems were evaluated for the diagnosis of dengue virus type 3 (DENV-3) infections. Out of 77 patients with clinical suspicion of dengue infection, specific IgM antibodies were detected in 40 patients. DENV-3 was detected and quantitated in 17 IgM-positive samples by both systems. These assays were shown to be rapid, and specific for detection of DENV-3, and that for diagnostic purposes, there is no difference between these two assays.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, BR-14049900 Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; Fonseca, Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Fonseca,
   Benedito/0000-0003-3159-5687
CR Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   CHAN SY, 1994, J VIROL METHODS, V49, P315, DOI 10.1016/0166-0934(94)90146-5
   De Paula SO, 2004, J CLIN VIROL, V30, P297, DOI 10.1016/j.jcv.2003.11.004
   De Paula SO, 2003, INTERVIROLOGY, V46, P227, DOI 10.1159/000072432
   De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gomes-Ruiz AC, 2006, J MED VIROL, V78, P760, DOI 10.1002/jmv.20620
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   Halstead SB, 2002, LANCET, V360, P1243, DOI 10.1016/S0140-6736(02)11276-1
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Laue T, 1999, J CLIN MICROBIOL, V37, P2543, DOI 10.1128/JCM.37.8.2543-2547.1999
   Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Pas SD, 2002, J CLIN VIROL, V25, P93, DOI 10.1016/S1386-6532(02)00016-1
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 18
TC 16
Z9 17
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUN
PY 2006
VL 78
IS 6
BP 760
EP 763
DI 10.1002/jmv.20620
PG 4
WC Virology
SC Virology
GA 040ID
UT WOS:000237371300009
PM 16628591
DA 2020-12-08
ER

PT J
AU Vilar, FC
   Neves, FF
   Colares, JKB
   da Fonseca, BAL
AF Vilar, Fernando Crivelenti
   Neves, Fabio Fernandes
   Baima Colares, Jeova Keny
   Lopes da Fonseca, Benedito Antonio
TI Spinal tuberculosis (Pott's disease) associated to psoas abscess: report
   of two cases and a literature review
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Pott's disease; spinal tuberculosis; Mycobacterium tuberculosis; psoas
   abscess
ID OSTEOARTICULAR TUBERCULOSIS; PARAPLEGIA
AB Tuberculosis is one of the most important infectious disease worldwide, with 3,9 million reported cases in the world in 2002. The skeletal form is responsible for 3% of the total number of cases, with 50% of these due to spinal tuberculosis. The psoas abscess is a rare clinical entity with approximately 12 cases per year described in the medical literature and has in the Mycobacterium tuberculosis, one of its etiologic agents. The objective of this work is to report two cases of spinal tuberculosis associated with psoas abscess attended at our service, as well as a review of the literature.
C1 USP, FMRP, Dept Clin Med, HC,Div Mol Infecciosas, BR-14048900 Ribeirao Preto, Brazil.
   USP, FMRP, Unidade Emergencia Hosp Clin, BR-14048900 Ribeirao Preto, Brazil.
RP da Fonseca, BAL (corresponding author), USP, FMRP, Dept Clin Med, HC,Div Mol Infecciosas, Av Bandeirantes 3900,Campus Univ, BR-14048900 Ribeirao Preto, Brazil.
EM baldfons@fmrp.usp.br
RI Vilar, Fernando Crivelenti/AAK-4233-2020; Colares, Jeova Keny
   Baima/C-5257-2014; Fonseca, Benedito/F-3252-2012
OI Colares, Jeova Keny Baima/0000-0003-1367-6272; Neves,
   Fabio/0000-0001-6536-3249; Fonseca, Benedito/0000-0003-3159-5687; vilar,
   fernando crivelenti/0000-0001-8232-5375
CR BACHIEADJEI O, 1996, ORTHOP CLIN N AM, V27, P95
   BALBBUKER SS, 1984, J BONE JOINT SURG BR, V66, P239
   *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P361
   Franco-Paredes C, 2001, AM J MED SCI, V321, P415, DOI 10.1097/00000441-200106000-00008
   FYFE IS, 1983, J BONE JOINT SURG BR, V65, P140
   Griffith JF, 2002, CLIN ORTHOP RELAT R, P32
   HAAS DW, 2000, PRINCIPLES PRACTICE, pCH240
   HSU LCS, 1984, J BONE JOINT SURG BR, V66, P1
   Imaz MS, 2004, J CLIN MICROBIOL, V42, P884, DOI 10.1128/JCM.42.2.884-887.2004
   Jain AK, 2002, CLIN ORTHOP RELAT R, P75
   Jellis JE, 2002, CLIN ORTHOP RELAT R, P27
   Khoo Larry T, 2003, Spine J, V3, P130, DOI 10.1016/S1529-9430(02)00410-2
   LIFESO RM, 1985, J BONE JOINT SURG AM, V67A, P1405, DOI 10.2106/00004623-198567090-00017
   Lodha Rakesh, 2004, Indian Journal of Pediatrics, V71, P221, DOI 10.1007/BF02724274
   *MED RES COUNC WOR, 1985, J BONE JOINT SURG BR, V67, P103
   *MIN SAUD, 1995, MAN NORM CONTR TUB
   Moon MS, 1996, CLIN ORTHOP RELAT R, P122
   Moon MS, 1997, SPINE, V22, P1791, DOI 10.1097/00007632-199708010-00022
   Muckley T, 2003, SPINE, V28, pE106, DOI 10.1097/00007632-200303150-00021
   PATTISSON PRM, 1986, PARAPLEGIA, V24, P77, DOI 10.1038/sc.1986.11
   POTT P, 1936, MED CLASSICS, V1, P271
   REJASEKARAN S, 1987, J BONE JOINT SURG AM, V69, P503
   Shembekar A, 2002, CLIN ORTHOP RELAT R, P20
   Tuli SM, 2002, CLIN ORTHOP RELAT R, P11
   *WHO, 2002, EST TUB INC MORT 200
NR 25
TC 10
Z9 10
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2006
VL 39
IS 3
BP 278
EP 282
DI 10.1590/S0037-86822006000300011
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 068HW
UT WOS:000239365200011
PM 16906254
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Lima, DM
   Bollela, VR
   Jacomo, BJT
   Martinez, R
   da Fonseca, BAL
AF Lima, DM
   Bollela, VR
   Jacomo, BJT
   Martinez, R
   da Fonseca, BAL
TI Identification of Mycobacterium species in contaminated cultures by
   polymerase chain reaction
SO CHEST
LA English
DT Article
DE contaminated culture; DNA; Mycobacterium tuberculosis; polymerase chain
   reaction
ID TUBERCULOSIS; CARE; PCR
AB Study objectives: The detection of Mycobacterium sp on a culture remains the "gold standard" technique for the diagnosis of mycobacterial infections. A small percentage of these cultures, however, may, be contaminated by other nonfastidious microorganisms, making accurate diagnosis difficult. We evaluated the use of a polymerase chain reaction (PCR) protocol that was specific for the genus Mycobacterium, and specifically for Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium intracellulare, for the identification of Mycobacterium sp growing on contaminated cultures.
   Design: This prospective study was designed to identify Mycobacterium sp growing on mycobacterial cultures contaminated with other microorganisms.
   Samples and patients: Twenty-six samples, taken from 23 patients with probable mycobacterial disease, that resulted in Mycobacterium growth but were contaminated during their processing were evaluated in this study. Clinical data and the clinical status of each patient were used to ascertain the final diagnosis.
   Results: All samples studied here exhibited Mycobacterium growth on solid media but were contaminated by nonfastidious bacteria, compromising the biochemical identification of the Mycobacterium sp. PCR correctly identified the genus Mycobacterium in all samples. M tuberculosis was identified in 14 samples, and 31 avium in 10 samples. No amplification of M intracellulare was obtained, and in two samples there was amplification only for the genus Mycobacterium. In the cultures of those patients in whom a mycobacterial infection was evident, PCR identified Ill avium and M tuberculosis in samples from 6 and 12 patients, respectively. However, PCR identified M avium (two patients) and M tuberculosis (two patients) in the cultures of four patients for whom a mycobacterial disease could not be confirmed by our case definition. Finally, in two samples from one patient only the genus Mycobacterium was amplified by PCR.
   Conclusion: PCR, with its advantages of greater speed and effectiveness than conventional detection methods, was successfully used to identify the Mycobacterium sp growing on contaminated cultures.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, BR-14049900 Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ave Bandeirantes,3900 Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Bollela, Valdes Roberto/F-9182-2014; Lima, Danielle/A-6108-2013;
   Fonseca, Benedito/F-3252-2012
OI Bollela, Valdes Roberto/0000-0002-8221-4701; Lima,
   Danielle/0000-0003-2734-6768; Fonseca, Benedito/0000-0003-3159-5687
CR ALLEN BW, 1982, MED LAB SCI, V39, P11
   BEIGE J, 1995, J CLIN MICROBIOL, V33, P90, DOI 10.1128/JCM.33.1.90-95.1995
   BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055
   Burman WJ, 2000, CLIN INFECT DIS, V31, P1390, DOI 10.1086/317504
   Chen ZH, 1996, J CLIN MICROBIOL, V34, P1267, DOI 10.1128/JCM.34.5.1267-1269.1996
   CORMICAN MG, 1995, DIAGN MICROBIOL INFE, V22, P20
   EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977
   Katila ML, 2000, J CLIN MICROBIOL, V38, P960, DOI 10.1128/JCM.38.3.960-964.2000
   Kaul KL, 2001, CLIN CHEM, V47, P1553
   Lima DM, 2003, CHEST, V124, P909, DOI 10.1378/chest.124.3.909
   Santis G, 1999, CRIT CARE MED, V27, P825, DOI 10.1097/00003246-199904000-00047
   TONY JC, 1995, CHEST, V108, P1393
   Zheng XT, 2001, J CLIN MICROBIOL, V39, P3718, DOI 10.1128/JCM.39.10.3718-3720.2001
NR 13
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0012-3692
J9 CHEST
JI Chest
PD APR
PY 2005
VL 127
IS 4
BP 1283
EP 1288
DI 10.1378/chest.127.4.1283
PG 6
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 915ZG
UT WOS:000228349900035
PM 15821206
DA 2020-12-08
ER

PT J
AU De Paula, SO
   De Melo Lima, C
   Torres, MP
   Pereira, MRG
   da Fonseca, BAL
AF De Paula, SO
   De Melo Lima, C
   Torres, MP
   Pereira, MRG
   da Fonseca, BAL
TI One-step RT-PCR protocols improve the rate of dengue diagnosis compared
   to two-step RT-PCR approaches
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE dengue; diagnosis; RT-PCR; one-step kits; two-step kits
ID IDENTIFICATION; VIRUS
AB Dengue is the most important arboviral disease transmitted to humans. In our laboratory, we have been working on the standardization of the polymerase chain reaction (PCR) diagnosis of this disease. In this work, we compared five commercial kits regularly used on reverse-transcription polymerase chain reaction (RT-PCR) protocols: two Two-Step kits (Superscript 11 RT/Super Mix kit and reverse transcription system/Taq DNA polymerase) and three One-Step kits (ready-to-go RT-PCR Beads kit, QIAGEN One-Step RT-PCR kit, and AcessQuick RT-PCR system). Thirty-one serum samples of patients with clinical diagnosis of dengue fever (DF) were analyzed by RT-PCR and serology. RNA extraction was done with the QIAamp Viral RNA kit, and cDNA synthesis and PCR done according to the manufacturer's protocol for the five kits. Out of the 31 serum samples collected from patients suspected of having dengue, 27 were IgM-positive, confirming the dengue diagnosis. Out of those, 24 were positive by the ready-to-go RT-PCR Beads kit, 25 were positive by AcessQuick RT-PCR system and 27 were positive by QIAGEN One-Step RT-PCR kit. On the other hand, only six samples were positive by the Superscript 11 RT/Super Mix kits and 10 were positive by reverse transcription system/Taq DNA polymerase kit. The best performance observed with the One-Step kits was confirmed in spiked samples with known quantities of dengue-1 virus since they detected up I X 10(2) PFU/ml, while the most sensitive Two-Step kit detected up I X 104 PFU/ml. These data show that One-Step RT-PCR kits yielded a higher rate of dengue virus detection than the Two-Step kits and correlated well with the serological diagnosis. (C) 2003 Published by Elsevier B.V.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Lab Mol Virol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl Microbiol & Immunol, Ribeirao Preto, SP, Brazil.
   Hlth Cent 3, Borborema, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Lab Mol Virol, Avenida Bandeirantes,3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; Fonseca, Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Fonseca,
   Benedito/0000-0003-3159-5687
CR De Paula SO, 2002, J MED VIROL, V66, P529, DOI 10.1002/jmv.2177
   De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5
   De Paula SO, 2001, J VIROL METHODS, V98, P119, DOI 10.1016/S0166-0934(01)00371-8
   Deubel Vincent, 1997, P335
   Grabensteiner E, 2001, CLIN DIAGN LAB IMMUN, V8, P93, DOI 10.1128/CDLI.8.1.93-104.2001
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   1998, DENGUE HEMORRAGIC FE
   2002, EPIDEMIOL B PAHO, V23, P1
NR 14
TC 21
Z9 23
U1 1
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD AUG
PY 2004
VL 30
IS 4
BP 297
EP 301
DI 10.1016/j.jcv.2003.11.004
PG 5
WC Virology
SC Virology
GA 831IN
UT WOS:000222188200003
PM 15163417
DA 2020-12-08
ER

PT J
AU da Fonseca, BAL
   Lima, DM
   Colares, JKB
AF da Fonseca, BAL
   Lima, DM
   Colares, JKB
TI Diagnosing pleural tuberculosis
SO CHEST
LA English
DT Letter
ID POLYMERASE-CHAIN-REACTION
C1 Univ Sao Paulo, Dept Clin Med, FMRP, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Clin Med, FMRP, Sch Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Trajman, Anete/C-7679-2016; Lima, Danielle/A-6108-2013
OI Trajman, Anete/0000-0002-4000-4984; Lima, Danielle/0000-0003-2734-6768
CR DEWIT D, 1992, TUBERCLE LUNG DIS, V73, P262, DOI 10.1016/0962-8479(92)90130-C
   QUEROL M, 1995, AM J RESP CRIT CARE, V152, P1977, DOI 10.1164/ajrccm.152.6.8520765
NR 2
TC 1
Z9 1
U1 0
U2 1
PU AMER COLL CHEST PHYSICIANS
PI NORTHBROOK
PA 3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA
SN 0012-3692
J9 CHEST
JI Chest
PD JUN
PY 2004
VL 125
IS 6
BP 2366
EP 2367
DI 10.1016/S0012-3692(16)59026-6
PG 2
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 832FQ
UT WOS:000222253100069
DA 2020-12-08
ER

PT J
AU Carbonell, GV
   Falcon, R
   Yamada, AT
   da Fonseca, BAL
   Yano, T
AF Carbonell, GV
   Falcon, R
   Yamada, AT
   da Fonseca, BAL
   Yano, T
TI Morphological and intracellular alterations induced by Serratia
   marcescens cytotoxin
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE Serratia marcescens; cytotoxin; apoptosis; virulence factors
ID CELLS; APOPTOSIS; DNA
AB In the present work, in vitro assays were used to investigate the toxicity of Serratia marcescens cytotoxin in cultured Chinese hamster ovary (CHO) cells. The time necessary to detect cellular alterations such as the onset of apoptosis, the perturbation of mitochondrial function, and cytoskeletal changes was assessed. The internalization of the cytotoxin by CHO cells was also examined. Within 10-15 min of exposure to cytotoxin, CHO cells became round, the nucleus shrank, the chromatin became more compact, and cytoplasmic blebs appeared on the cell surface. TUNEL (TdT-mediated dUTP nick end labeling) and propidium iodide staining identified some nuclei with fragmented DNA, and electrophoresis of CHO cell DNA obtained after 30-min exposure to S. marcescens toxin showed a pattern of DNA fragments typically associated with apoptosis. The cells also lost their characteristic actin organization within 10 min of exposure to cytotoxin. Lactate dehydrogenase leakage was detected after 20-min exposure to the cytotoxin and increased with time thereafter. Concomitantly, there was a time-dependent reduction in mitochondrial activity. Fluorescein-labeled S. marcescens cytotoxin was detected only on the surface of CHO cells, even after 30-min exposure to the toxin. These results show that there was no internalization of the toxin by CHO cells, and that, once bound to the cell surface, the toxin was able to induce changes in intracellular metabolism and to trigger cell death by apoptosis. (C) 2003 Elsevier SAS. All rights reserved.
C1 UNICAMP, Inst Biol, Dept Microbiol & Immunol, Sao Paulo, Brazil.
   Inst Pedro Kouri, Havana, Cuba.
   UNICAMP, Inst Biol, Dept Histol & Embryol, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Hosp Clin, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP Carbonell, GV (corresponding author), UNICAMP, Inst Biol, Dept Microbiol & Immunol, Sao Paulo, Brazil.
EM gleize@yahoo.com
RI Yamada, Aureo T/F-7752-2012; Fonseca, Benedito/F-3252-2012
OI Yamada, Aureo T/0000-0003-3620-9685; Falcon,
   Rosabel/0000-0003-1273-6835; Fonseca, Benedito/0000-0003-3159-5687
CR Byrne AH, 2000, J HOSP INFECT, V45, P242, DOI 10.1053/jhin.2000.0761
   Carbonell GV, 1997, BRAZ J MED BIOL RES, V30, P1291, DOI 10.1590/S0100-879X1997001100005
   Carbonell GV, 2000, FEMS IMMUNOL MED MIC, V28, P143, DOI 10.1111/j.1574-695X.2000.tb01469.x
   Carbonell GV, 2003, BRAZ J MED BIOL RES, V36, P351, DOI 10.1590/S0100-879X2003000300010
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x
   Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193
   Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903
   Hertle R, 1999, INFECT IMMUN, V67, P817, DOI 10.1128/IAI.67.2.817-825.1999
   Johnson JS, 1998, J CLIN PATHOL, V51, P789, DOI 10.1136/jcp.51.10.789
   KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989
   MATSUMOTO K, 1984, J BACTERIOL, V157, P225, DOI 10.1128/JB.157.1.225-232.1984
   MITCHELL DB, 1980, J TISSUE CULTURE MET, V6, P113, DOI DOI 10.1007/BF02082861
   Souza-Pinto Nadja C. De, 1996, Free Radical Biology and Medicine, V20, P657
   vanOgtrop ML, 1997, J HOSP INFECT, V36, P95, DOI 10.1016/S0195-6701(97)90115-8
   Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155
   Yamazaki Y, 2000, EXP CELL RES, V259, P64, DOI 10.1006/excr.2000.4970
   Yu W L, 1998, J Microbiol Immunol Infect, V31, P171
NR 18
TC 8
Z9 9
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-2508
EI 1769-7123
J9 RES MICROBIOL
JI Res. Microbiol.
PD JAN-FEB
PY 2004
VL 155
IS 1
BP 25
EP 30
DI 10.1016/j.resmic.2003.09.009
PG 6
WC Microbiology
SC Microbiology
GA 779PE
UT WOS:000189308500004
PM 14759705
DA 2020-12-08
ER

PT J
AU Lima, DM
   Colares, JKB
   da Fonseca, BAL
AF Lima, DM
   Colares, JKB
   da Fonseca, BAL
TI Combined use of the polymerase chain reaction and detection of adenosine
   deaminase activity on pleural fluid improves the rate of diagnosis of
   pleural tuberculosis
SO CHEST
LA English
DT Article
DE adenosine deaminase activity; diagnosis; Mycobacterium tuberculosis;
   pleural fluid; polymerase chain reaction; tuberculosis pleuritis
ID MYCOBACTERIUM-TUBERCULOSIS; CLINICAL-SAMPLES; DIFFERENTIAL-DIAGNOSIS;
   RAPID DIAGNOSIS; AMPLIFICATION; DNA; IDENTIFICATION; EFFUSIONS; SEQUENCE
AB Study objectives: Evaluation of the combined use of polymerase chain reaction (PCR) and adenosine deaminase (ADA) activity on the diagnosis of pleural tuberculosis (pTB) in a region of high prevalence of tuberculosis.
   Patients: PCR and determination of ADA activity were performed on the pleural fluid of every patient presenting with pleural effusion suspected to be associated with tuberculosis. The case definition of pTB involved parameters including the combination of clinical and radiologic findings; biochemical, microbiologic, and cytologic examination of the pleural fluid; and the histopathologic findings of pleural fragments obtained by biopsy. The diagnosis of pTB was confirmed in any patient presenting with positive culture findings of Mycobacterium tuberculosis, either on the pleural fluid or other biological material, or the presence of histopathologic findings suggestive of pTB on pleural biopsy, and also, in the absence of negative laboratory results, those patients with clinical improvement after empirical treatment.
   Results: We studied 45 patients with pleural effusion. Of these, 16 patients met the diagnosis of pTB by our broad case definition. PCR findings were positive in six patients. The reaction was also positive in a patient whose diagnosis of tuberculosis could not be confirmed. ADA activity was considered positive in 11 patients with pTB. The combined use of PCR and ADA activity confirmed pTB in 14 patients; however, when analyzed in combination with the conventional methods, diagnosis of pTB was achieved in all 16 patients.
   Conclusion: Our results show that, even in a highly endemic area, neither PCR nor ADA activity should be relied on as a single test that substitutes for the diagnostic methods already available, but rather they should be used as an extra tool in the diagnosis of pTB. The combined analysis of PCR and ADA activity, however, is a very useful diagnostic approach to achieve a more rapid and precise diagnosis in the cases of pTB.
C1 Univ Sao Paulo, Sch Med, Dept Internal Med, Ribeirao Preto, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Avenida Bandeirantes 3900, BR-14049900 Ribeirao Preto, Sao Paulo, Brazil.
RI Colares, Jeova Keny Baima/C-5257-2014; Lima, Danielle/A-6108-2013;
   Fonseca, Benedito/F-3252-2012
OI Colares, Jeova Keny Baima/0000-0003-1367-6272; Lima,
   Danielle/0000-0003-2734-6768; Fonseca, Benedito/0000-0003-3159-5687
CR BENALES JL, 1991, CHEST, V99, P355
   BERGER HW, 1973, CHEST, V63, P88, DOI 10.1378/chest.63.1.88
   BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055
   De Paula SO, 2002, J VIROL METHODS, V102, P113, DOI 10.1016/S0166-0934(02)00005-8
   DEWIT D, 1992, TUBERCLE LUNG DIS, V73, P262, DOI 10.1016/0962-8479(92)90130-C
   EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977
   FOLGUEIRA L, 1993, J CLIN MICROBIOL, V31, P1019, DOI 10.1128/JCM.31.4.1019-1021.1993
   Giusti G, 1974, METHOD ENZYMAT AN, P1092
   GRANGE JM, 1989, TUBERCLE, V70, P1, DOI 10.1016/0041-3879(89)90059-7
   JAY SJ, 1985, CLIN CHEST MED, V6, P33
   Nagesh BS, 2001, CHEST, V119, P1737, DOI 10.1378/chest.119.6.1737
   PAO CC, 1990, J CLIN MICROBIOL, V28, P1877, DOI 10.1128/JCM.28.9.1877-1880.1990
   PFALLER MA, 1994, AM J CLIN PATHOL, V101, P329, DOI 10.1093/ajcp/101.3.329
   PIERRE C, 1993, AM REV RESPIR DIS, V147, P420, DOI 10.1164/ajrccm/147.2.420
   PIERRE C, 1991, J CLIN MICROBIOL, V29, P712, DOI 10.1128/JCM.29.4.712-717.1991
   PIRAS MA, 1978, BRIT MED J, V2, P1751, DOI 10.1136/bmj.2.6154.1751-a
   Raviglione M C, 1996, Curr Issues Public Health, V2, P192
   Reechaipichitkul Wipa, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P383
   SHANKAR P, 1991, LANCET, V337, P5, DOI 10.1016/0140-6736(91)93328-7
   SOINI H, 1992, J CLIN MICROBIOL, V30, P2025, DOI 10.1128/JCM.30.8.2025-2028.1992
   THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990
   Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158
   VALDES L, 1995, THORAX, V50, P600, DOI 10.1136/thx.50.6.600
   VANKEIMPEMA ARJ, 1987, EUR J RESPIR DIS, V71, P15
   Villegas MV, 2000, CHEST, V118, P1355, DOI 10.1378/chest.118.5.1355
   WOLINSKY E, 1994, CLIN INFECT DIS, V19, P396, DOI 10.1093/clinids/19.3.396
NR 26
TC 37
Z9 42
U1 0
U2 1
PU AMER COLL CHEST PHYSICIANS
PI NORTHBROOK
PA 3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA
SN 0012-3692
J9 CHEST
JI Chest
PD SEP
PY 2003
VL 124
IS 3
BP 909
EP 914
DI 10.1378/chest.124.3.909
PG 6
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 721XQ
UT WOS:000185344100024
PM 12970016
DA 2020-12-08
ER

PT J
AU De Paula, SO
   Lima, DM
   Clotteau, M
   Neto, RDP
   da Fonseca, BAL
AF De Paula, SO
   Lima, DM
   Clotteau, M
   Neto, RDP
   da Fonseca, BAL
TI Improved detection of dengue-1 virus from IgM-Positive serum samples
   using C6/36 cell cultures in association with RT-PCR
SO INTERVIROLOGY
LA English
DT Article
DE dengue virus; diagnosis, dengue; immunofluorescence assay, indirect;
   polymerase chain reaction; RT-PCR
ID POLYMERASE CHAIN-REACTION; RAPID IDENTIFICATION; YELLOW-FEVER;
   DIAGNOSIS; SENSITIVITY; INFECTIONS
AB Dengue is the most important arboviral disease in the world, and its diagnosis is primarily made by serology. Virus isolation has been successful mainly in clinical samples obtained during the acute phase of illness, and is carried out through inoculation of clinical samples into C6/36 cell monolayers followed by the detection of infection by indirect immunofluorescence assay (IFA). We compared the efficiency of RT-PCR and IFA in the detection of dengue-1 virus after inoculation of C6/36 cells with samples obtained in the convalescent period of dengue infection. Out of 75 IgM-positive samples inoculated into C6/36 cells, 2 were positive by IFA while 17 were positive by RT-PCR. The 2 IFA-positive samples were collected during the acute phase of the illness; 17 positive samples were found by RT-PCR, including the 2 detected by IFA. For both methods, we also investigated the time necessary for viral detection using a fixed dose of 1 x 104 viruses/ml. RT-PCR and IFA detected the dengue virus 1 and 4 days after virus inoculation, respectively. The results obtained here indicate that RT-PCR is the most sensitive method in the detection of dengue viruses using C6/36 cells for viral isolation. Copyright (C) 2003 S. Karger AG, Basel.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab,Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med,Program Grad Studies Appl Microbiol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab,Sch Med Ribeirao Preto, Avenida Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Lima, Danielle/A-6108-2013; da Justa Pires Neto, Roberto/AAB-3425-2020;
   De Paula, Sergio/N-2609-2018; Fonseca, Benedito/F-3252-2012
OI Lima, Danielle/0000-0003-2734-6768; da Justa Pires Neto,
   Roberto/0000-0003-0291-9523; De Paula, Sergio/0000-0002-2275-5768;
   Fonseca, Benedito/0000-0003-3159-5687
CR CHAN YC, 1985, B WORLD HEALTH ORGAN, V63, P1043
   De Paula SO, 2002, J MED VIROL, V66, P529, DOI 10.1002/jmv.2177
   De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5
   De Paula SO, 2001, J VIROL METHODS, V98, P119, DOI 10.1016/S0166-0934(01)00371-8
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   GUBLER DJ, 1988, P INT S YELL FEV DEN, P291
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HEINZ FX, 2000, VIRUS TAXONOMY CLASS, P1167
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KUNO G, 1985, B WORLD HEALTH ORGAN, V63, P279
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Suk-Yin Chan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P258
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
NR 20
TC 12
Z9 14
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PD JUL-AUG
PY 2003
VL 46
IS 4
BP 227
EP 231
DI 10.1159/000072432
PG 5
WC Virology
SC Virology
GA 720WV
UT WOS:000185283600005
PM 12931031
DA 2020-12-08
ER

PT J
AU De Paula, SO
   Lima, DM
   da Fonseca, BAL
AF De Paula, SO
   Lima, DM
   da Fonseca, BAL
TI Detection and identification of dengue-1 virus in clinical samples by a
   nested-PCR followed by restriction enzyme digestion of amplicons
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE restriction enzyme digestion; dengue diagnosis; polymerase chain
   reaction; nested-PCR
ID POLYMERASE CHAIN-REACTION; RAPID IDENTIFICATION; HEMORRHAGIC-FEVER;
   DIAGNOSIS; NUMBERS
AB Dengue viruses cause a disease with clinical findings ranging from asymptomatic infections to severe manifestations, characterised by haemorrhage and shock and known as dengue haemorrhagic fever/dengue shock syndrome. Since this fever and syndrome usually results from sequential infections by distinct dengue serotypes, rapid detection and identification of dengue viruses circulating in endemic areas are important to implement control measures, and ultimately to avoid secondary infections that could result in dengue haemorrhagic fever/ dengue shock syndrome. A nested-PCR was developed followed by restriction enzyme (Kpn I) digestion of the amplicons to differentiate dengue-1 from dengue-2. Seventy-five IgM-containing samples collected from 2 to 17 days after the beginning of the symptoms were examined. These samples were submitted to nested-PCR amplification, the amplicons were digested with Kpn 1, and the results compared to virus isolation in C6/36 cells and to results obtained by the standard PCR. Out of 75 tested samples, virus was isolated from 2 (2.6%), 17 (22.7%) were positive by the regular PCR protocol, and 58 (77.3%) were positive by nested-PCR. All of the amplicons digested by Kpn I identified dengue-1 virus as the infecting strain. These results indicate that the nested-PCR provided a high yield of dengue genome amplification even in the presence of IgM antibodies, and restriction enzyme digestion defined rapidly the circulating serotype. Therefore, the combination of these techniques may be useful to rapidly identify dengue viruses in countries where dengue-1 and dengue-2 circulates, and this approach can also be applied to the other two serotypes. (C) 2002 Wiley-Liss, Inc.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl Microbiol & Immunol, Ribeirao Preto, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Lab Virol Mol, Dept Clin Med, Fac Med Ribeirao Preto, Ave dos Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; Lima, Danielle/A-6108-2013; Fonseca,
   Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Lima,
   Danielle/0000-0003-2734-6768; Fonseca, Benedito/0000-0003-3159-5687
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3
   CHAN SY, 1994, J VIROL METHODS, V49, P315, DOI 10.1016/0166-0934(94)90146-5
   CHAN YC, 1985, B WORLD HEALTH ORGAN, V63, P1043
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   GIBBS RA, 1990, ANAL CHEM, V62, P1202, DOI 10.1021/ac00212a004
   Gubler D J, 1987, P R Health Sci J, V6, P107
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   GUBLER DJ, 1994, INFECT AGENT DIS, V2, P283
   GUBLER DJ, 1988, P INT S YELL FEV DEN, P291
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Harris E, 1999, VIROLOGY, V253, P86, DOI 10.1006/viro.1998.9481
   HENCHAL EA, 1983, AM J TROP MED HYG, V32, P164, DOI 10.4269/ajtmh.1983.32.164
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Mullis K B, 1991, PCR Methods Appl, V1, P1
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Suk-Yin Chan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P258
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   VORNDAM V, 1994, ARCH VIROL, V136, P191, DOI 10.1007/BF01538828
   VORNDAM V, 1994, J VIROL METHODS, V48, P237, DOI 10.1016/0166-0934(94)90122-8
   ZHANG XY, 1994, BIOTECHNIQUES, V16, P502
   ZIMMERMANN K, 1994, BIOTECHNIQUES, V17, P18
   1998, DENGUE HEMORRAGIC FE
   1994, SCI PUBLICATION PAN, V548
NR 31
TC 9
Z9 10
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2002
VL 66
IS 4
BP 529
EP 534
DI 10.1002/jmv.2177
PG 6
WC Virology
SC Virology
GA 525BP
UT WOS:000174047600014
PM 11857533
DA 2020-12-08
ER

PT J
AU De Paula, SO
   da Fonseca, BAL
AF De Paula, SO
   da Fonseca, BAL
TI Optimizing dengue diagnosis by RT-PCR in IgM-positive samples:
   comparison of whole blood, buffy-coat and serum as clinical samples
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE dengue diagnosis; clinical sample; polymerase chain reaction
ID POLYMERASE CHAIN-REACTION; HEPATITIS-C VIRUS; RAPID IDENTIFICATION; RNA;
   INFECTIONS; STORAGE; ASSAY
AB Dengue, a major public health problem in tropical and sub-tropical regions, is the most important arboviral disease of humans. Early diagnosis is very important on follow-up of infected patients, especially those at risk of the severe manifestations of this disease. Aiming at the improvement of the molecular diagnosis of these infections and due to the lack of studies that indicated the best sample for dengue virus detection by RT-PCR, viral detection by RT-PCR in blood, serum and buffy-coat of 75 IgM-positive serum samples for dengue was evaluated. Out of the 75 samples, 17 were positive for dengue using RT-PCR and from these samples, three were positive in the blood, 14 positive in the serum and eight positive in the buffy-coat. These results indicate that serum is the best clinical sample for RT-PCR amplification of dengue genomes. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl Microbiol & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, Avenida dos Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RI De Paula, Sergio/N-2609-2018; Fonseca, Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Fonseca,
   Benedito/0000-0003-3159-5687
CR BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487
   BUSCH MP, 1992, TRANSFUSION, V32, P420, DOI 10.1046/j.1537-2995.1992.32592327714.x
   CHAN SY, 1994, J VIROL METHODS, V49, P315, DOI 10.1016/0166-0934(94)90146-5
   DITTMAR D, 1979, J CLIN MICROBIOL, V9, P498
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HENCHAL EA, 1983, AM J TROP MED HYG, V32, P164, DOI 10.4269/ajtmh.1983.32.164
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418
   Higuchi R., 1989, PCR TECHNOLOGY PRINC, P31
   IZRAELI S, 1991, NUCLEIC ACIDS RES, V19, P6051
   LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   MORITA K, 1991, J CLIN MICROBIOL, V29, P2107, DOI 10.1128/JCM.29.10.2107-2110.1991
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Wang HL, 2000, INTERVIROLOGY, V43, P107, DOI 10.1159/000025032
   WANG JT, 1992, J CLIN MICROBIOL, V30, P750, DOI 10.1128/JCM.30.3.750-753.1992
   1994, SCI PUBLICATION PAN, V548
NR 19
TC 14
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
J9 J VIROL METHODS
JI J. Virol. Methods
PD APR
PY 2002
VL 102
IS 1-2
BP 113
EP 117
AR PII S0166-0934(02)00005-8
DI 10.1016/S0166-0934(02)00005-8
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 536DY
UT WOS:000174686500013
PM 11879699
DA 2020-12-08
ER

PT J
AU Rodrigues, EMS
   Dal-Fabbro, AL
   Salomao, R
   Ferreira, IB
   Rocco, IM
   da Fonseca, BAL
AF Rodrigues, EMS
   Dal-Fabbro, AL
   Salomao, R
   Ferreira, IB
   Rocco, IM
   da Fonseca, BAL
TI Epidemiology of dengue infection in Ribeirao Preto, SP, Brazil
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE dengue, transmission; disease outbreaks; seroepidemiologic studies;
   Aedes; insect vectors; dengue, epidemiology; Aedes aegypti
ID VIRUS
AB Objective To assess dengue transmission in a correctional facility juvenile delinquents in Ribeirao Preto, state of Sao Paulo, Brazil.
   Methods A serological and virology investigation vas carried out among inmates and employees of a correctional facility for juvenile delinquents in Ribeirao Preto, Brazil. The study population consisted of 105 inmates and 91 employees representing 89% of the exposed. The collected blood was stored and processed using MAC-ELISA and virus isolation. A questionnaire was applied to each subject at the time of blood collection.
   Results Of the total of blood samples collected (n = 196), 42 (21.4%) were positive for IgM antibodies and 43 (21.9%)for IgG antibodies; of which, 15 were both IgM and IgG positive and 28 (14.3%) were IgG positive only. Serotype I dengue virus was isolated in 5 samples. Out of 42 IgM positive samples, 14 (33.0%) subjects did not have any physical complaints. The incidence rate was 23.8% and 18.6% among inmates and employees, respectively. The first cases in the facility were reported in 1997 and the last ones in March 1997 though results are suggestive of an earlier onset of transmission.
   Conclusions The high incidence rate of dengue infection can be explained by the high population density of the facility, high Aedes aegypti infestation, high numbers of asymptomatic subjects, and a higher transmission of disease in a closed setting.
C1 Municipal Saude Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, BR-14100 Ribeirao Preto, SP, Brazil.
   Inst Adolpho Lutz, Secao Virus Transmitidos Artropodes, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14100 Ribeirao Preto, SP, Brazil.
RP Rodrigues, EMS (corresponding author), Projeto Promocao Saude, Ave W3 Norte,SEPN 511,Block C,Edif Bittar 4,4 And, BR-70750543 Brasilia, DF, Brazil.
RI Dal-Fabbro, Amaury/H-7307-2012; Fonseca, Benedito/F-3252-2012
OI Dal-Fabbro, Amaury/0000-0002-0824-4603; Fonseca,
   Benedito/0000-0003-3159-5687
CR Chen WJ, 1996, AM J TROP MED HYG, V55, P12, DOI 10.4269/ajtmh.1996.55.12
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   COBRA C, 1995, AM J EPIDEMIOL, V142, P1204, DOI 10.1093/oxfordjournals.aje.a117579
   DIETZ VJ, 1990, AM J EPIDEMIOL, V131, P696
   FERREIRA JBB, 1998, THESIS USP
   Figueiredo L T, 1995, Bull Pan Am Health Organ, V29, P59
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   Lima V L, 1999, Rev Saude Publica, V33, P566
   Passos A D, 1998, Cad Saude Publica, V14 Suppl 2, P123, DOI 10.1590/S0102-311X1998000600011
   PONTES RSJ, 1992, THESIS USP
NR 10
TC 12
Z9 12
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 2002
VL 36
IS 2
BP 160
EP 165
DI 10.1590/S0034-89102002000200007
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 557BL
UT WOS:000175887400007
PM 12045796
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU da Fonseca, BAL
   Nunes, S
   Fonseca, S
AF da Fonseca, BAL
   Nunes, S
   Fonseca, S
TI Dengue virus infections
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
ID MONOCLONAL-ANTIBODIES; CELL; IMMUNOGENICITY; GLYCOPROTEIN; PATTERN;
   BINDING
AB Dengue is the most important arthropod-borne viral disease of public health significance. Its geographic distribution includes more than 100 countries worldwide, where more than 2.5 billion people are at risk for dengue infections. Most people will have asymptomatic infections, but the disease manifestations range from an influenza-like disease known as dengue fever to a severe, sometimes fatal disease characterized by hemorrhage and shock, known as dengue hemorrhagic fever/dengue shock syndrome. Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are caused by the dengue viruses (dengue-1, dengue-2, dengue-3, and dengue-4) transmitted from viremic to susceptible humans mainly by the bites of Aedes aegypti. There is no specific management of dengue infections, no vaccine is commercially available, and vector control is the only alternative for stopping the spread of the disease. Knowledge of several aspects of dengue infections, especially of diagnosis and vaccine development, is continuously evolving, but several issues are still unresolved. (C) 2002 Lippincott Williams Wilkins, Inc.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Ribeirao Preto, Brazil.
   Hosp Sao Franciscico, Serv Controle Infeccao Hosp, Maternidade Sinha Junqueira, Fdn Waldemar B, Ribeirao Preto, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, Brazil.
EM baldfons@fmrp.usp.br
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
CR [Anonymous], 2000, Wkly Epidemiol Rec, V75, P193
   Barrett ADT, 1997, BIOLOGICALS, V25, P27, DOI 10.1006/biol.1997.0057
   Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   Bhamarapravati Natth, 1997, P115
   Bielefeldt-Ohmann H, 2001, VIRUS RES, V73, P81, DOI 10.1016/S0168-1702(00)00233-1
   Chang G.-J, 1997, P175
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   Fung Chang-Phone, 2000, Journal of Microbiology Immunology and Infection, V33, P217
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350
   Heinz FX, 2001, CURR OPIN MICROBIOL, V4, P450, DOI 10.1016/S1369-5274(00)00234-4
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   Kanesa-thasan N, 2001, VACCINE, V19, P3179, DOI 10.1016/S0264-410X(01)00020-2
   Kelly EP, 2000, VACCINE, V18, P2549, DOI 10.1016/S0264-410X(00)00032-3
   MARKOFF LJ, 1991, J INFECT DIS, V164, P294, DOI 10.1093/infdis/164.2.294
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Monroy V, 2000, VIRUS GENES, V21, P197, DOI 10.1023/A:1008191530962
   NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398
   Nimmannitya Suchitra, 1997, P133
   OCAZIONEZ JR, 2000, VACCINE, V19, P648
   Reiter Paul, 1997, P425
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rodhain Francois, 1997, P45
   Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656
   SUMARMO, 1982, PEDIATRICS, V69, P45
   TASSNIYOM S, 1993, PEDIATRICS, V92, P111
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang HL, 2000, INTERVIROLOGY, V43, P107, DOI 10.1159/000025032
   Westaway E. G., 1997, P147
   2001, NUMBER REPORTED CASE
   1999, GUIDELINES TREATMENT
   1997, DENGUE HEMORRHAGIC F, P12
   1999, STRENGTHENING IMPLEM
   2001, 35 SESS SUBC EX COMM
   1997, DENGUE HEMORRHAGIC F, P1
NR 45
TC 40
Z9 42
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2002
VL 14
IS 1
BP 67
EP 71
PG 5
WC Pediatrics
SC Pediatrics
GA 525NZ
UT WOS:000174079000012
PM 11880737
DA 2020-12-08
ER

PT J
AU De Paula, SO
   Nunes, C
   Matos, R
   de Oliveira, ZM
   Lima, DM
   da Fonseca, BAL
AF De Paula, SO
   Nunes, C
   Matos, R
   de Oliveira, ZM
   Lima, DM
   da Fonseca, BAL
TI Comparison of techniques for extracting viral RNA from
   isolation-negative serum for dengue diagnosis by the polymerase chain
   reaction
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE RNA extraction; dengue diagnosis; polymerase chain reaction
ID PHENOL-CHLOROFORM; IDENTIFICATION; VIRUSES; PLASMA; KIT
AB Aiming at the improvement of the molecular diagnosis of dengue, three well-established methods of RNA extraction from serum of patients with clinical symptoms of dengue were compared. The methods were based on the QIAamp (R) Viral RNA kit, the Chomczynski-Sacchi technique and TRIzol (R). One hundred samples were examined using the same protocol for reverse transcription-polymerase chain reaction (RT-PCR). Out of the 100 samples tested, none was positive by either the Chomczynski-Sacchi technique or TRIzol (R), and six were positive using the QIAamp (R) viral RNA kit. Of the six positive samples, only one was collected before 5 days of the beginning of the disease, and it was also positive for viral isolation. These results were confirmed later by serology (MAC-ELISA) that showed that 19 samples were positive for IgM antibodies against dengue. These data indicate that PCR is a useful method for detection of dengue virus infections in IgM-positive samples, and the best method of RNA extraction from clinical samples, to be used for dengue diagnosis by PCR is the QIAamp (R) Viral RNA kit. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Program Grad Studies Appl Microbiol & Immunol, BR-14049 Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; Lima, Danielle/A-6108-2013; Fonseca,
   Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; Lima,
   Danielle/0000-0003-2734-6768; Fonseca, Benedito/0000-0003-3159-5687
CR [Anonymous], 1986, DENGUE HEMORRHAGIC F
   Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Fanson BG, 2000, J VIROL METHODS, V89, P23, DOI 10.1016/S0166-0934(00)00192-0
   Frank Richard G., 1998, J Ment Health Policy Econ, V1, P153
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HENCHAL EA, 1983, AM J TROP MED HYG, V32, P164, DOI 10.4269/ajtmh.1983.32.164
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418
   Konet DS, 2000, J VIROL METHODS, V84, P95, DOI 10.1016/S0166-0934(99)00131-7
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Shafer RW, 1997, J CLIN MICROBIOL, V35, P520, DOI 10.1128/JCM.35.2.520-522.1997
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Verhofstede C, 1996, J VIROL METHODS, V60, P155, DOI 10.1016/0166-0934(96)02062-9
   1994, SCI PUBLICATION, V548
NR 16
TC 14
Z9 15
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD NOV
PY 2001
VL 98
IS 2
BP 119
EP 125
DI 10.1016/S0166-0934(01)00371-8
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 482LB
UT WOS:000171576700003
PM 11576638
DA 2020-12-08
ER

PT J
AU Jimenez, RO
   da Fonseca, BAL
AF Jimenez, RO
   da Fonseca, BAL
TI Recombinant plasmid expressing a truncated dengue-2 virus E protein
   without co-expression of prM protein induces partial protection in mice
SO VACCINE
LA English
DT Article; Proceedings Paper
CT 2nd Annual Conference on Vaccine Research
CY MAR 27-30, 1999
CL BETHESDA, MARYLAND
DE dengue; DNA-vaccine; glycoprotein E
ID JAPANESE ENCEPHALITIS-VIRUS; INCREASED IMMUNOGENICITY; NEUTRALIZING
   ANTIBODIES; VACCINIA VIRUSES; BACTERIAL-DNA; CELL-SURFACE; INSECT CELLS;
   IMMUNIZATION; EFFICACY; IMMUNITY
AB A nucleic acid vaccine candidate against dengue-2 virus was constructed to express a truncated dengue-2 E glycoprotein without concomitant expression of prM. The truncated E protein was properly expressed even in the absence of prM. Mice inoculated intramuscularly with the recombinant plasmid containing 94% of the E gene did not respond with anti-dengue antibodies, cellular proliferation, or synthesis of cytokines by their lymphoid cells when stimulated with purified dengue-2 virus. However, protection was observed in 20% of the challenged mice immunized with this recombinant plasmid and the mice survived longer than the control group. The low percentage of protection might be explained by a weak activation of the immune system resulting from an imperfect secretion of E due to lack of the prM protein. This study corroborates with the hypothesis that prM is important for the processing of the E glycoprotein and should be incorporated on candidate vaccines engineered by recombinant DNA technology. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, BR-14049900 Ribeirao Preto, SP, Brazil.
   Ind Univ Santander, Sch Med, Dept Basic Sci, Bucaramanga, Colombia.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, Av Banderiantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
CR AESADI G, 1991, NATURE, V352, P815
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   ANZARI MZ, 1993, J CLIN LAB ANAL, V7, P230
   Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3
   CHENG L, 1993, P NATL ACAD SCI USA, V90, P4455, DOI 10.1073/pnas.90.10.4455
   COLE SR, 1987, MOL IMMUNOL, V24, P699, DOI 10.1016/0161-5890(87)90051-4
   DAVIS HL, 1993, FEBS LETT, V333, P146, DOI 10.1016/0014-5793(93)80393-9
   DELENDA C, 1994, ARCH VIROL, V139, P197, DOI 10.1007/BF01309465
   DEUBEL V, 1991, VIROLOGY, V180, P442, DOI 10.1016/0042-6822(91)90055-G
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   FRANCKI RIB, 1991, ARCH VIROL         S, V2, P223
   FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478
   GUBLER DJ, 1988, EPIDEMIOLOGY ARTHROP, P223
   GUIRAKHOO F, 1992, VIROLOGY, V191, P912
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1977, J EXP MED, V146, P210
   HAYES EB, 1992, PEDIATR INFECT DIS J, V11, P311, DOI 10.1097/00006454-199204000-00010
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   JAN LR, 1993, AM J TROP MED HYG, V48, P412, DOI 10.4269/ajtmh.1993.48.412
   Kochel T, 1997, VACCINE, V15, P547, DOI 10.1016/S0264-410X(97)00215-6
   KONISHI E, 1991, VIROLOGY, V185, P401, DOI 10.1016/0042-6822(91)90788-D
   Konishi E, 1998, J VIROL, V72, P4925, DOI 10.1128/JVI.72.6.4925-4930.1998
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998
   MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419
   MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991
   MESSINA JP, 1991, J IMMUNOL, V147, P1759
   MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P778
   PEDROZAMARTINS L, 1995, J VIROL, V69, P2574
   Phillpotts RJ, 1996, ARCH VIROL, V141, P743, DOI 10.1007/BF01718332
   Porter KR, 1998, ARCH VIROL, V143, P997, DOI 10.1007/s007050050348
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   XIANG ZQ, 1995, VIROLOGY, V209, P569, DOI 10.1006/viro.1995.1289
NR 34
TC 24
Z9 24
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2000
VL 19
IS 6
BP 648
EP 654
DI 10.1016/S0264-410X(00)00247-4
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 375LL
UT WOS:000165400800009
PM 11090717
DA 2020-12-08
ER

EF